Our Projects Portfolio
Discover our extensive range of quality approved pharmaceutical formulations.
Tablets Index
- Analgesic (Pain Relief)
- Anti-allergic
- Anti-asthmatic / Cough & Cold
- Anti-diabetic
- Anti-fungal
- Anti-parasitic
- Anti-viral
- Antibiotic
- Cardiovascular
- CNS & Neuropathic
- Corticosteroid
- Erectile Dysfunction
- Gastrointestinal & Antacid
- General / Unclassified
- Neuroprotective
- Nutritional Supplement
- Opioid Analgesic
- Thyroid Hormone
- Urological
| Formulation | Therapeutic Usage | Composition |
|---|---|---|
| Aceclofenac & Paracetamol Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Aceclofenac & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Approved Color to be use in Tablet |
| Aceclofenac & Serratiopeptidase Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Serratiopeptidase IP 10 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Aceclofenac & Thiocochicoside Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Thiocochicoside IP 4 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yelley or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron oxide Yellow |
| Aceclofenac & Thiocochicoside Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Thiocochicoside IP 8 mg Colour: Brilliant Blue / Crythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Aceclofenac & Tizanidine Tablets | Analgesic (Pain Relief) | Each sustain release tablet contains Aceclofenac IP 100 mg Tizanidine Hydrochloride 2 mg Colour: Brilliant Blue / Erythrosine /Tartrazine or Titanium Dioxide IP / Sunset Yellow |
| Aceclofenac & Trypsin Chymotrypsin Tablets | Analgesic (Pain Relief) | Each enteric coated tablet contains : Aceclofenac IP 100 mg 5000 Armour units of enzymatic activity (Supplied by a purified concentrate which specific Trypsin & Chymotrypsin IP activity in a ratio of approximate six to one) Approved colour to be used |
| Aceclofenac (SR) &, Pregabalin (SR) Tablets | Analgesic (Pain Relief) | Each uncoated biylayered tablet contains : Aceclofenac (As sustained release) IP 200 mg Pregabalin (As sustained release) IP 75 mg Excipients q.s. Approved colour to be used |
| Aceclofenac , Paracetamol & Chlorzoxazone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Colour: Brilliant Blue / Erythrosine/Tartrazine I Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Aceclofenac , Paracetamol & Serratiopeptidas Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase (An enteric coated) IP 10 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Aceclofenac , Paracetamol & Serratiopeptidas Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase (An enteric coated) IP 15 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Aceclofenac Sustained Release Tablets | Analgesic (Pain Relief) | Each sustained release tablet contains : Aceclofenac IP 200 mg Permitted Color Used |
| Aceclofenac Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red Iron oxide Yellow |
| Aceclofenac Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Aceclofenac IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Aceclofenac and Paraceamol Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 50 mg Paracetamol IP 250 mg Approved colour to used |
| Aceclofenac and Tizanidine Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Tizanidine Hydrochloride IP Equivalent to Tizanidine 2 mg Excipients q.s. Approved color to be use |
| Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Analgesic (Pain Relief) | Each film coated tablet contains Aceclofenac IP 100 mg Paracetamol IP 325 mg Thiocolchicoside 4 mg Colour:Sunset yellow or Apple Green / Titanium Dioxide IP |
| Aceclofenac, Paracetamol & Tramadol Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Tramadol Hydrochloride IP 37.5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets | Analgesic (Pain Relief) | Each enteric coated tablet contains : Aceclofenac IP 100 mg Paracetmol IP 325 mg 5000 Armour units of enzymatic activity (Supplied by a purified concentrate which specific Trypsin & Chymotrypsin IP activity in a ratio of approximate six to one) Approved colour to be used |
| Aceclofenac, Paracetamol, Cetirizine HCI,Phenylephrine HCL | Analgesic (Pain Relief) | Each flim coated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Cetirizine HCI IP 10 mg Phenylephrine Hydrochloride IP 5 mg Approved colour to be used |
| Aceclofenac, Paracetamol, Cetirizine HCI,Phenylephrine HCL and Caffeine | Analgesic (Pain Relief) | Each flim coated tablet contains : Aceclofenac IP 100 mg Paracetamol IP 325 mg Cetirizine HCI IP 10 mg Phenylephrine Hydrochloride IP 5 mg Caffeine (Anhydrous) IP 25 mg Approved colour to be used |
| Aceclofenac, Paracetamol, Tolperisone Hydrochloride | Analgesic (Pain Relief) | Each film coated tablet contains Aceclofenac IP 100 mg Paracetamol IP 325 mg Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Camylofen Dihydrochloride and Paracetamol Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Camylofen Dihydrochloride 50 mg Paracetamol IP 325 mg Approved colour to used |
| Camylofin Dihydrchloride and Paracetamol Tablets | Analgesic (Pain Relief) | Each film coated tablet contains: Camylofin Dihydrchloride IP 50 mg Paracetamol IP 325 mg Excipients q.s. Approved colour to be use |
| Cetirizine HCI, Paracetamol With Nimesulide Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains: Cetirizine Hydrochloride IP 5 mg Paracetamol IP 325 mg Nimesulide IP 100 mg Excipients q.s. Approved colour to be use |
| Cetirizine Hydrochloride, Phenylephrine Hydrochloride AND PARACETAMOL | Analgesic (Pain Relief) | Each uncoated tablet contains : Cetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Paracetmol IP 325 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Cetirizine Hydrochloride, Phenylephrine Hydrochloride AND PARACETAMOL | Analgesic (Pain Relief) | Each uncoated tablet contains : Cetirizine Hydrochloride IP 10 mg Phenylephrine Hydrochloride IP 5 mg Paracetmol IP 325 mg Caffeine (Anhydrous) IP 20 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Cyclobenzaprine Hydrochloride & Aceclofenac Tablets | Analgesic (Pain Relief) | Each film coated sustained release bilayered tablet contains Cyclobenzaprine Hydrochloride IP 15 mg Aceclofenac IP 200 mg Excipients q.s. |
| Dexchlorpheniramine Maleate, Paracetamol, Caffeine & | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Dexchlorpheniramine Maleate IP 2 mg Caffeine (Anhydrous) IP 25 mg Phenylephrine Hydrochloride IP 5 mg Excipients q.s. Approved colour to be used |
| Diclofenac Potasium , Paracetamol & Serratiopeptidase Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Potasium IP 50 mg Paracetamol IP 325 mg Serratiopeptidase ( An enteric coated) IP 10 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Diclofenac Potasium, Paracetamol & | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Potasium IP 50 mg Paracetamol IP 250 mg Serratiopeptidase ( An enteric coated) IP 10 mg Excipients q.s. Approved Color to be use in Tablet |
| Diclofenac Potassium & Serratiopeptidase Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Potassium IP 50 mg Serratiopeptidase (As Enteric Coated) IP 10 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxid IP |
| Diclofenac Potassium & Thiocolchicoside Tablets | Analgesic (Pain Relief) | Each film coated tablet contains Diclofenac Potassium IP 50 mg Thiocolchicoside 4 mg Colour: Brilliant Blue / Erythrosine (Tartrazine/ Sunset yellow or Apple Green / Titanium Dioxide IP |
| Diclofenac Potassium & Thiocolchicoside Tablets | Analgesic (Pain Relief) | Each film coated tablet contains Diclofenac Potassium IP 50 mg Thiocolchicoside 8 mg Colour: Erythrosine (Tartrazine/ Sunset yellow / Titanium Dioxide IP |
| Diclofenac Potassium & Tolperisone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Potassium IP 50 mg Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Diclofenac Potassium & Trypsin Chymotrypsin Tablets | Analgesic (Pain Relief) | Each enteric coated tablet contains : Diclofenac Potassium BP 50 mg 5000 Armour units of enzymatic activity (Supplied by a purified concentrate which specific Trypsin & Chymotrypsin IP activity in a ratio of approximate 6:1 ) Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Diclofenac Potassium , Paracetamol With Chlorzoxazone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Potassium IP 50 Mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron oxide Yellow |
| Diclofenac Potassium Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Potassium BP 50 mg Permitted Color Used |
| Diclofenac Potassium Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Potassium BP 50 mg Permitted Color Used |
| Diclofenac Potassium Tablets Sustained Release Tablets | Analgesic (Pain Relief) | Each sustained release tablet contains : Diclofenac Potassium IP 100 mg Permitted Color Used |
| Diclofenac Potassium, Paracetamol and Magnesium Trisilicate | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Potassium IP 50 mg Paracetarmol IP 325 mg Magnesium Trisilicate IP 100 mg Approved colour to be used |
| Diclofenac Potassium, Paracetamol, Cetirizine Hydrochloride and Magnesium Trisilicate | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Potassium IP 50 mg Paracetamol IP 325 mg Cetirizine Hydrochloride IP 5 mg Magnesium Trisilicate IP 100 mg Excipients q.s. Approved colour to be used |
| Diclofenac Potassium, Trypsin & Bromelain | Analgesic (Pain Relief) | Each film coated tablet contains Diclofenac Potassium IP 50 mg Trypsin IP 48 mg Bromelain 90 mg Rutoside Trihydrate USP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Diclofenac Sodium & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 25 mg Paracetamol IP 250 mg |
| Diclofenac Sodium & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 25 mg Paracetamol IP 325 mg |
| Diclofenac Sodium & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Diclofenac Sodium & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Diclofenac Sodium & Paracetamol Tablets | Analgesic (Pain Relief) | Each sugar coated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Diclofenac Sodium & Tolperisone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Sodium IP 50 mg Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Diclofenac Sodium (SR) & Tolperisone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Sodium IP 100 mg Tolperisone Hydrochloride JP 450 mg Excipients q.s. Approved colour to be used |
| Diclofenac Sodium (SR) and With Tramadol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains Diclofenac Sodium IP 75 mg (As Sustained release) Tramadol Hydrochloride IP 50 mg Approved color to be use |
| Diclofenac Sodium Gastro-Resistant Tablets IP | Analgesic (Pain Relief) | Each gastro-resistant tablet contains : Diclofenac Sodium IP 25 mg Permitted Color Used |
| Diclofenac Sodium Gastro-Resistant Tablets IP | Analgesic (Pain Relief) | Each gastro-resistant tablet contains : Diclofenac Sodium IP 100 mg Permitted Color Used |
| Diclofenac Sodium Prolonged Release Tablets IP 100 mg | Analgesic (Pain Relief) | Each film coated prolonged release tablets contains : Diclofenac Sodium IP 100 mg Excipients q.s. Approved colour to be used |
| Diclofenac Sodium Prolonged release Tablets IP 75 mg | Analgesic (Pain Relief) | Each sustained release film coated tablets contains : Diclofenac Sodium IP 75 mg Excipients q.s. Approved colour to be used |
| Diclofenac Sodium Tablets IP | Analgesic (Pain Relief) | Each enteric coated tablet contains : Diclofenac Sodium IP 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Diclofenac Sodium Tablets IP | Analgesic (Pain Relief) | Each film coated tablet contains : Diclofenac Sodium IP 50 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Diclofenac Sodium Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg |
| Diclofenac Sodium Tablets IP 75 mg | Analgesic (Pain Relief) | Each film coated tablets contains : Diclofenac Sodium IP 75 mg Excipients q.s. Approved colour to be used |
| Diclofenac Sodium, Magnesium Trisilicate ,Paracetamol and Chlorpheniramine Maleate | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Magnesium Trisilicate IP 100 mg Paracetamol IP 325 mg Chlorpheniramine Maleate IP 4 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Diclofenac Sodium, Paracetamol & Magnesium Trisilicate Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 250 mg Magnesium Trisilicate IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / iron oxide red, iron oxide Yellow |
| Diclofenac Sodium, Paracetamol With Magnesium Trisilicate Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Magnesium Trisilicate IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Diclofenac Sodium, Paracetamol, Chlorphenramine Maleate | Analgesic (Pain Relief) | Each uncoated tablet contains : Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Chlorphenramine Maleate IP 4 mg Excipients q.s. Approved colour to be used |
| Dicyclomine Hydrochloride & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Dicyclomine Hydrochloride IP 10 mg Paracetamol IP 325 mg |
| Dicyclomine Hydrochloride & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Dicyclomine Hydrochloride IP 20 mg Paracetamol IP 325 mg |
| Dicyclomine Hydrochloride & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Dicyclomine Hydrochloride IP 10 mg Paracetamol IP 250 mg |
| Drotaverine and Aceclofenac Tablets | Analgesic (Pain Relief) | Each film coated tablet contains: Drotaverine Hydrochloride IP 80 mg Aceclofenac IP 100 mg Approved coloured used |
| Etodolac & Paracetamol Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Etodolac IP 400 mg Paracetamol IP 325 mg Approved coloured used |
| Etoricoxib & THIOCOLCHICOSIDE Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Etoricoxib IP 60 mg Thiocochicoside IP 4 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, iron oxide Yellow |
| Etoricoxib & Thiocolchicoside Tablets IP | Analgesic (Pain Relief) | Each film coated tablet contains Etoricoxib IP 60 mg Thiocolchicoside 4 mg Colour: Brilliant Blue / Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| Etoricoxib & Thiocolchicoside Tablets IP | Analgesic (Pain Relief) | Each film coated tablet contains Etoricoxib IP 90 mg Thiocolchicoside 4 mg Colour: Brilliant Blue / Erythrosine Tartrazine/ Sunset yellow or Apple Green / Titanium Dioxide IP |
| Etoricoxib Tablets IP 120 mg | Analgesic (Pain Relief) | Each film coated tablet contains : Etoricoxib IP 120 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red dron oxide Yellow |
| Etoricoxib Tablets IP 90 mg | Analgesic (Pain Relief) | Each film coated tablet contains Etoricoxib IP 90 mg Colour: Brilliant Blue / Erythrosine/ Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP Apple Green / Iron oxide red,Iron oxide Yellow |
| Flunarizine Dihydrochloride, Domperidone Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains Flunarizine Dihydrochloride IP 5 mg Domperidone IP 10 mg Paracetamol IP 325 mg Colour: Brilliant Blue / Erythrosine /Tartrazine or Titanium Dioxide IP / Ferric Oxide Yellow |
| Flupirtine Maleate & Paracetamol Tablets | Analgesic (Pain Relief) | Each Uncoated bilayered coated tablets contains: Flupirtine Maleate 100 mg Paracetamol IP 325 mg Excipients q.s. |
| Ibuprofen & Paracetamol Dispersible Tablets | Analgesic (Pain Relief) | Each uncoated dispersible tablet contains Ibuprofen IP 100 mg Paracetamol IP 125 mg Colour: Brilliant Blue / Erythrosine/ Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP IApple Green / Iran oxide red,Iron oxide Yellow |
| Ibuprofen & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Ibuprofen IP 200 mg Paracetamol IP 325 mg |
| Ibuprofen & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Ibuprofen IP 400 mg Paracetamol IP 325 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ibuprofen Tablets IP 200 mg | Analgesic (Pain Relief) | Each film coated tablet contains : Ibuprofen IP 200 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ibuprofen Tablets IP 400 mg | Analgesic (Pain Relief) | Each film coated tablet contains : Ibuprofen IP 400 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ibuprofen Tablets IP 600 mg | Analgesic (Pain Relief) | Each film coated tablet contains : Ibuprofen IP 600 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ketorolac Tromethamine Tablets IP 10 mg | Analgesic (Pain Relief) | Each Uncoated tablet contains: Ketorolac Tromethamine IP 10 mg Excipients q.s. |
| Mefenamic Acid & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Mefenamic Acid IP 250 mg Paracetamol IP 325 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron Oxide Yellow |
| Mefenamic Acid, Paracetamol and Dicyclomine Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains: Mefenamic Acid IP 250 mg Paracetamol IP 325 mg Dicyclomine Hydrochloride IP 10 mg Approved colour to be used |
| Naproxen Sodium & Domperidone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains: Naproxen Sodium IP 500 mg Domperidone Maleate IP Eq. to Domperidone 10 mg Approved colour to be used |
| Naproxen Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Naproxen IP 250 mg Excipients q.s. Approved coloured to be used |
| Naproxen Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Naproxen IP 500 mg Excipients q.s. Approved coloured to be used |
| Naproxen and Domperidone Tablet | Analgesic (Pain Relief) | Each uncoated tablet contains : Naproxen IP 250 mg Domperidone IP 10 mg Excipients q.s. |
| Nimesulide & Dicyclomine Hydrochloride Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Nimesulide IP 100 mg Dicyclomine Hydrochloride IP 10 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Nimesulide & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Nimesulide BP 100 mg Paracetamol IP 325 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow/Sunset yellow for Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Nimesulide & Serratiopeptidase Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Nimesulide BP 100 mg Serratiopeptidase IP 10 mg (20,000 Uints of Serratiopeptidase As Enteric Coated) Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Nimesulide & Tizanidine Hydrochloride Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Nimesulide BP 100 mg Tizanidine Hydrochloride IP Eq. to Tizanidine 2 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Nimesulide Dispersible Tablets | Analgesic (Pain Relief) | Each uncoated dispersible tablet contains : Nimesulide BP 100 mg |
| Nimesulide Orally Disintegrating Tablets | Analgesic (Pain Relief) | Each orally disintegrating tablet contains : Nimesulide BP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Nimesulide Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains Nimesulide BP 200 mg |
| Nimesulide Tablets BP | Analgesic (Pain Relief) | Each uncoated tablet contains : Nimesulide BP 100 mg |
| Nimesulide, Cetirizine Hydrochloride With Phenylephrine Hydrochloride | Analgesic (Pain Relief) | Each uncoated tablet contains : Nimesulide IP 100 mg Cetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide ip /Apple Green / Iron oxide red,Iron oxide Yellow |
| Nimesulide, Paracetamol & Tizanidine Hydrochloride Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Nimesulide BP 100 mg Paracetamol IP 325 mg Tizanidine Hydrochloride IP Eq. to Tizanidine 2 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide iP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Nimesulide, Paracetamol and Serratiopeptidase Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Nimesulide BP 100 mg Paracetamol IP 325 mg Serratiopeptidase(As enteric coat IP 15 mg Excipients q.s. Approved colour to be used |
| Paracetamol & Caffeine Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Caffeine (Anhydrous) IP 30 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow Jor Titanium Dioxide IP /Apple Green/Iron oxide red iron oxide Yellow |
| Paracetamol & Caffeine Tablets | Analgesic (Pain Relief) | Each Uncoated tablet contains: Paracetamol IP 325 mg Caffeine (Anhydros) IP 10 mg Excipients q.s. Approved colour to be used |
| Paracetamol & Chlorpheniramine Maleate Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Chlorpheniramine Maleate IP 2 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Paracetamol & Chlorzoxazone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Chlorzoxazone USP 250 mg |
| Paracetamol & Diclofenac Potassium Tablets | Analgesic (Pain Relief) | Each sugar-coated tablet contains : Paracetamol IP 250 mg Diclofenac Potassium IP 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Paracetamol & Diclofenac Potassium Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Diclofenac Potassium IP 50 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Paracetamol & Domperidone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Paracetamol IP 325 mg Domperidone IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline ellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron Oxide Yellow |
| Paracetamol & Metoclopramide Hydrochloride Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol 325mg Metoclopramide Hydrochloride IP 10 mg Eq. to Anhydrous Metoclopramide Hydrochloride Excipients qs |
| Paracetamol & Phenylephrine Hydrochloride Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green /tron oxide red,Iron oxide Yellow |
| Paracetamol & Tolperisone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Paracetamol IP 500 mg Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Paracetamol & Tolperisone Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Paracetamol IP 325 mg Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Paracetamol , Caffeine & Chlorpheniramine Maleate Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 300 mg Caffeine (Anhydrous) IP 20 mg Chlorpheniramine Maleate IP 4 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron Oxide Yelloy |
| Paracetamol , Phenylephrine Hcl & Chlorpheniramine Maleate and Caffeine | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 4 mg Caffeine (Anhydrous) IP 20 mg Approved colour to be used |
| Paracetamol , Phenylephrine Hydrochloride & Chlorpheniramine Maleate | Analgesic (Pain Relief) | Each Uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 4 mg Excipients q.s. Approved colour to be used |
| Paracetamol Dispersible Tablets | Analgesic (Pain Relief) | Each uncoated dispersible tablet contains : Paracetamol BP 125 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Paracetamol Effervescent Tablets | Analgesic (Pain Relief) | Each uncoated Effervescent tablet contains : Paracetamol IP 500 mg Approved coloured used |
| Paracetamol Effervescent Tablets | Analgesic (Pain Relief) | Each uncoated Effervescent tablet contains : Paracetamol IP 1000 mg Approved coloured used |
| Paracetamol Phenylephrine Hydrochloride & | Analgesic (Pain Relief) | Each uncoated tablet contains Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Colour : Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| Paracetamol Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 500 mg |
| Paracetamol Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 650 mg |
| Paracetamol Tablets IP 300 mg | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 300 mg |
| Paracetamol and Caffeine Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 500 mg Caffeine (Anhydrosu) IP 25 mg Excipients q.s. Approved coloured used |
| Paracetamol and Caffeine Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 650 mg Caffeine (Anhydrosu) IP 50 mg Excipients q.s. Approved coloured used |
| Paracetamol and Domperidone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains Paracetamol IP 325 mg Domperidone IP 10 mg Excipients q.s. Approved coloured used |
| Paracetamol and Domperidone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains Paracetamol IP 500 mg Domperidone IP 20 mg Excipients q.s. Approved coloured used |
| Paracetamol and Zaltoprofen Tablets | Analgesic (Pain Relief) | Each film coated tablet contains: Paracetamol IP 325 mg Zaltoprofen JP 80 mg Excipients q.s. Approved colour to be used |
| Paracetamol, Caffeine & Chlorpheniramine Maleate Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Caffeine (Anhydrous) IP 10 mg Chlorpheniramine Maleate IP 2 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Paracetamol, Caffeine, Phenylephrine HCL, and Chlorpheniramine maleate | Analgesic (Pain Relief) | Each uncoated tablet contains Paracetamol IP 500 mg Caffeine (Anhydrous) IP 30 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine maleate IP 4 mg Excipients q.s. |
| Paracetamol, Nimesulide & Chlorzoxazone Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Nimesulide BP 100 mg Chlorzoxazone USP 375 mg Colour: Brilliant Blue / Crythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron oxide Yellow |
| Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets | Analgesic (Pain Relief) | Each Uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 2 mg Excipients q.s. Approved colour to be used |
| Paracetamol, Phenylephrine HCl and Chlorpheniramine Maleate Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Approved colour to used |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate | Analgesic (Pain Relief) | Each Uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Excipients q.s. Approved colour to be used |
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate Tablets | Analgesic (Pain Relief) | Each uncoated tablets contains Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 4 mg Approved colour to be used |
| Paracetamol, Phenylephrine, Bromhexine, Gualphenesin and Chlorpheniramine maleate | Analgesic (Pain Relief) | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine HCI IP 5 mg Bromhexine Hydrochloride IP 4 mg Gualphenesin IP 50 mg Chlorpheniramine maleate IP 4 mg Approved colour to used |
| Paracetamol, Phenylephrine, Caffeine & | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 500 mg Caffeine (Anhydrous) IP 30 mg Phenylephrine Hydrochloride IP 5 mg Diphenhydramine Hydrochloride IP 25 mg Approved colour to used |
| Paracetamol, Phenylephrine, Caffeine & Diphenhydramine Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Paracetamol IP 325 mg Caffeine (Anhydrous) IP 30 mg Phenylephrine Hydrochloride IP 5 mg Diphenhydramine Hydrochloride IP 25 mg Permitted Color Used |
| Paracetamol, Phenylephrine, Caffeine and Chlorpheniramine | Analgesic (Pain Relief) | Each uncoated tablet contains: Paracetamol IP 325 mg Phenylephrine HCI IP 10 mg Caffeine (Anhydrous) IP 30 mg Chlorpheniramine maleate IP 4 mg Approved colour to used |
| Paracetamol, Phenylephrine,Caffeine and Diphenhydramine Tablets | Analgesic (Pain Relief) | Each uncoated bilayered tablets contains Paracetamol IP 500 mg Caffeine (Anhydrous) IP 30 mg Phenylephrine Hydrochloride IP 5 mg Diphenhydramine Hydrochloride IP 25 mg Approved colour to be used |
| Piroxicam Dispersible Tablets | Analgesic (Pain Relief) | Each uncoated dispersible tablet contains: Piroxicam IP 20mg Approved colour to used |
| Piroxicam Dispersible Tablets | Analgesic (Pain Relief) | Each dispersible tablet contains : Piroxicam IP 20 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunsel yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Piroxicam Tablets IP | Analgesic (Pain Relief) | Each uncoated tablet contains : Piroxicam IP 20 mg Approved colour to used |
| Piroxicam and Betacyclodextrin Dispersible Tablets | Analgesic (Pain Relief) | Each uncoated dispersible tablet contains: Piroxicam IP 20mg Betacyclodextrin IP 50mg Approved colour to used |
| Piroxicam and Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Piroxicam IP 20 mg Paracetamol IP 500 mg Excipients q.s. |
| Piroxicam and Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Piroxicam IP 20 mg Paracetamol IP 325 mg Excipients q.s. |
| Propyphenazone, Paracetamol With Caffeine Tablets | Analgesic (Pain Relief) | Each uncoated tablet contains : Propyphenazone IP 150 mg Paracetamol IP 250 mg Caffeine (Anhydrous) IP 50 mg |
| Sumatriptan & Naproxen Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Sumatriptan IP 85 mg Naproxen IP 500 mg Approved colour to be used |
| Sumatriptan & Naproxen Tablets | Analgesic (Pain Relief) | Each film coated tablet contains : Sumatriptan IP 50 mg Naproxen IP 275 mg Approved colour to be used |
| Tolperisone Hydrochloride and Diclofenac sodium Tablets | Analgesic (Pain Relief) | Each film coated tablet contains: Tolperisone Hydrochloride JP 150 mg Diclofenac Sodium IP 50 mg Excipients q . s. Approved colour to used |
| Tolperisone Hydrochloride and Diclofenac sodium Tablets | Analgesic (Pain Relief) | Each sustained released tablet contains: Tolperisone Hydrochloride JP 450 mg Diclofenac Sodium IP 100 mg Excipients q . s. Approved colour to used |
| Tramadol Hydrochloride & Aceclofenac Tablets | Analgesic (Pain Relief) | Each film coated tablet contains Aceclofenac IP 100 mg Tramadol Hydrochloride IP 50 mg Excipients q.s. |
| Tramadol Hydrochloride & Paracetamol Tablets | Analgesic (Pain Relief) | Each uncoated bilayered tablet contains : Tramadol Hydrochloride IP 37.5 mg Paracetamol IP 325 mg Excipients q.s. Approved colour to used |
| Acetaminophen, Phenylephrine, Caffeine and Dexchlorpheniramine | Anti-allergic | Each uncoated tablet contains : Acetaminophen IP 500 mg Phenylephrine Hydrochloride IP 10 mg Caffeine (Anhydrous) IP 30 mg Dexchlorpheniramine maleate IP 2 mg Approved colour to used |
| Cetirizine Hydrochloride & Phenylephrine Hydrochloride | Anti-allergic | Each film coated tablet contains : Cetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 10 mg Excipients q.s. Approved colour to be use |
| Cetirizine Hydrochloride & Phenylephrine Hydrochloride | Anti-allergic | Each film coated tablet contains : Cetirizine Hydrochloride IP 10 mg Phenylephrine Hydrochloride IP 10 mg Excipients q.s. Approved colour to be use |
| Cetirizine Hydrochloride Phenylephrine Hydrochloride With Paracetmol | Anti-allergic | Each uncoated tablet contains : Cetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 10 mg Paracetmol IP 325 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Cetirizine Hydrochloride Tablets IP | Anti-allergic | Each uncoated tablet contains : Cetirizine Hydrochloride IP 10 mg Permitted Color Used |
| Cetirizine Hydrochloride Tablets IP | Anti-allergic | Each film coated tablet contains : Cetirizine Hydrochloride IP 10 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Chlorpheniramine Maleate Tablets IP | Anti-allergic | Each uncoated tablet contains : Chlorpheniramine Maleate IP 4 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron Oxide Yellow |
| Cyproheptadine Hydrochloride Tablets IP | Anti-allergic | Each uncoated tablet contains : Cyproheptadine Hydrochloride IP 4 mg |
| Desloratadine Tablets 5 mg | Anti-allergic | Each film coated tablets contains : Desloratadine BP 5 mg Excipients q.s. Approved colour to be used |
| Diphenhydramine HCI Tablets | Anti-allergic | Each uncoated tablet contains : Diphenhydramine Hydrochloride IP 25 mg Approved colour to used |
| Fexofenadine Hydrochloride Tablets | Anti-allergic | Each uncoated tablet contains : Fexofenadine Hydrochloride IP 30 mg |
| Fexofenadine Tablets IP | Anti-allergic | Each film / uncoated tablet contains : Fexofenadine Hydrochloride IP 120 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Fexofenadine Tablets IP | Anti-allergic | Each film / uncoated tablet contains : Fexofenadine Hydrochloride IP 180 mg Colour: Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Griseofulvin & Cetirizine Hydrochloride Tablets | Anti-allergic | Each uncoated tablet contains : Griseofulvin IP 250 mg Cetirizine Hydrochloride IP 5 mg Excipients q.s. Approved colour to be used |
| Levocetirizine Hydrochloride Phenylephrine Hydrochloride & | Anti-allergic | Each uncoated tablet contains Levocetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Paracetamol IP 325 mg Colour: Brilliant Blue / Erythrosine /Tartrazine or Titanium Dioxide IP/Ferric Oxide Yellow |
| Levocetirizine Hydrochloride Phenylephrine Hydrochloride & | Anti-allergic | Each uncoated tablet contains Levocetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Paracetamol IP 500 mg Excipients q.s. Approved colour to be used |
| Levocetirizine Hydrochloride Tablets | Anti-allergic | Each film coated tablet contains : Levocetirizine Hydrochloride IP 10 mg Approved colour used |
| Levocetirizine Hydrochloride Tablets IP | Anti-allergic | Each film coated tablet contains: Levocetirizine Hydrochloride IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Survet yellow |
| Levocetirizine With Dispersible Tablets | Anti-allergic | Each uncoated dispersible tablet contains : Levocetirizine Hydrochloride IP 2.5 mg Montelukast Sodium IP eq. to Montelukast 4 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Senset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Paracetmol , Chlorpheniramine Maleate Caffeine Tablets | Anti-allergic | Each uncoated tablet contains: Paracetmol IP 325 mg Chlorpheniramine Maleate IP 4 mg Caffeine (Anhydrous) IP 20 mg Colour Brillow Blue/Frythrosine/Tartrazine/Quinoline Yellow/Suret yellow Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Paracetmol , Phenylephrine Hydrochloride With Chlorpheniramine Maleate | Anti-allergic | Each uncoated tablet contains: Paracetmol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 4 mg Colour Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunsel yellow or Titanium Dioxide ip /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Paracetmol , Phenylephrine Hydrochloride With Chlorpheniramine Maleate, Caffeine (Anhydrous) | Anti-allergic | Each uncoated tablet contains : Paracetmol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Caffeine (Anhydrous) IP 30 mg Colour: Brilliant Blue/Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Parácetamol, Phenylephrine, Cetirizine HCI Tablets | Anti-allergic | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 5 mg Cetirizine Hydrochloride IP 5 mg Excipients q.s. |
| Parácetamol, Phenylephrine, Cetirizine HCI Tablets | Anti-allergic | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg Cetirizine Hydrochloride IP 5 mg Excipients q.s. |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate | Anti-allergic | Each uncoated tablet çontains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 4 mg Excipients q.s. Approved color to be use |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets | Anti-allergic | Each uncoated tablet contains Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 4 mg Approved Color to be use in Tablet |
| Acebrophyline (SR), Montelukast sodium and Desloratidine | Anti-asthmatic / Cough & Cold | Each film coated tablet contains: Acebrophylline (Sustained released) 200 mg Montelukast sodium IP Eq. to Montelukast 10 mg Desloratidine 5 mg Excipients q.s. Approved colour to be use |
| Acebrophylline (SR) and montelukast Tablets | Anti-asthmatic / Cough & Cold | Each uncoated billayer tablet contains : Acebrophylline 200mg Montelukast Sodium IP Eq. to Montelukast 10mg Approved colour to be use |
| Acebrophylline Sustained Release Tablets 200 mg | Anti-asthmatic / Cough & Cold | Each uncoated Sustained Release tablet contains : Acebrophylline 200 mg Approved colour to be use |
| Acebrophylline and N-Acetylcysteine Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Acebrophylline 100mg N-Acetylcysteine BP 600mg Approved colour to used |
| Acetylcysteine and Ambroxol HCl Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Acetylcysteine BP 200 mg Ambroxol Hydrochloride IP 30 mg Excipients q.s. Approved colour to used |
| Acetylcysteine and Ambroxol HCl Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Acetylcysteine BP 300 mg Ambroxol Hydrochloride IP 30 mg Excipients q.s. Approved colour to used |
| Bilastine & Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Blistine 20 mg Montelukast Sodium IP eq. to Montelukast 10 mg Excipients q.s. Approved colour to used |
| Bromhexine, Guaiphenesin Chlorpheniramine Maleate,Paracetamol and Phenylephrine HCL | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Bromhexine Hcl IP 8 mg Guaiphenesin IP 50 mg Chlorpheniramine Maleate IP 4 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| Cetirizine Hydrochloride With Ambroxol Hydrochloride Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Cetirizine Hydrochloride IP 5 mg Ambroxol HCL IP 60 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Dextromethorphan , Guaiphenesin & Chlorpheniramine Maleate With Dextromethorphan Hbr, Bromhexine Hydrochloride, Titanium Dioxide | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Dextromethorphan Hbr IP 10 mg Guaiphenesin IP 100 mg Chlorpheniramine Maleate IP 2 mg Bromhexine Hydrochloride IP 8 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| Dextromethorphan HBr, Cetirizine Hydrochioride,Phenylephrine HCL and Ambroxol HCL | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Dextromethorphan Hydrobromi IP 10 mg Cetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Ambroxol Hydrochloride IP 15 mg Approved colour to be used |
| Dextromethorphan HBr, Chlorpheniramine Maleate,Phenylephrine HCL and Ambroxol HCL | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains: Dextromethorphan HBr IP 10 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine Hydrochloride IP 5 mg Ambroxol Hydrochloride IP 30 mg Approved color to be use |
| Dextromethorphan Hbr, Guaiphenesin & Ambroxol Hcl | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains Dextromethorphan Hbr IP 10 mg Guaiphenesin IP 100 mg Ambroxol Hydrochloride IP 8 mg Chlorpheniramine Maleate IP 2 mg |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Dextromethorphan HBO IP 10 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Excipients q.s. Approved colour to be used |
| Doxofylline SR and Acebrophylline Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains Doxofylline (Sustained released) IP 400 mg Acebrophylline IP 100 mg Excipients q.s. |
| Doxofylline Sustained Released and Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each uncoated Sustained Released tablet contains : Doxofylline IP 400 mg Montelukast Sodium IP Eq. to Montelukast 10 mg Approved colour to be use |
| Doxofylline Sustained Released and Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each uncoated Sustained Released tablet contains : Doxofylline IP 800 mg Montelukst Sodium IP Eq. to Montelukast 10 mg Approved colour to be use |
| Doxofylline Tablets 200 mg | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Doxofylline IP 200 mg Approved colour to be use |
| Doxofylline Tablets IP | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains: Doxofylline IP 400 mg Colour: Brilliant Blue / Erythrosine / Tartraz ine /Quinoline Yellow / Sunset yellow or Titanium Dioxide P /Apple Green / Iron oxide red,lron oxide Yellow |
| Doxofylline and Acebrophylline Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Doxofylline IP 400 mg Acebrophylline IP 100 mg Approved colour to be use |
| Doxofylline and Ambroxol HCl Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Doxofylline IP 400 mg Ambroxol Hydrochloride IP 30 mg Approved colour to be use |
| Doxolyline & Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each film / uncoated tablet contains : Doxofyline IP 400 mg Montelukast Sodium IP eq. to Montelukast 10 mg Approved colour to used Contains : Povidone – lodine IP 7.5 % W/V Permitted Color Used Contains : Povidone – lodine IP 2 % W/V (Available lodine 0.2% w/v) Permitted Color Used |
| Doxycycline and Ambroxol Tablete | Anti-asthmatic / Cough & Cold | Each filin coated tablet contains: Doxycycline Hydrochloride IP Equivalent to Doxycycline 100 mg Ambroxol Hydrochloride IP 75 mg Approved colour to be use |
| Doxycycline and Ambroxol Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Doxycycline Hydrochloride IP Equivalent to Doxycycline 100 mg Ambroxol Hydrochloride IP 7.5 mg Approved colour to be use |
| Doxycycline, Ambroxol and Bromhexine HCI Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Doxycycline Hydrochloride IP Equivalent to Doxycycline 100 mg Ambroxol Hydrochloride IP 8 mg Bromhexine HCI IP 4 mg Approved colour to be use |
| Ebastine and Montelukast Sodium Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Ebastine IP 10 mg Montelukast Sodium IP Eq. to Montelukast 10mg Approved colour to used |
| Fexofenadine & Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each film / uncoated tablet contains : Fexofenadine Hydrochloride IP 120 mg Montelukast Sodium IP eq. to Montelukast 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow/ Runsel yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellon |
| Fexofenadine and Montelukast Chewable Tablets | Anti-asthmatic / Cough & Cold | Each uncoated chewable tablet contains: Fexofenadine Hydrochloride IP 120 mg Montelukast Sodium IP eq. to Montelukast 10 mg Approved color to be use |
| Fexofenadine, Montelukast and Acebrophylline Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Fexofenadine Hydrochloride IP 120 mg Montelukast sodium IP Eq. to Montelukast 10 mg Acebrophylline 200 mg Approved coloured used |
| Guaiphenesin, Bromhexine Hcl, and Chlorpheniramine | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Guaiphenesin IP 50 mg Bromhexine HCl IP 4 mg Chlorpheniramine maleate IP 2 mg Approved colour to used |
| Levocetirizine Hydrochloride With Ambroxol Hdrochloride Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Levocetirizine Hydrochloride IP 5 mg Ambroxol Hdrochloride IP 60 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Levocetirizine Hydrochloride and Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Levocetirizine Hydrochloride IP 2.5 mg Montelukast Sodium IP Eq. to Montelikast 5 mg Approved colour used |
| Levocetirizine Hydrochloride and Montelukast dispersible Tablets | Anti-asthmatic / Cough & Cold | Each uncoated dispersible tablet contains : Levocetirizine Hydrochloride IP 2.5 mg Montelukast Sodium IP Eq. to Montelukast 5 mg Approved colour used |
| Levocetirizine Hydrochloride, Phenylephrine Hydrochloride,Ambroxol HCL and Paracetamol | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Levocetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Ambroxol Hydrochloride IP 30 mg Paracetmol IP 325 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Levocetirizine With Montelukast Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Levocetirizine Hydrochloride IP 5 mg Montelukast Sodium IP Eq. to Montelukast 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Levocetirizine, Montelukast & Ambroxol Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains Levocetirizine Hydrochloride IP 5 mg Montelukast Sodium IP eq. to Montelukast 10 mg Ambroxol Hydrochloride IP 75 mg Colour: Brilliant Blue / Erythrosine/Tartrazine |
| Levocetirizine, Montelukast and Ambroxol HCI (SR) tablets | Anti-asthmatic / Cough & Cold | Each uncoated bilayered tablet contains Levocetirizine Hydrochloride IP 5 mg Montelukast sodium IP Eq. to Montelukast 10 mg Ambroxol Hydrochloride 75 mg (As Sustained Release form) Approved coloured used |
| Loratadine and Ambroxol HCI Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Loratadine IP 5 mg Ambroxol Hydrochloride IP 60 mg Approved coloured used |
| Montelukast Tablets IP | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Montelukast Sodium IP Eq. Montelukast 10 mg Approved coloured used |
| Montelukast Tablets IP | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Montelukast Sodium IP Eq. Montelukast 5 mg Approved coloured used |
| Montelukast sodium and Hydroxyzine Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains: Montelukast Sodium IP eq. to Montelukast 10 mg Hydroxyzine Hydrochloride IP 25 mg Approved colour to be used |
| Montelukast, Acebrophylline and Levocetirizine HCI Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Montelukast Sodium IP Eq. to Montelukast 10 mg Acebrophylline 200 mg (As prolonged release) Levocetirizine Hydrochloride IP 5 mg Approved colour to used |
| Paracetamol, Ambroxol HCI, Guaiphenesin, Cetirizine Hcl & | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains: Paracetamol IP 325 mg Ambroxol Hydrochloride IP 15 mg Guaiphenesin IP 50 mg Phenylephrine Hydrochloride IP 5 mg Cetirizine Hydrochloride IP 5mg Excipients q.s. Approved colour to be used |
| Paracetamol, Guaiphenesin Chlorpheniramine Maleate,Phenylephrine HCL and Bromhexine HCL | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Paracetamol IP 450 mg Guaiphenesin IP 50 mg Chlorpheniramine Maleate IP 4 mg Phenylephrine Hydrochloride IP 5 mg Bromhexine Hydrochloride IP 4 mg Approved colour to used |
| Paracetamol, Guaiphenesin, Chlorpheniramine maleate and Bromhexine Hydrochloride | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Paracetamol IP 325 mg Guaiphenesin IP 100 mg Bromhexine Hydrochloride IP 8 mg Chlorpheniramine Maleate IP 2 mg Approved colour to used |
| Paracetamol, Phenylephrine, Cetirizine and Ambroxol Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Cetirizine Hydrochloride IP 5 mg Ambroxol Hydrochloride IP 30 mg Approved colour to used |
| Roxithromycin and Ambroxol Hel Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Roxithromycin IP 150 mg Ambroxol Hydrochloride IP 60 mg Approved colour to be us |
| Roxithromycin, Ambroxol Mcl and Lactic Acid Basillus Tablets | Anti-asthmatic / Cough & Cold | Each film coated tablet contains : Roxithromycin IP 150 mg Ambroxol Hydrochloride IP 30 mg Lactic Acid Basillus IP 30 mil.Sp. Approved colour to be use |
| Salbutamol Sulphate & Bromhexine Hydrochloride Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Salbutamol Sulphate IP Equivalent to Salbutamol 2 mg Bromhexine Hydrochloride IP 8 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Salbutamol Sulphate & Bromhexine Hydrochloride Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Salbutamol Sulphate IP Equivalent Salbutamol 2 mg Bromhexine Hydrochloride IP 4 mg Colour: Brilliant Blue / Erythrosine / Tartrazine Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Salbutamol Sulphate Tablets IP 2 mg. | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Salbutamol Sulphate IP Eq. to Salbutamol 2 mg |
| Salbutamol Sulphate Tablets IP 2 mg. | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Salbutamol Sulphate IP Eq. to Salbutamol 4 mg |
| Terbutaline Sulphate & Bromhexine Hcl Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains Terbutaline Sulphate IP 2.5 mg Bromhexine Hydrochloride IP 8 mg Approved colour to be used |
| Terbutaline Sulphate & Bromhexine Hydrochloride Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Terbutaline Sulphate IP 2.50 mg Bromhexine Hydrochloride IP 16 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Terbutaline Sulphate , Guaiphensin & Bromhexine Hydrochloride Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Terbutaline Sulphate IP 1.25 mg Guaiphensin IP 50 mg Bromhexine Hydrochloride IP 4 mg Colour: Brilliant Blue/Erytheosine / Tartrazine/Quinoline Yellow / Sunsel yellow or Thanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Terbutaline Sulphate With Bromhexine Hydrochloride Tablets | Anti-asthmatic / Cough & Cold | Each uncoated tablet contains : Terbutaline Sulphate IP 1.25 mg Bromhexine Hydrochloride IP 4 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Acarbose Tablets IP | Anti-diabetic | Each uncoated tablet contains : Acarbose IP 25 mg |
| Acarbose Tablets IP | Anti-diabetic | Each uncoated tablet contains : Acarbose IP 50 mg |
| Atorvastatin & Metformin Hydrochloride (ER) | Anti-diabetic | Each uncoated tablet contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg Metformin HCI IP 500 mg As extand release |
| Dapagliflozin Tablets 10 mg | Anti-diabetic | Each film coated tablet contains : Dipagliflozin IP 10 mg Approved colour to used |
| Dapagliflozin tablets | Anti-diabetic | Each film coated tablet contains: Dapagliflozin Propanediol monohydrate Eq. to Dapagliflozin 5 mg Excipients q.s. Approved colour to used |
| Dapagliflozin tablets | Anti-diabetic | Each film coated tablet contains: Dapagliflozin Propanediol monohydrate Eq. to Dapagliflozin 10 mg Excipients q.s. Approved colour to used |
| Glibenclamide and Metformin HCl Sustained Release Tablets | Anti-diabetic | Each uncoated tablet contains : Glibenclamide IP 5 mg Metformin HCl (As Sustained Release) IP 500 mg Approved colour used |
| Glibenclamide and Metformin HCl Sustained Release Tablets | Anti-diabetic | Each uncoated tablet contains : Glibenclamide IP 2.5 mg Metformin HCl (As Sustained Release) IP 500 mg Approved colour used |
| Glibenclamide and Metformin HCl Tablets IP | Anti-diabetic | Each uncoated tablet contains : Glibenclamide IP 5 mg Metformin HCl IP 500 mg Approved colour used |
| Glibenclamide and Metformin HCl Tablets IP | Anti-diabetic | Each uncoated tablet contains : Glibenclamide IP 2.5 mg Metformin HCl IP 400 mg Approved colour used |
| Glibenclamide, Pioglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains : Glibenclamide IP 5 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg Approved colour to be used |
| Gliclazide and Rosiglitazone with Metformin HCl Tablets | Anti-diabetic | Each uncoated tablet contains : Gliclazide IP 40 mg Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Metformin HCl IP 500 mg Approved colour to used |
| Gliclazide and Rosiglitazone with Metformin HCl Tablets | Anti-diabetic | Each uncoated tablet contains : Gliclazide IP 80 mg Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Metformin HCl IP 500 mg Approved colour to used |
| Gliclazide, Metformin HCl and Pioglitzone Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Gliclazide IP 80 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Excipients q.s. Approved coloured used |
| Glimepiride Tablets IP 0.5 mg | Anti-diabetic | Each film coated tablets contains : Glimepiride IP 0.5 mg Excipients q.s. Approved colour to be used |
| Glimepiride and Metformin HCl Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Glimepiride IP 1 mg Approved coloured used |
| Glimepiride and Metformin HCl Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Glimepiride IP 2 mg Approved coloured used |
| Glimepiride, Metformin HC (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 2 mg Voglibose IP 0.3 mg Approved coloured used |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 2 mg Voglibose IP 0.2 mg Approved coloured used |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 1 mg Voglibose IP 0.2 mg Approved coloured used |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 1 mg Voglibose IP 0.3 mg Approved coloured used |
| Glimepiride, Metformin HCI (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Glimepiride IP 3 mg Voglibose IP 0.2 mg Approved colour to be used |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 3 mg Voglibose IP 0.3 mg Approved coloured used |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Glimepiride IP 3 mg Voglibose IP .03 mg Approved coloured used |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Glimepiride IP 2 mg Voglibose IP 0.2 mg Approved coloured used |
| Glimepiride, Metformin HCl (SR) and Voglibose Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Glimepiride IP 1 mg Voglibose IP 0.2 mg Approved coloured used |
| Linagliptin Tablets | Anti-diabetic | Each uncoated tablet contains Linagliptin IP 400 mg Excipients q.s. Approved colour to be used |
| Linagliptin Tablets | Anti-diabetic | Each uncoated tablet contains Linagliptin IP 5 mg Excipients q.s. Approved colour to be used |
| Metformin & Glibenclamide Pioglitazone Tablets | Anti-diabetic | Each film coated tablet contains Metformin Hydrochloride IP 500 mg Glibenclamide IP 5 mg Pioglitazone IP 15 mg Permitted Color Used |
| Metformin & Gliclazide with Pioglitazone Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Gliclazide IP 40 mg Pioglitazone IP 15 mg Permitted Color Used |
| Metformin & Gliclazide with Pioglitazone Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Gliclazide IP 80 mg Pioglitazone IP 15 mg Permitted Color Used |
| Metformin (SR) & Glimepiride Tablets | Anti-diabetic | Each uncoated sustain release tablet contains Metformin HCl (as sustain release) IP 1000 mg Glimepiride IP 1 mg Colour : Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| Metformin (SR) & Glimepiride Tablets | Anti-diabetic | Each uncoated sustain release tablet contains Metformin HCl (as sustain release) IP 1000 mg Glimepiride IP 2 mg Colour : Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| Metformin (SR) & Glimepride Tablets IP | Anti-diabetic | Each film coated tablet contains Metformin Hydrochloride (as sustain release) IP 500 Mg Glimepride IP 1 mg Permitted Color Used |
| Metformin (SR) & Glimepride Tablets IP | Anti-diabetic | Each film coated tablet contains Metformin Hydrochloride (as sustain release) IP 500 mg Glimepride IP 2 mg Permitted Color Used |
| Metformin (SR) & Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride (SR) IP 500 mg Voglibose IP 0.20 mg Permitted Color Used |
| Metformin (SR), Gliclazide Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (As sustained release ) Gliclazide IP 80 mg Excipients q.s. Approved coloured to be used |
| Metformin (SR), Glimepride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (As sustained release form) Glimepride IP 2 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Metformin (SR), Glimepride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride (As sustained rel IP 500 mg (As sustained release form) Glimepride IP 1 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Metformin (sustained released) and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Voglibose IP 0.2 mg Excipients q.s. Approved coloured to be used |
| Metformin (sustained released) and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Voglibose IP 0.3 mg Excipients q.s. Approved coloured to be used |
| Metformin HCI (SR) Gliclazide (SR) & Pioglitazone | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Gliclazide (As sustained release) IP 30 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Approved colour to be used |
| Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 4 mg Excipients q.s. Approved coloured to be used |
| Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 3 mg Excipients q.s. Approved coloured to be used |
| Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Glimepiride IP 3 mg Excipients q.s. Approved coloured used |
| Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg (As sustained release) Glimepiride IP 4 mg Excipients q.s. Approved coloured to be used |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 750 mg Glimepiride IP 0.5 mg |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 750 mg Glimepiride IP 1 mg |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 750 mg Glimepiride IP 2 mg |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Glimepiride IP 3 mg Excipients q.s. Approved coloured to be used |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Glimepiride IP 4 mg Excipients q.s. Approved coloured to be used |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg Glimepiride IP 3 mg Excipients q.s. Approved coloured to be used |
| Metformin HCl and Glimepiride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg Glimepiride IP 4 mg Excipients q.s. Approved coloured to be used |
| Metformin Hydrochloride & Repaglinide Tablets | Anti-diabetic | Each uncoated bilayered-tablet contains Metformin Hydrochloride IP 500 mg Repaglinide IP 2 mg Excipients q.s. Approved coloured used |
| Metformin Hydrochloride (ER). Teneligliptin Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (as extaned release form) Tenengliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20 mg Approved colour to used |
| Metformin Hydrochloride (ER). Teneligliptin Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 1000 mg (as extaned release form) Tenengliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20 mg Approved colour to used |
| Metformin Hydrochloride (SR) Tablets | Anti-diabetic | Each uncoated sustain release tablet contains Metformin HCI IP 850 mg |
| Metformin Hydrochloride (SR) Tablets | Anti-diabetic | Each uncoated sustain release tablet contains Metformin HCI IP 500 mg Colour: Brilliant Blue / Erythrosine /Tartrazine / Sunset yellow or Apple Green / Titanium Dioxide IP |
| Metformin Hydrochloride (SR) Tablets | Anti-diabetic | Each uncoated sustain release tablet contains Metformin HCI IP 1000 mg Colour: Brilliant Blue / Erythrosine /Tartrazine / Sunset yellow or Apple Green / Titanium Dioxide IP |
| Metformin Hydrochloride (SR) and Dapagliflozin tablets | Anti-diabetic | Each uncoated bilayered tablet contains : Metformin Hydrochloride IP 500 mg (As sustained release) Dapagliflozin propanediol Monohydrate Equivalent to Dapagliflozin IP 10 mg Approved colour to be used |
| Metformin Hydrochloride (SR) and Dapagliflozin tablets | Anti-diabetic | Each uncoated bilayered tablet contains : Metformin Hydrochloride IP 1000 mg (As sustained release) Dapagliflozin propanediol Monohydrate Equivalent to Dapagliflozin IP 10 mg Approved colour to be used |
| Metformin Hydrochloride (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 850 mg (As sustained release) Glimepiride IP 1 mg Approved colour to used |
| Metformin Hydrochloride (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 850 mg (As sustained release) Glimepiride IP 2 mg Approved colour to used |
| Metformin Hydrochloride (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 850 mg (As sustained release) Glimepiride IP 3 mg Approved colour to used |
| Metformin Hydrochloride (SR) and Glimepiride tablets | Anti-diabetic | Each uncoated bilayered tablet contains : Metformin Hydrochloride IP 750 mg (As sustained release) Glimepiride IP 0.5 mg Approved colour to used |
| Metformin Hydrochloride (SR) and Glimepiride tablets | Anti-diabetic | Each uncoated bilayered tablet contains : Metformin Hydrochloride IP 750 mg (As sustained release) Glimepiride IP 1 mg Approved colour to used |
| Metformin Hydrochloride (SR) and Glimepiride tablets | Anti-diabetic | Each uncoated bilayered tablet contains : Metformin Hydrochloride IP 750 mg (As sustained release) Glimepiride IP 2 mg Approved colour to used |
| Metformin Hydrochloride (SR) tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 850 mg (As sustained release) |
| Metformin Hydrochloride (SR) tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 750 mg (As sustained release) |
| Metformin Hydrochloride (SR), Glimepride Tablets | Anti-diabetic | Each uncoated bilayered tablet contains Metformin Hydrochloride IP 500 mg (As sustained release form) Glimepride IP 0.5 mg Approved colour to used |
| Metformin Hydrochloride Prolonged release and glimepiride Tablets | Anti-diabetic | Each Uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000 mg ( As prolonged release form Glimepiride IP 0.5 mg Excipients q.s. Approved colour to be used |
| Metformin Hydrochloride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin HCI IP 1000 mg Colour: Brilliant Blue / Erythrosine Tartrazine / Sunset yellow or Apple Green / Titanium Dioxide IP |
| Metformin Hydrochloride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 750 mg |
| Metformin Hydrochloride Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 850 mg |
| Metformin Hydrochloride Tablets IP | Anti-diabetic | Each uncoated tablet contains Metformin HCI IP 850 mg |
| Metformin Hydrochloride Tablets IP | Anti-diabetic | Each uncoated tablet contains : Metformin Hydrochloride IP 500 mg |
| Metformin Hydrochloride With Gliclazide Tablets | Anti-diabetic | Each uncoated tablet contains : Metformin Hydrochloride IP 500 mg Gliclazide BP 80 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Metformin Hydrochloride With Gliclazide Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin Hydrochloride IP 500 mg Gliclazide BP 80 mg Approved colour to be used |
| Metformin Sustain Release Tablets IP | Anti-diabetic | Each film coated sustain release tablet contains Metformin Hydrochloride IP 500 mg Permitted Color Used |
| Metformin Sustain Release Tablets IP | Anti-diabetic | Each film coated sustain release tablet contains Metformin Hydrochloride IP 1000 mg Permitted Color Used |
| Metformin Tablets IP | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 250 mg |
| Metformin, Gliclazide and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains : Metformin Hydrochloride IP 500 mg Gliclazide IP 80 mg Voglibose IP 0.2 mg Excipients q.s. Approved colour to be use |
| Metformin, Gliclazide and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains : Metformin Hydrochloride IP 500 mg Gliclazide IP 80 mg Voglibose IP 0.3 mg Excipients q.s. Approved colour to be use |
| Myo-Inositol and Metformin HCI (SR) Tablets | Anti-diabetic | Each uncoated bilayer tablet contains Myo-Inositol IP 600 mg Metformin Hydrochloride IP 250 mg (As sustained release form) Approved colour to be used |
| Myo-Inositol and Metformin HCI Tablets | Anti-diabetic | Each film coated tablet contains Myo-lnositol IP 600 mg Metformin Hydrochloride IP 250 mg Approved colour to be use |
| Pioglitazone & Metformin Hydrochloride (ER) | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP 15 mg Eq. to Pioglitazone Metformin HCI IP 500 mg As extand release |
| Pioglitazone & Metformin Hydrochloride (ER) | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP 30 mg Eq. to Pioglitazone Metformin HCI IP 500 mg As extand release |
| Pioglitazone & Metformin Hydrochloride (ER) | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Metformin HCI IP 1000 mg As extand release |
| Pioglitazone & Metformin Hydrochloride , and Glimepride | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP Eq. to Ploglitazone 15 mg Metformin HCI IP 500 mg Glimepride IP 1 mg |
| Pioglitazone & Metformin Hydrochloride , and Glimepride | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP Eq. to Ploglitazone 15 mg Metformin HCI IP 500 mg Glimepride IP 2 mg |
| Pioglitazone Tablets IP | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP Eq. to Pioglitazone 7.5 mg |
| Pioglitazone Tablets IP | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg |
| Pioglitazone Tablets IP | Anti-diabetic | Each uncoated tablet contains Pioglitazone Hydrochloride IP Eq. to Pioglitazone 30 mg |
| Pioglitazone, Metformin HCI (SR) and Gliclazide (SR) Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Gliclazide (As sustained release) IP 60 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Excipients q.s. Approved coloured to be used |
| Pioglitazone, Metformin HCI (SR) and Gliclazide (SR) Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg (As sustained release) Gliclazide (As sustained release) IP 30 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Excipients q.s. Approved coloured to be used |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 1 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 7.5 mg Approved coloured used |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 500 mg Glimepiride IP 1 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 7.5 mg |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 2 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 7.5 mg Approved coloured used |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 500 mg Glimepiride IP 2 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 7.5 mg |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 1 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Approved coloured used |
| Pioglitazone, Metformin HCI (SR) and Glimepiride Tablets | Anti-diabetic | Each uncoated bilayred tablet contains : Metformin Hydrochloride IP 500 mg (As sustained release) Glimepiride IP 2 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Approved coloured used |
| Pioglitazone, Metformin HCI and Gliclazide Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Gliclazide IP 60 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Excipients q.s. Approved coloured to be used |
| Pioglitazone, Metformin HCI and Gliclazide Tablets | Anti-diabetic | Each uncoated tablet contains Metformin Hydrochloride IP 500 mg Gliclazide IP 30 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Excipients q.s. Approved coloured to be used |
| Ploglitazone & Metformin Hydrochloride (ER) | Anti-diabetic | Each uncoated tablet contains Ploglitazone Hydrochloride IP Eq. to Ploglitazone 30 mg Metformin HCI IP 1000 mg As extand release |
| Repaglinide and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Repaglinide IP 0.5 mg Voglibose IP 0.2 mg Excipients q.s. |
| Repaglinide and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Repaglinide IP 1 mg Voglibose IP 0.2 mg Excipients q.s. |
| Repaglinide and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Repaglinide IP 0.5 mg Voglibose IP 0.3 mg Excipients q.s. |
| Repaglinide and Voglibose Tablets | Anti-diabetic | Each uncoated tablet contains Repaglinide IP 1 mg Voglibose IP 0.3 mg Excipients q.s. |
| Rosiglitazone and Glimepiride Tablets | Anti-diabetic | Each flim coated tablet contains : Glimepiride IP 1 mg Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Approved colour to used |
| Rosiglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin HCI IP 500 mg Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Approved colour to used |
| Rosiglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin HCI IP 500 mg Rosiglitazone Maleate Eq. to Rosiglitazone 4 mg Approved colour to used |
| Rosiglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin HCI IP 1000 mg (As Sustained Release) Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Approved colour to used |
| Rosiglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin HCI IP 1000 mg (As Sustained Release) Rosiglitazone Maleate Eq. to Rosiglitazone 4 mg Approved colour to used |
| Rosiglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin HCI IP 500 mg (As Sustained Release) Rosiglitazone Maleate Eq. to Rosiglitazone 4 mg Approved colour to used |
| Rosiglitazone and Metformin HCI Tablets | Anti-diabetic | Each uncoated tablet contains: Metformin HCI IP 500 mg (As Sustained Release) Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Approved colour to used |
| Rosiglitazone and Metformin HCl Tablets | Anti-diabetic | Each uncoated tablet contains : Metformin HCl IP 500 mg Rosiglitazone Maleate Eq. to Rosiglitazone 1 mg Approved colour to used |
| Rosuvastatin and Teneligliptin Tablets | Anti-diabetic | Each film coated tablets contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Teneligliptin Hydrobromide hydrat IP Eq. to Teneligliptin 5 mg Excipients q.s. Approved colour to be used |
| Rosuvastatin and Teneligliptin Tablets | Anti-diabetic | Each film coated tablets contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Teneligliptin Hydrobromide hydrat IP Eq. to Teneligliptin 10 mg Excipients q.s. Approved colour to be used |
| Rosuvastatin and Teneligliptin Tablets | Anti-diabetic | Each film coated tablets contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Teneligliptin Hydrobromide hydrat IP Eq. to Teneligliptin 20 mg Excipients q.s. Approved colour to be used |
| Saxagliptin and Metformin HCI Extended Release Tablets | Anti-diabetic | Each film coated tablet contains Metformin Hydrochloride IP 1000 mg (As extended release) Saxagliptin Hydrochloride Eq. to Saxagliptin 5 mg Approved coloured used |
| Sitagliptin Tablets IP | Anti-diabetic | Each film coated tablet contains Sitagliptin (As Phosphate IP 25 mg Colur: Titanium Dioxide |
| Sitagliptin Tablets IP | Anti-diabetic | Each film coated tablet contains Sitagliptin (As Phosphate IP 50 mg Colur: Titanium Dioxide |
| Sitagliptin Tablets IP | Anti-diabetic | Each film coated tablet contains Sitagliptin (As Phosphate IP 100 mg Colur: Titanium Dioxide |
| Sitagliptin and Metformin Hydrochloride Tablets | Anti-diabetic | Each film coated tablet contains Sitagliptin (As Phosphate) IP 50 mg Metformin Hydrochloride IP 500 mg Colur: Titanium Dioxide |
| Sitagliptin and Metformin Hydrochloride Tablets | Anti-diabetic | Each film coated tablet contains Sitagliptin IP 50 mg Metformin Hydrochloride IP 1000 mg Colur: Titanium Dioxide |
| Sitagliptin and Metformin Hydrochloride Tablets | Anti-diabetic | Each film coated tablet contains Sitagliptin IP 50 mg Metformin Hydrochloride IP 850 mg Colur: Titanium Dioxide |
| Teneligliptin Tablets 20 mg. | Anti-diabetic | Each film coated tablets contains : Teneligliptin Hydromide Hydrate eq. to Teneligliptin 20 mg Permitted Color Used |
| Teneligliptin and Pioglitazone Hydrochloride Tablets | Anti-diabetic | Each film coated tablets contains : Teneligliptin Hydrobromide Hydrate IP Eq. to Teneligliptin 20 mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Excipients q.s. Approved colour to be used |
| Vildagliptin and Metformin Hydrochloride Tablets | Anti-diabetic | Each uncoated tablet contains Vildagliptin 50 mg Metformin Hydrochloride IP 500 mg |
| Vildagliptin and Metformin Hydrochloride Tablets | Anti-diabetic | Each uncoated tablet contains Vildagliptin 50 mg Metformin Hydrochloride IP 850 mg |
| Vildagliptin and Metformin Hydrochloride Tablets | Anti-diabetic | Each uncoated tablet contains Vildagliptin 50 mg Metformin Hydrochloride IP 1000 mg |
| Vildagliptin tablets IP | Anti-diabetic | Each uncoated tablet contains : Vildagliptin IP 50 mg Excipients q.s. |
| Vildagliptin tablets IP | Anti-diabetic | Each uncoated tablet contains : Vildagliptin IP 100 mg Excipients q.s. |
| Voglibose Tablets IP | Anti-diabetic | Each uncoated tablet contains : Voglibose IP 0.2 mg |
| Voglibose Tablets IP | Anti-diabetic | Each uncoated tablet contains : Voglibose IP 0.3 mg |
| Voglibose and Metformin Hydrochloride (SR) Tablet | Anti-diabetic | Each uncoated tablet contains Voglibose 0.3 mg Metformin Hydrochloride IP 500 mg (As Sustain Release) |
| Fluconazole Tablets IP 150 mg | Anti-fungal | Each uncoated tablet contains : Fluconazole IP 150 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Fluconazole Tablets IP 150 mg. | Anti-fungal | Each uncoated tablet contains : Fluconazole USP 150 mg Excipients q.s. |
| Fluconazole Tablets IP 200 mg. | Anti-fungal | Each uncoated tablet contains Fluconazole IP 200 mg Excipients q.s. Approved colour to be used |
| Itraconazole Sustained Release Tablets | Anti-fungal | Each film coated (SR) tablet contains : Itraconazole USP 200 mg Approved coloured used |
| Ketoconazole Tablets IP | Anti-fungal | Each uncoated tablet contains Ketoconazole IP 200 mg |
| Terbinafine Hydrochloride Tablets IP | Anti-fungal | Each uncoated tablet contains : Terbinafine Hydrochloride IP Eq. to Terbinafine 250 mg Approved colour to used |
| Terbinafine Hydrochloride Tablets USP | Anti-fungal | Each uncoated tablet contains Terbenafine Hydrochloride USP 250 mg |
| Albendazole Chewable Tablets IP | Anti-parasitic | Each uncoated chewable tablet contains : Albendazole IP 400 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Albendazole and Ivermectin Tablets | Anti-parasitic | Each uncoated tablet contains : Albendazole IP 400 mg lvermectin IP 6 mg Approved coloured used |
| Ivermectin Tablets | Anti-parasitic | Each uncoated tablet contains : Ivermectin IP 6 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / tron oxide red iron oxide Yellow |
| Ivermectin Tablets | Anti-parasitic | Each uncoated tablet contains Ivermectin IP 10 mg Colour : Erythrosine |
| Ivermectin Tablets For Veterinary Use | Anti-parasitic | Each uncoated tablet contains Ivermectin IP 100 mg Colour : Sunset Yellow |
| Ivermectin Tablets USP | Anti-parasitic | Each uncoated tablet contains Ivermectin IP 12 mg Approved colour to be used |
| Levamisole Hydrochloride & Albendazole Tablets | Anti-parasitic | Each film coated tablets contains : Levamisole Hydrochloride IP Eq. to Levamisole 50 mg Albendazole IP 400 mg Approved colour to be used |
| Acyclovir Tablets IP | Anti-viral | Each uncoated tablet contains Acyclovir IP 200 mg |
| Acyclovir Tablets IP | Anti-viral | Each uncoated tablet contains Acyclovir IP 400 mg |
| Azithromycin Dispersible Tablets | Antibiotic | Each uncoated dispersible tablet contains : Azithromycin Anhydrous IP 100 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP Apple Green / Iron oxide red,Iron oxide Yellow |
| Azithromycin Tablets | Antibiotic | Each filmcoated tablet contains : Azithromycin (As Di hydratel) IP Eq. to Anhydrous Azithromycin 100 mg Approved colour to be used |
| Azithromycin Tablets IP 250 mg. | Antibiotic | Each film coated tablet contains : Azithromycin Anhydrous IP 250 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Azithromycin Tablets IP 500 mg. | Antibiotic | Each film coated tablet contains : Azithromycin Anhydrous IP 500 mg Excipients q.s. Approved Color to be use in Tablet |
| Cefixime Dispersible Tablets | Antibiotic | Each uncoated dispersible tablet contains Cefixime Trihydrate IP eq. to Cefixime 100 mg Colour: Brilliant Blue / Erythrosine /Tartrazine / Ponceau 4R or Titanium Dioxide IP/Sunset Yellow |
| Cefixime Dispersible Tablets | Antibiotic | Each uncoated dispersible tablet contains Cefixime Trihydrate IP eq. to Cefixime 200 mg Colour: Brilliant Blue / Erythrosine /Tartrazine / Ponceau 4R or Titanium Dioxide IP/Sunset Yellow |
| Ciprofloxacin Hydrochloride & Tinidazole Tablets | Antibiotic | Each film coated tablet contains : Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 500 mg Tinidazole IP 600 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red Iron oxide Yellow |
| Ciprofloxacin Hydrochloride Tablets IP 250 mg | Antibiotic | Each film coated tablet contains : Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | Antibiotic | Each film coated tablet contains : Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 500 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Doxycycline Lactic Acid Bacillus | Antibiotic | Each film coated tablet contains : Doxycycline Hyclate IP Equivalent to Doxycycline 100 mg Lactic Acid Bacillus 60 ms Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Doxycycline Tablets IP | Antibiotic | Each film coated tablet contains : Doxycycline Hyclate LP Equivalent to Doxycycline 100 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Doxycycline and Bromhexine HCl Tablets | Antibiotic | Each film coated tablet contains : Doxycycline Hydrochloride IP Equivalent to Doxycycline 100 mg Bromhexine HCl IP 8 mg Approved colour to be use |
| Levofloxacin Tablets IP 250 mg | Antibiotic | Each film coated tablet contains : Levofloxacin Hemihydrate IP Equivalent to Levofloxacin 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yelloy / Sunset yellow or Tanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yeller |
| Levofloxacin Tablets IP 500 mg | Antibiotic | Each film coated tablet contains : Levofloxacin Hemihydrate IP Equivalent to Levofloxacin 500 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron oxide Yellow |
| Levofloxacin Tablets IP 750 mg | Antibiotic | Each film coated tablet contains : Levofloxacin Hemihydrate IP Equivalent to Levofloxacin 750 mg Approved colour to be used |
| Levofloxacin and Ornidazole Tablets | Antibiotic | Each film coated tablet contains : Levofloxacin Hemihydrate IP Eq. to Levofloxacin 250 mg Ornidazole IP 500 mg Excipients q.s. Approved coloured used |
| Linezolide Tablets | Antibiotic | Each film coated tablet contains Linezolide IP 600 mg |
| Ofloxacin & Ornidazole Tablets | Antibiotic | Each film coated tablet contains : Ofloxacin IP 200 mg Ornidazole IP 500 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ofloxacin & Tinidazole Tablets | Antibiotic | Each film coated tablet contains : Ofloxacin IP 200 mg Tinidazole IP 600 mg Colour: Brilliant Blue/Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red, Iron oxide Yellow |
| Ofloxacin Dispersible Tablets | Antibiotic | Each dispersible tablet contains : Ofloxacin IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ofloxacin Tablets IP 200 mg | Antibiotic | Each film coated tablet contains : Ofloxacin IP 200 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Ofloxacin Tablets IP 400 mg | Antibiotic | Each film coated tablet contains : Ofloxacin IP 400 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Ofloxacin With Cefixime Tablets | Antibiotic | Each flim coated tablet contains Ofloxacin IP 200 mg Cefixime Trihydrate IP eq. to Cefixime 200 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ofloxacin With Lactic Acid Bacillus Tablets | Antibiotic | Each film coated tablet contains : Ofloxacin IP 200 mg Lactic Acid Bacillus IP 60 ml s.p. Approved Color to be use in Tablet |
| Alprazolam (PR) Tablets IP | CNS & Neuropathic | Each uncoated prolonged-release tablet contains : Alprazolam IP 0.5 mg Approved colour to be used |
| Alprazolam Sustained Released Tablets | CNS & Neuropathic | Each uncoated sustained released tablet contains : Alprazolam (Sustained Released) IP 1.5 mg Excipients q.s. Approved colour to be used |
| Alprazolam Sustained Released and Sertraline Tablets | CNS & Neuropathic | Each uncoated bilayered tablet contains : Alprazolam (Sustained Released) IP 0.25 mg Sertraline Hydrochloride IP Eq. to Sertraline 50 mg Excipients q.s. Approved colour to be used |
| Alprazolam Tablets IP 0.25 mg | CNS & Neuropathic | Each uncoated tablet contains : Alprazolam IP 0.25 mg Approved colour to be used |
| Alprazolam Tablets IP 0.5 mg | CNS & Neuropathic | Each uncoated tablet contains : Alprazolam IP 0.5 mg Approved colour to be used |
| Alprazolam Tablets IP 1 mg | CNS & Neuropathic | Each uncoated tablet contains : Alprazolam IP 1 mg Excipients q.s. Approved colour to used |
| Alprazolam and Propranolol Hydrochloride Tablets | CNS & Neuropathic | Each uncoated tablet contains : Alprazolam IP 0.25 mg Propranolo Hydrochloride IP 10 mg Excipients q.s. Approved colour to used |
| Alprazolam and Propranolol Hydrochloride Tablets | CNS & Neuropathic | Each uncoated tablet contains : Alprazolam IP 0.25 mg Propranolo Hydrochloride IP 20 mg Excipients q.s. Approved colour to used |
| Amitriptyline Hydrochloride Tablets | CNS & Neuropathic | Each film coated tablet contains : Amitriptyline Hydrochloride IP 75 mg Approved colour to be used |
| Amitriptyline Hydrochloride Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Amitriptyline Hydrochloride IP 10 mg Approved colour to be used |
| Amitriptyline Hydrochloride Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Amitriptyline Hydrochloride IP 25 mg Approved colour to be used |
| Amitriptyline Hydrochloride Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Amitriptyline Hydrochloride IP 50 mg Approved colour to be used |
| Clonazepam Mouth Dissoving Tablets | CNS & Neuropathic | Each orally disintegrating tablets contains Clonazepam IP 0.5 mg Approved color to be use |
| Clonazepam Mouth Dissoving Tablets | CNS & Neuropathic | Each orally disintegrating tablets contains Clonazepam IP 0.25 mg Approved color to be use |
| Clonazepam Tablets IP | CNS & Neuropathic | Each Uncoated tablet contains : Clonazepam IP 0.5 mg Excipients q.s. |
| Clonazepam Tablets IP | CNS & Neuropathic | Each Uncoated tablet contains : Clonazepam IP 1 mg Excipients q.s. |
| Clonazepam Tablets IP | CNS & Neuropathic | Each Uncoated tablet contains : Clonazepam IP 2 mg Excipients q.s. |
| Clonazepam Tablets IP | CNS & Neuropathic | Each uncoated tablet contains : Clonazepam IP 0.25 mg Excipients q.s. |
| Clonazepam and Escitalopram Oxelate Tablets IP | CNS & Neuropathic | Each uncoated tablet contains: Clonazepam IP 0.25 mg Escitalopram Oxelate IP Eq. to Escitalopram 10 mg Excipients q.s. |
| Clonazepam and Escitalopram Tablet IP | CNS & Neuropathic | Each uncoated tablet contains : Clonazepam IP 0.50 mg Escitalopram Oxelate IP Eq. to Escitalopram 10 mg Excipients q.s. |
| Clonazepam and Escitalopram Tablets | CNS & Neuropathic | Each film coated tablet contains : Clonazepam IP 0.5 mg Escitalopram Oxelate IP Eq. to Escitalopram 10 mg Excipients q.s. |
| Clonazepam and Escitalopram Tablets | CNS & Neuropathic | Each film coated tablet contains : Clonazepam IP 0.5 mg Escitalopram Oxelate IP Eq. to Escitalopram 5 mg Excipients q.s. |
| Clonazepam and Paroxetine Tablets | CNS & Neuropathic | Each uncoated bilayer tablet contains: Clonazepam IP 0.25mg Paroxetine Hydrochloride IP Eq. to Paroxetine 12.5 mg Excipients q.s |
| Clonazepam and Propranolol HCI Tablets | CNS & Neuropathic | Each uncoated tablet contains : Clonazepam IP 0.25 mg Propranolol Hydrochloride IP 10 mg Approved coloured used q.s. |
| Clonazepam and Propranolol HCI Tablets | CNS & Neuropathic | Each uncoated tablet contains : Clonazepam IP 0.5 mg Propranolol Hydrochloride IP 20 mg Approved coloured used q.s. |
| Desvenlafexine Extened Release and clonazepam Tablets | CNS & Neuropathic | Each Uncoated bilayered tablet contains: Desvenlafexine Succinate USP Eq. to Desvenlafexine 50 mg (As extened release form) Clonazepam IP 0.5 mg Excipients q.s. Approved colour to be used |
| Diazepam Tablets IP | CNS & Neuropathic | Each uncoated tablet contains : Diazepam IP 5 mg |
| Diazepam Tablets IP | CNS & Neuropathic | Each uncoated tablet contains: Diazepam IP 10 mg Approved colour to used |
| Duloxetine Gastro- resistant Tablets IP | CNS & Neuropathic | Each entric coated tablet contains Duloxetine Hydrochloride IP 30 mg |
| Duloxetine Gastro- resistant Tablets IP | CNS & Neuropathic | Each entric coated tablet contains Duloxetine Hydrochloride IP 40 mg |
| Duloxetine Gastro-Resistant Tablets IP | CNS & Neuropathic | Each enteric coated tablet contains : Duloxetine Hydrochloride IP Eq. to Duloxetine 20 mg Approved color to be use |
| Duloxetine Gastro-Resistant Tablets IP | CNS & Neuropathic | Each enteric coated tablet contains : Duloxetine Hydrochloride IP Eq. to Duloxetine 30 mg Approved color to be use |
| Duloxetine Gastro-Resistant Tablets IP | CNS & Neuropathic | Each enteric coated tablet contains : Duloxetine Hydrochloride IP Eq. to Duloxetine 40 mg Approved color to be use |
| Duloxetine Tablets IP | CNS & Neuropathic | Each uncoated tablet contains Duloxetine Hydrochloride IP 20 mg |
| Escitalopram Tablets IP | CNS & Neuropathic | Each uncoated tablet contains Escitalopram Oxalate 10 mg |
| Escitalopram Tablets IP | CNS & Neuropathic | Each uncoated tablet contains Escitalopram Oxalate 20 mg |
| Escitalopram Tablets IP | CNS & Neuropathic | Each uncoated tablet contains : Escitalopram Oxalate IP Eq. to Escitalopram 10 mg Approved colour to used |
| Escitalopram Tablets IP | CNS & Neuropathic | Each uncoated tablet contains : Escitalopram Oxalate IP Eq. to Escitalopram 20 mg Approved colour to used |
| Escitalopram and Etizolam Tablets | CNS & Neuropathic | Each uncoated tablets contains Escitalopram Exalate IP Eq. to Escitalopram 5 mg Etizolam IP 0.5 mg Approved colour to be used |
| Etizolam & Escitalopram Tablets | CNS & Neuropathic | Each uncoated tablet contains Etizolam IP 0.50 mg Escitalopram 10 mg Colour: Brilliant Blue / Erythrosine /Tartrazine or Titanium Dioxide IP |
| Etizolam & Escitalopram Tablets | CNS & Neuropathic | Each uncoated tablets contains Etizolam IP 0.5 mg Escitalopram Oxalate IP Eq. to Escitalopram 10 mg Approved color to be use |
| Fluoxetine Hydrochloride Tablets | CNS & Neuropathic | Each film coated tablet contains Fluoxetine Hydrochloride BP eq. to Fluoxetine 20 mg Colour: Brilliant Blue / Erythrosine Tartrazine or Titanium Dioxide IP / Ferric Oxide Yellow |
| Gabapentin Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Gabapentin IP 100 mg Approved coloured used |
| Gabapentin Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Gabapentin IP 300 mg Approved coloured used |
| Gabapentin Tablets IP | CNS & Neuropathic | Each uncoated tablet contains Gabapentin IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Gabapentin and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Gabapentin IP 400 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg | Approved coloured used |
| Gabapentin and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Gabapentin IP 300 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Approved coloured used |
| Gabapentin and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Gabapentin IP 100 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Approved colour to be used |
| Gabapentin and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablets contains : Gabapentin IP 200 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Excipients q.s. Approved colour to be used |
| Lorazepam Tablets IP | CNS & Neuropathic | Each Uncoated tablet contains : Lorazepam IP 1 mg Excipients q.s. |
| Lorazepam Tablets IP | CNS & Neuropathic | Each Uncoated tablet contains : Lorazepam IP 2.0 mg Excipients q.s. |
| Pregabalin Sustained Release Tablets | CNS & Neuropathic | Each uncoated tablet contains : Pregabaline IP 75 mg Approved colour to be use q.s |
| Pregabalin Sustained Release Tablets | CNS & Neuropathic | Each uncoated tablet contains : Pregabaline IP 150 mg Approved colour to be use |
| Pregabalin Sustained Release Tablets | CNS & Neuropathic | Each uncoated tablet contains : Pregabaline IP 300 mg Approved colour to be use |
| Pregabalin and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Pregabalin IP 75 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg | Approved coloured used |
| Pregabaline & Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains : Pregabaline IP 75 mg Nortriptyline HCI IP Eq. to Nortriptyline 10 mg Approved colour to be use q.s. |
| Pregabaline and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Pregabaline IP 75 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Excipients q.s. Approved colour to be use |
| Pregabaline and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Pregabaline IP 50 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Excipients q.s. Approved colour to be use |
| Pregabaline and Nortriptyline Tablets | CNS & Neuropathic | Each film coated tablet contains: Pregabaline IP 37.5 mg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Excipients q.s. Approved colour to be use |
| Sertraline Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Sertraline Hydrochloride IP Eq. to Paroxetine 25 mg Excipients q.s |
| Sertraline Tablets IP | CNS & Neuropathic | Each film coated tablet contains : Sertraline Hydrochloride IP Eq. to Paroxetine 50 mg Excipients q.s |
| Sertraline Tablets IP | CNS & Neuropathic | Each uncoated tablet contains : Sertraline Hydrochloride IP Eq. to Paroxetine 100 mg Excipients q.s |
| Zolpidem Tartrate Prolonged release Tablets IP | CNS & Neuropathic | Each Uncoated prolonged release tablet contains : Zolpidem Tartrate IP 6.25 mg Excipients q.s. |
| Zolpidem Tartrate Prolonged release Tablets IP | CNS & Neuropathic | Each Uncoated prolonged release tablet contains : Zolpidem Tartrate IP 12.50 mg Excipients q.s. |
| Zolpidem Tartrate Tablets IP | CNS & Neuropathic | Each Uncoated prolonged release tablet contains : Zolpidem Tartrate IP 5.0 mg Excipients q.s. |
| Zolpidem Tartrate Tablets IP | CNS & Neuropathic | Each Uncoated prolonged release tablet contains : Zolpidem Tartrate IP 10.0 mg Excipients q.s. |
| Zolpidem Tartrate orally Disintegrating Tablets | CNS & Neuropathic | Each uncoated orally Disintegrating tablet contains : Zolpidem Tartrate IP 5 mg Excipients q.s. |
| Zolpidem Tartrate orally Disintegrating Tablets | CNS & Neuropathic | Each uncoated orally Disintegrating tablet contains : Zolpidem Tartrate IP 10 mg Excipients q.s. |
| Amlodipine Besiylate & Atenolol Tablets | Cardiovascular | Each uncoated tablet contains : Amlodipine Besiylate BP Eq. to Amlodipine 5 mg Atenolol IP 50 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunsel yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Amlodipine Besiylate Tablets | Cardiovascular | Each uncoated tablet contains : Amlodipine Besiylate BP Eq. to Amlodipine 2.5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Amlodipine Besiylate Tablets | Cardiovascular | Each uncoated tablet contains : Amlodipine Besiylate BP Eq. to Amlodipine 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Amlodipine Besiylate Tablets | Cardiovascular | Each uncoated tablet contains : Amlodipine Besiylate BP Eq. to Amlodipine 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Amlodipine Besylate and Hydrochlorothizide tablets | Cardiovascular | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine IP 5 mg Hydrochlorothizide IP 12.5 mg Excipients q.s. Approved coloured used |
| Amlodipine Besylate and Metoprolol Succinate | Cardiovascular | Each uncoated bilayred tablet contains : Amlodipine Besylate Eq. to Amlodipine IP 5 mg Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50.0 mg Excipients q.s. Approved colour to be used |
| Amlodipine Besylate and Metoprolol Succinate | Cardiovascular | Each uncoated bilayred tablet contains : Amlodipine Besylate Eq. to Amlodipine IP 5 mg Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25.0 mg Excipients q.s. Approved colour to be used |
| Amlodipine and Nebivolol Tablets IP | Cardiovascular | Each uncoated tablet contains : Amlodipine Besylate IP Eq. to Amlodipine 5 mg Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Approved colour to be used |
| Atorvastatin & Clopidogrel Tablets | Cardiovascular | Each filmcoated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Clopidogrel Bisulphate BP Eq. to Clopidogrel 75 mg |
| Atorvastatin & Clopidogrel Tablets | Cardiovascular | Each filmcoated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Clopidogrel Bisulphate BP Eq. to Clopidogrel 75 mg |
| Atorvastatin & Ezetimibe Tablets | Cardiovascular | Each film coated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Ezetimibe IP 10 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Atorvastatin & Fenofibrate Tablets | Cardiovascular | Each filmcoated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Fenofibrate IP 160 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Atorvastatin Tablets IP | Cardiovascular | Each film coated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| Atorvastatin Tablets IP | Cardiovascular | Each filmcoated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Atorvastatin Tablets IP | Cardiovascular | Each filmcoated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 30 mg Colour: Erythrosine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Atorvastatin Tablets IP | Cardiovascular | Each filmcoated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 40 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Titanium Dioxide IP |
| Atorvastatin Tablets IP | Cardiovascular | Each film coated tablet contains : Atorvastatin Calcium IP eq. to Atorvastatin 80 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Atorvastatin and Aspirin tablets | Cardiovascular | Each Film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin IP 10 mg Aspirin IP 75 mg Excipients q.s. Approved coloured be used |
| Benedipine Hydrochloride & Telmisartan Tablets | Cardiovascular | Each film coated bilayered tablets contains Benedipine Hydrochloride 4 mg Telmisartan IP 40 mg Excipients q.s. Approved colour to be used |
| Cilnidipine & Telmisartan Tablets | Cardiovascular | Each film coated tablet contains : Cilnidipine IP 10 mg Telmisartan IP 40 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Cilnidipine Tablets IP 10 mg | Cardiovascular | Each film coated tablets contains: Cilnidipine IP 10 mg Approved colour use |
| Cilnidipine Tablets IP 20 mg | Cardiovascular | Each film coated tablets contains : Cilnidipine IP 20 mg Approved colour to be used |
| Cilnidipine Tablets IP 5 mg | Cardiovascular | Each film coated tablets contains: Cilnidipine IP 5 mg Approved colour use |
| Cilnidipine and Telmisartan Metoprolol Succinate SR Tablets | Cardiovascular | Each uncoated bilayered tablet contains Cilnidipine IP 10 mg Telmisartan IP 40 mg MetoprololSuccinate IP 23.75 mg Eq.to Metoprolol Tartrate 25 mg (As sustained release) Excipients q.s. Approved color to be use |
| Cilnidipine and Telmisartan Metoprolol Succinate SR Tablets | Cardiovascular | Each uncoated bilayered tablet contains Cilnidipine IP 10 mg Telmisartan IP 40 mg Metoproioi Succinate IP 47.5 mg Eq.to Metoprolol Tartrate 50 mg (As sustained release) Excipients q.s. Approved color to be use |
| Clopidogrel Bisulphate Tablets IP | Cardiovascular | Each film coated tablet contains : Clopidogrel Bisulphate BP Eq. to Clopidogrel 75 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Indapamide (Sustained Release) and Nebivolol Hydrochloride Tablets | Cardiovascular | Each uncoated bilayered tablet contains : Indapamide IP 1.5 mg (As sustained release) Nebivolol Hydrochloride IP Eq. to Nebivolol 2.5 mg Approved colour to used |
| Indapamide (Sustained Release) and Nebivolol Hydrochloride Tablets | Cardiovascular | Each uncoated bilayered tablet contains : Indapamide IP 1.5 mg (As sustained release) Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Approved colour to be used |
| Losartan & Hydrochlorothiazide Tablets | Cardiovascular | Each film coated tablet contains : Losartan Potassium IP 50 mg Hydrochlorothiazide IP 12.5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Losartan Potassium & Atenolol Tablets | Cardiovascular | Each uncoated tablet contains : Losartan Potassium IP 50 mg Atenolol IP 5 mg Approved color to be use |
| Losartan Potassium Tablets | Cardiovascular | Each film coated tablets contains Losartan Potassium IP 100 mg Approved colour to be use |
| Losartan Potassium and Amlodipine Tablets IP | Cardiovascular | Each film coated tablet contains : Losartan Potassium IP 50 mg Amlodipine besylate IP Eq. to Amlodipine 5 mg Approved colour to used |
| Losartan Potassium and Hydrochlorothiazide Tablets IP | Cardiovascular | Each uncoated tablet contains : Losartan Potassium IP 25 mg Hydrochlorothiazide IP 5 mg |
| Losartan Potassium and Hydrochlorothiazide Tablets IP | Cardiovascular | Each film coated tablet contains : Losartan Potassium IP 25 mg Hydrochlorothiazide IP 12.5 mg Approved colour to used |
| Losartan Tablets | Cardiovascular | Each film coated tablet contains : Losartan Potassium IP 25 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Losartan Tablets | Cardiovascular | Each film coated tablet contains : Losartan Potassium IP 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Meloloprol Succinate & Amlodipine Tablets IP | Cardiovascular | Each uncoated tablet contains : Metoloprol Succinate IP 47.5 mg Amlodipine Besiylate IP Eq. to Amlodipine 5 mg |
| Metoloprol Succinate with Amlodipine Tablets | Cardiovascular | Each uncoated tablet contains : Metoloprol Succinate IP 50 mg Amlodipine Besiylate IP Eq. to Amlodipine 5 mg |
| Metoloprol Succinate with Amlodipine Tablets IP | Cardiovascular | Each uncoated tablet contains : Metoloprol Succinate IP 23.7 mg Amlodipine Besiylate IP Eq. to Amlodipine 5 mg |
| Nebivolol Hcl Tablets IP | Cardiovascular | Each uncoated tablet contains : Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Approved colour to be use |
| Nebivolol Hcl Tablets IP | Cardiovascular | Each uncoated tablet contains : Nebivolol Hydrochloride IP Eq. to Nebivolol 10 mg Approved colour to be use |
| Nebivolol Hydrochloride and Hydrochlorothiazide Tablets | Cardiovascular | Each uncoated tablet contains : Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Hydrochlorothiazide IP 12.5 mg Approved colour to used |
| Nebivolol and Telmisartan Tablets | Cardiovascular | Each film coated tablets contains Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Telmisartan IP 40 mg Approved color to be use |
| Olmesartan Medoxomil & Hydrochlorothiazide Tablets | Cardiovascular | Each uncoated tablet contains : Olmesartan Medoxomil IP 40 mg Hydrochlorothiazide IP 12.5 mg |
| Olmesartan Medoxomil & Hydrochlorothiazide Tablets | Cardiovascular | Each film coated tablet contains: Olmesartan Medoxomil IP 20 mg Hydrochlorothiazide IP 12.5 mg Colour: Brilliant Blue/ Erythrosine/ Tartraz ine / Quinoline Yellow/ Sunset yelow or Titanium Dioxide IP IApple Green /Iron oxide red,Iron oxide Yellow |
| Olmesartan Medoxomil & Hydrochlorothiazide With Amlodipine Besiylate IP | Cardiovascular | Each uncoated tablet contains : Olmesartan Medoxomil IP 40 mg Hydrochlorothiazide IP 12.5 mg Amlodipine Besiylate IP Eq. to Amlodipine 5 mg |
| Olmesartan Medoxomil Hydrochlorothiazide with Amlodipine Besiylate IP | Cardiovascular | Each uncoated tablet contains Olmesartan Medoxomil IP 40 mg Hydrochlorothiazide IP 25 mg Amlodipine Besiylate IP Eq.to Amlodipine 10 mg |
| Olmesartan Medoxomil Hydrochlorothiazide with Amlodipine Besiylate IP | Cardiovascular | Each uncoated tablet contains: Olmesartan Medoxomil IP 20 mg Hydrochlorothiazide IP 12.5 mg Amlodipine Besiylate IP Eq. to Amlodipine 5 mg |
| Olmesartan Medoxomil Hydrochlorothiazide with Amlodipine Besiylate IP | Cardiovascular | Each uncoated tablet contains: Olmesartan Medoxomil IP 5 mg Hydrochlorothiazide IP 12.5 mg Amlodipine Besiylate IP Eq. to Amlodipine 2. 5 mg |
| Olmesartan Medoxomil Hydrochlorothiazide with Amlodipine Besiylate IP | Cardiovascular | Each uncoated tablet contains: Olmesartan Medoxomil IP 40 mg Hydrochlorothiazide IP 25 mg Amlodipine Besiylate IP Eq. to Amlodipine 5 mg |
| Olmesartan Medoxomil Tablets IP | Cardiovascular | Each film coated tablet contains : Olmesartan Medoxomil IP 20 mg Permitted Color Used |
| Olmesartan Medoxomil Tablets IP | Cardiovascular | Each film coated tablet contains : Olmesartan Medoxomil IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Olmesartan Medoxomil Tablets IP | Cardiovascular | Each film coated tablet contains : Olmesartan Medoxomil IP 40 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Olmesartan Medoxomil Tablets IP | Cardiovascular | Each film coated tablet contains: Olmesartan Medoxomil IP 20 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Olmesartan Medoxomil, Chlorothiazide Tablets | Cardiovascular | Each uncoated tablet contains Olmesartan Medoxomil IP 20 mg Chlorothiazide IP 12.5 mg |
| Olmesartan Medoxomil, Chlorothiazide Tablets | Cardiovascular | Each uncoated tablet contains Olmesartan Medoxomil IP 40 mg Chlorothiazide IP 12.5 mg |
| Olmesartan, Cilnidipine with Chlorthalidone Tablets | Cardiovascular | Each film coated tablet contains Olmisartan Medoxomil IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 12.5 mg Permitted Color Used |
| Ramipiril and Amlodipine tablet | Cardiovascular | Each uncoated tablet contains : Ramipril IP 2.5mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Approved colour to be use |
| Ramipiril and Amlodipine tablet | Cardiovascular | Each uncoated tablet contains : Ramipril IP 5mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Approved colour to be use |
| Ramipiril and Amlodipine tablet | Cardiovascular | Each uncoated tablet contains : Ramipril IP 10mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Approved colour to be use |
| Rosuvastatin & Clopidogrel Tablets | Cardiovascular | Each filmcoated tablet contains : Rosuvastatin Calcium IP 20 mg eq. to Rosuvastatin Clopidogrel Bisulphate BP Eq. to Clopidogrel 75 mg |
| Rosuvastatin & Clopidogrel Tablets | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP eq. to Rosuvastatin 40 mg Clopidogrel Bisulphate BP Eq. to Clopidogrel 75 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Rosuvastatin & Fenofibrate Tablets | Cardiovascular | Each filmcoated tablet contains : Rosuvastatin Calcium IP 10 mg eq. to Rosuvastatin Clopidogrel Bisulphate BP Eq. to Clopidogrel 75 mg |
| Rosuvastatin & Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg Fenofibrale IP 160 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ |
| Rosuvastatin Tablets IP | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Rosuvastatin Tablets IP | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP eq. to Rosuvastatin 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| Rosuvastatin Tablets IP | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP eq. lo Rosuvastatin 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| Rosuvastatin Tablets IP | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP eq. lo Rosuvastatin 40 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| Rosuvastatin and Aspirin Tablets | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Aspirin IP 75 mg Approved colour to be used |
| Rosuvastatin and Aspirin Tablets | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Aspirin IP 75 mg Approved colour to be used |
| Rosuvastatin and Ezetimibe Tablets IP | Cardiovascular | Each film coated tablet contains : Ezetimibe IP 10 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 5 mg Approved coloured used |
| Rosuvastatin and Ezetimibe Tablets IP | Cardiovascular | Each film coated tablet contains : Ezetimibe IP 10 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Approved coloured used |
| Rosuvastatin and Ezetimibe Tablets IP | Cardiovascular | Each film coated tablet contains : Ezetimibe IP 10 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 40 mg Approved coloured used |
| Rosuvastatin and Fenofibrate Tablets | Cardiovascular | Each film coated tablet contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Fenofibrate IP 160 mg Approved colour to be use |
| Rosuvastatin and Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains : Fenofibrate IP 160 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 5 mg Approved coloured used |
| Rosuvastatin and Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains : Fenofibrate IP 80 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Approved coloured used |
| Rosuvastatin and Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains : Fenofibrate IP 145 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Approved coloured used |
| Rosuvastatin and Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains : Fenofibrate IP 145 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Approved coloured used |
| Rosuvastatin and Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains : Fenofibrate IP 67.5 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Approved coloured used |
| Rosuvastatin and Fenofibrate Tablets IP | Cardiovascular | Each film coated tablet contains : Fenofibrate IP 67.5 mg Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Approved coloured used |
| Telmisartan & Hydrochlorothiazide Tablets | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 80 mg Hydrochlorothiazide IP 12.5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Telmisartan Tablets IP | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 40 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Telmisartan Tablets IP | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 80 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Telmisartan With Amlodipine Besylate Tablets | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 40 mg Amlodipine Besylate BP Eq. to Amlodipine 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Telmisartan With Hydrochlorothiazide Tablets IP | Cardiovascular | Each uncoated bilayered tablet contains: Telmisartan IP 80 mg Hydrochlorothiazide IP 25 mg Excipients q . s. Approved colour to used |
| Telmisartan With Hydrochlorothiazide Tablets IP | Cardiovascular | Each uncoated bilayered tablet contains: Telmisartan IP 80 mg Hydrochlorothiazide IP 12.5 mg Excipients q . s. Approved colour to used |
| Telmisartan and Amlodioine Tablets IP | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 80 mg Amlodipine Besylate IP Eq. to Amlodipine 10 mg |
| Telmisartan and Ramipiril Tablets | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 40 mg Ramipril IP 5 mg Approved colour to used |
| Telmisartan and Ramipiril Tablets | Cardiovascular | Each uncoated tablet contains : Telmisartan IP 40 mg Ramipril IP 2.5 mg Approved colour to used |
| Telmisartan with Chlorthalidone Tablets | Cardiovascular | Each film coated tablet contains Telmisartan IP 40 mg Chlorthalidone IP 6.25 mg Permitted Color Used |
| Telmisartan with Chlorthalidone Tablets | Cardiovascular | Each film coated tablet contains Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Permitted Color Used |
| Telmisartan with Chlorthalidone Tablets | Cardiovascular | Each film coated tablet contains Telmisartan IP 80 mg Chlorthalidone IP 6.25 mg Permitted Color Used |
| Telmisartan with Hydrochlorothazide | Cardiovascular | Each film coated tablet contains Telmisartan IP 40 mg Hydrochlorothazide IP 12.5 mg Permitted Color Used |
| Telmisartan, Amlodioine and Hydrochlorothiazide Tablets | Cardiovascular | Each uncoated tablet contains: Telmisartan IP 20 mg Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Hydrochlorothiazide IP 6.25 mg |
| Telmisartan, Chlorthalidone and Metoprolol (ER) Tablets | Cardiovascular | Each film coated tablet contains Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 47.5 mg Eq.to Metoprolol Tartrate 50 mg Approved colour to be used |
| Telmisartan, Chlorthalidone and Metoprolol Tablets | Cardiovascular | Each film coated tablet contains Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 23.75 mg Eq.to Metoprolol Tartrate 25 mg Approved colour to be used |
| Telmisartan, Hydrochlorothiazide and Amlodipine Tablets | Cardiovascular | Each film coated tablets contains Telmisartan IP 40 mg Hydrochlorothiazide IP 12.5 mg Amlodipine Besylate IP Eq.to Amlodipine 5 mg Approved colour to be used |
| Deflazacort Tablets | Corticosteroid | Each uncoated tablet contains : Deflazacort IP 6 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Deflazacort Tablets | Corticosteroid | Each uncoated tablet contains : Deflazacort 12 mg Excipients q.s. |
| Deflazacort Tablets | Corticosteroid | Each uncoated tablet contains : Deflazacort 18 mg Excipients q.s. |
| Deflazacort Tablets | Corticosteroid | Each uncoated tablet contains : Deflazacort 24 mg Excipients q.s. |
| Dexamethasone Tablets | Corticosteroid | Each uncoated tablet contains: Dexomethasone IP 2 mg |
| Dexamethasone Tablets IP | Corticosteroid | Each uncoated tablet contains : Dexamethasone IP 0.50 mg Excipients q.s. |
| Dexamethasone tablets | Corticosteroid | Each uncoated tablet contains : Dexamethasone IP 4 mg |
| Dexamethasone tablets | Corticosteroid | Each uncoated tablet contains : Dexamethasone IP 8 mg |
| Hydrocortisone Tablets USP 10 mg | Corticosteroid | Each Uncoated tablet contains: Hydrocortisone IP 10 mg |
| Hydrocortisone Tablets USP 20 mg | Corticosteroid | Each Uncoated tablet contains: Hydrocortisone IP 20 mg |
| Hydrocortisone Tablets USP 5 mg | Corticosteroid | Each Uncoated tablet contains: Hydrocortisone IP 5 mg |
| Methylprednisolone Tablets IP 16 mg. | Corticosteroid | Each uncoated tablet contains : Methylprednisolone IP 16 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Methylprednisolone Tablets IP 4 mg. | Corticosteroid | Each uncoated tablet contains : Methylprednisolone IP 4 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Methylprednisolone Tablets IP 8 mg. | Corticosteroid | Each uncoated tablet contains : Methylprednisolone IP 8 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Prednisolone Tablets IP | Corticosteroid | Each uncoated tablet contains : Prednisolone IP 5 mg Excipients q.s. |
| Prednisolone Tablets IP | Corticosteroid | Each uncoated tablet contains : Prednisolone IP 10 mg Excipients q.s. |
| Prednisolone Tablets IP | Corticosteroid | Each uncoated tablet contains Prednisolone IP 20 mg |
| Avanafil and Dapoxetine HCI Tablets | Erectile Dysfunction | Each film coated tablet contains : Avanafil 50 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 30 mg Approved colour to be used |
| Avanafil and Dapoxetine HCI Tablets | Erectile Dysfunction | Each film coated tablet contains : Avanafil 100 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 60 mg Approved colour to be used |
| Avanafil and Dapoxetine HCI Tablets | Erectile Dysfunction | Each film coated tablet contains : Avanafil 200 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 60 mg Approved colour to be used |
| Dapoxetine Tablets | Erectile Dysfunction | Each film coated tablet contains : Dapoxetine Hydrochloride IP eq. to Dapoxetine 60 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Dapoxetine Tablets | Erectile Dysfunction | Each film coated tablet contains : Dapoxetine Hydrochloride IP eq. to Dapoxetine 30 mg Colour: Brilliant Blue/Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| SILDENAFIL CITRATE ORALLY DISINTEGRATING TABLETS | Erectile Dysfunction | Each orally disintegrating tablet contains : Sildenafil Citrate IP Equivalent to Sildenafil 25 mg Excipients q.s. Approved colour to be used |
| SILDENAFIL CITRATE ORALLY DISINTEGRATING TABLETS | Erectile Dysfunction | Each orally disintegrating tablet contains : Sildenafil Citrate IP Equivalent to Sildenafil 50 mg Excipients q.s. Approved colour to be used |
| Sildenafil Chewable Tablets | Erectile Dysfunction | Each uncoated chewable tablet contains : Sildenafil Citrate IP Eq. to Sildenfil 100 mg Approved colour to be used |
| Sildenafil Citrate & Dapoxetine HCl Tablets | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Eq. to Sildenafil 100 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 60 mg Excipients q.s. Approved colour to used |
| Sildenafil Citrate & Dapoxetine HCl Tablets | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Eq. to Sildenafil 100 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 30 mg Excipients q.s. Approved colour to be used |
| Sildenafil Citrate & Dapoxetine Hcl Tablets | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Eq. to Sildenafil 50 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 30 mg Approved colour to used |
| Sildenafil Citrate Orally Disintegrating Tablets | Erectile Dysfunction | Each orally disintegrating tablet contains : Sildenafil Citrate IP Equivalent to Sildenafil 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Sildenafil Citrate Tablets IP | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Equivalent to Sildenafil 25 mg Permitted Color Used |
| Sildenafil Citrate Tablets IP 100 mg | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Equivalent to Sildenafil 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Sildenafil Citrate Tablets IP 50 mg | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Equivalent to Sildenafil 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide ip /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Sildenafil Citrate tablets | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Eq. to Sildenafil 150 mg Approved coloured used |
| Sildenafil Citrate tablets | Erectile Dysfunction | Each film coated tablet contains : Sildenafil Citrate IP Eq. to Sildenafil 200 mg Approved coloured used |
| Tadalafil Orally Tablets Disintegrating Tablets | Erectile Dysfunction | Each orally disintegrating tablet contains : Tadalafil IP 20 mg Approved colour lo used |
| Tadalafil Tablets | Erectile Dysfunction | Each film coated tablel contains Tadalafil IP 2.5 mg Approved colour to used |
| Tadalafil Tablets | Erectile Dysfunction | Each film coated tablel contains Tadalafil IP 5 mg Approved colour to used |
| Tadalafil Tablets | Erectile Dysfunction | Each film coated tablel contains Tadalafil IP 10 mg Approved colour to used |
| Tadalafil Tablets USP | Erectile Dysfunction | Each film coated tablet contains : Tadalafil Citrate IP Equivalent to Tadalafil 20 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide yellow |
| Tadalafil With Dapoxetine Tablets | Erectile Dysfunction | Each film coated tablet contains : Tadalafil Citrate IP Equivalent to Tadalafil 20 mg Dapoxetine Hydrochloride IP eq. to Dapoxetine 30 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Tadalafil With Dapoxetine Tablets | Erectile Dysfunction | Each film coated tablet contains : Tadalafil IP 10 mg Dapoxetine Hydrochloride IP eq. to Dapoxetine 30 mg Approved colour to used |
| Udenafil & Dapoxetine Hcl Tabłets | Erectile Dysfunction | Each film coated tablet contains : Udenafil IP 100 Mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 60 mg Excipients q.s. Approved colour to be used |
| Vardenafil & Dapoxetine HCI Tablets | Erectile Dysfunction | Each film coated tablet contains : Vardenafil Hydrochloride Eq. to Vardenafil 20 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 60 mg Approved colour to be used |
| Cinnarizine and Domperidone Tablets | Gastrointestinal & Antacid | Each uncoated tablets contains Cinnarizine IP 20 mg Domperidone IP 15 mg Excipients q.s. Approved color to be use |
| Domperidone Dispersible Tablets IP | Gastrointestinal & Antacid | Each dispersible tablet contains : Domperidone IP 10 mg Colour: Brilliant Blue/Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Domperidone Tablets IP | Gastrointestinal & Antacid | Each uncoated tablet contains : Domperidone IP 10 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Domperidone Tablets IP | Gastrointestinal & Antacid | Each uncoated tablet contains : Domperidone Maleate IP eq.to Domperidone 10 mg Colour: Brilliant Blue/ Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Esomeprazole Tablets IP | Gastrointestinal & Antacid | Each enteric-coated tablet contains :- Esomeprazole magnesium trihydrate IP Eq. to Esomeprazole 40 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Famotidine Tablets IP 20 mg | Gastrointestinal & Antacid | Each film coated tablet contains : Famotidine IP 20 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Famotidine Tablets IP 40 mg | Gastrointestinal & Antacid | Each film coated tablet contains : Famotidine IP 40 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Magnesium Hydroxide, Dried Aluminium Hydroxide With Dried Aluminium Hydroxide Gel, Simethicone, Titanium Dioxide | Gastrointestinal & Antacid | Each uncoated chewable tablet contains : Magnesium Hydroxide IP 250 mg Dried Aluminium Hydroxide Gel IP 250 mg Simethicone IP 25 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron Oxide Yollow |
| Magnesium Hydroxide, Dried Aluminium Hydroxide With Simethicone ( Actvated Dimethicone) | Gastrointestinal & Antacid | Each Uncoated chewable tablet contains: Magnesium Hydroxide IP 250 mg Dried Aluminium Hydroxide Gel IP 250 mg Simethicone (Activated Dimethicone) IP 50 mg Excipients q.s. Approved colour to be used |
| Magnesium Trisilicate & Dried Aluminium Hydroxide | Gastrointestinal & Antacid | Each chewable tablet contains : Magnesium Trisilicate IP 250 mg Dried Aluminium Hydroxide Gel IP 120 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Ondansetron Hydrochloride Tablets IP | Gastrointestinal & Antacid | Each uncoated tablet contains : Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ondansetron Hydrochloride Tablets IP | Gastrointestinal & Antacid | Each uncoated tablet contains: Ondansetron Hydrochloride IP eq. to Ondansetron 8 mg Approved colour to be used |
| Ondansetron Orally Disintegrating Tablets IP | Gastrointestinal & Antacid | Each orally disintegrating tablets contains : Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg Colour: Brilliant Blue/Erythrosine/Tartrazine/Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ondansetron Orally Disintegrating Tablets IP | Gastrointestinal & Antacid | Each orally disintegrating tablet contains: Ondansetron Hydrochloride IP eq. to Ondansetron 8 mg Approved colour to be used |
| Pantoprazole & Domperidone Tablets | Gastrointestinal & Antacid | Each enteric coated tablet contains : Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40mg Domperidone IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red, iron oxide kllow |
| Pantoprazole & Domperidone Tablets | Gastrointestinal & Antacid | Each enteric coated tablet contains: Pantoprazole Sodium Sesquihydrate IP Eq. lo Pantoprazole 20 mg Domperidone IP 10 mg Approved colour to used |
| Pantoprazole Dual-release gastro-resistant Tablets | Gastrointestinal & Antacid | Each Dual-release gastro-resistant tablet contains : Pantoprazole Sodium IP 80 mg Eq.to Pantoprazole Approved colour to be used |
| Pantoprazole Sodium Gastro-Resistant Tablets IP 20 mg | Gastrointestinal & Antacid | Each enteric coated tablet contains : Pantoprazole Sodium IP Eq. to Pantoprazole 20 mg Excipients q.s. Approved colour to be used |
| Pantoprazole Tablets | Gastrointestinal & Antacid | Each enteric coated tablet contains : Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Rabeprazole Sodium & Domperidone Tablets IP | Gastrointestinal & Antacid | Each enteric-coated tablet contains: Rabeprazole Sodium IP 20 mg Domperidone IP 10 mg Colour: Brilliant Blue / Erythrosine/ Tartraz ine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP IApple Green / Iron oxide red,Iron oxide Yellow |
| Rabeprazole Sodium Tablets IP | Gastrointestinal & Antacid | Each enteric-coated tablet contains Rabeprazole Sodium IP 20 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP IApple Green / Iron oxide red, ron oxide Yellow |
| Ranitidine Hydrochloride & Domperidone Tablets | Gastrointestinal & Antacid | Each film coated tablet contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg Domperidone IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red Iron oxide Yellow |
| Ranitidine Hydrochloride Tablets IP | Gastrointestinal & Antacid | Each film coated tablet contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ranitidine Hydrochloride Tablets IP | Gastrointestinal & Antacid | Each film coated tablet contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 300 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Ranitidine Hydrochloride, Dicyclomine Hydrochloride & | Gastrointestinal & Antacid | Each film coated tablet contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg Dicyclomine Hydrochloride IP 10 mg Simethicone IP 20 mg Excipients qs Approved colour to be used |
| Ranitidine Hydrochloride, Dicyclomine Hydrochloride & Simethicone Tablets | Gastrointestinal & Antacid | Each film coated tablets contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg Dicyclomine Hydrochloride IP 10 mg Simethicone IP 20 mg |
| Ranitidine Hydrochloride, Domperidone & | Gastrointestinal & Antacid | Each film coated tablet contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg Domperidone IP 10 mg Simethicone IP 20 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Sucralfate Tablet IP | Gastrointestinal & Antacid | Each uncoated tablet contains Sucralfate IP 1000 mg |
| Sucralfate Tablets | Gastrointestinal & Antacid | Each uncoated tablet contains : Sucralfate IP 500 mg Approved colour to used |
| Acetylcysteine 600 mg Effervescent Tablets | General / Unclassified | Each Effervescent tablet contains : Acetylcysteine BP 600 mg Excipients q.s. |
| Acetylsalicylic Acid Tablets IP | General / Unclassified | Each uncoated tablet contains: Acetylsalicylic Acid IP 300 mg |
| Activated Charcoal & Simethicone Tablets | General / Unclassified | Each film coated tablets contains : Activated Charcoal IP 250 mg Simethicone IP 80 mg Excipients q.s. Approved colour to used |
| Activated Charcoal & Simethicone Tablets | General / Unclassified | Each Dual coated tablets contains : Outer layer (Sugar Coated for Gastric release) Simethicone IP 80 mg Inner layer (Enteric Coated for Intestinal release) Activated Charcoal IP 250 mg Excipients q.s. Approved colour to used |
| Allopurinol Tablets IP 100 mg | General / Unclassified | Each uncoated tablets contains Allopurinol IP 100 mg Excipients q.s. Approved colour to be used |
| Allopurinol Tablets IP 300 mg | General / Unclassified | Each uncoated tablets contains Allopurinol IP 300 mg Approved colour to be used |
| Allylestrenol Tablets | General / Unclassified | Each film coated tablet contains: Allylestrenol IP 5mg Approved colour to used |
| Amiloride Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Amiloride Hydrochloride IP Eq. to Anhydrous Amiloride Hydrochloride 5 mg Approved colour to used |
| Amiloride Hydrochloride and Hydrochlorothiazide Tablets IP | General / Unclassified | Each uncoated tablet contains : Amiloride Hydrochloride IP Eq. to Anhydrous Amiloride Hydrochloride 2.5 mg Hydrochlorothiazide 25 mg Approved colour to used |
| Amiloride Hydrochloride and Hydrochlorothiazide Tablets IP | General / Unclassified | Each uncoated tablet contains : Amiloride Hydrochloride IP Eq. to Anhydrous Amiloride Hydrochloride 5 mg Hydrochlorothiazide IP 50 mg Approved colour to used |
| Aminophylline Tablets IP | General / Unclassified | Each uncoated tablet contains: Aminophylline Eq, to Anhydrous Aminophylline IP 100 mg |
| Amiodarone Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains : Amiodarone Hydrochloride IP 100 mg |
| Amisulpride (Sustained Release) Tablets | General / Unclassified | Each uncoated sustained released tablet contains: Amisulpride IP 200 mg Approved colour to used |
| Amisulpride (Sustained Release) Tablets | General / Unclassified | Each uncoated sustained released tablet contains: Amisulpride IP 400 mg Approved colour to used |
| Amisulpride Tablets IP | General / Unclassified | Each uncoated tablet contains : Amisulpride IP 50 mg Approved colour to used |
| Amisulpride Tablets IP | General / Unclassified | Each uncoated tablet contains : Amisulpride IP 100 mg Approved colour to used |
| Amisulpride Tablets IP | General / Unclassified | Each uncoated tablet contains : Amisulpride IP 200 mg Approved colour to used |
| Amisulpride Tablets IP | General / Unclassified | Each uncoated tablet contains : Amisulpride IP 400 mg Approved colour to used |
| Amodiaquine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Amodiaquine Hydrochloride IP Eq. to Amodiaquine 200 mg Approved colour to used |
| Analgin Tablets IP | General / Unclassified | Each uncoated tablet contains : Analgin IP 500 mg |
| Apixaban Tablets | General / Unclassified | Each film coated tablet contains : Apixaban 2.5 mg Approved colour to used |
| Apixaban Tablets | General / Unclassified | Each film coated tablet contains : Apixaban 5 mg Approved colour to used Each uncoated tablet contains: |
| Apixaban Tablets 2.5 mg | General / Unclassified | Each film coated tablet contains : Apixaban IP 2.5 mg Approved colour to used |
| Apixaban Tablets 5 mg | General / Unclassified | Each film coated tablet contains : Apixaban IP 5 mg Approved colour to used |
| Aripiprazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Aripiprazole IP 5 mg Approved colour to used |
| Aripiprazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Aripiprazole IP 10 mg Approved colour to used |
| Aripiprazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Aripiprazole IP 15 mg Approved colour to used |
| Aripiprazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Aripiprazole IP 20 mg Approved colour to used |
| Aripiprazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Aripiprazole IP 30 mg Approved colour to used |
| Armodafinil Tablets | General / Unclassified | Each uncoated tablet contains : Armodafinil IP 50 mg Approved colour to be used |
| Armodafinil Tablets | General / Unclassified | Each uncoated tablet contains : Armodafinil IP 150 mg Approved colour to be used |
| Armodafinil Tablets | General / Unclassified | Each uncoated tablet contains : Armodafinil IP 250 mg Approved colour to be used |
| Artemether With Lumefantrine Tablets | General / Unclassified | Each uncoated tablet contains: Artemether IP 20 mg Lumefantrine 120 mg Excipients q . s. |
| Artemether With Lumefantrine Tablets | General / Unclassified | Each uncoated tablet contains: Artemether IP 60 mg Lumefantrine 360 mg Excipients q.s. |
| Artemether With Lumefantrine Tablets | General / Unclassified | Each uncoated tablet contains: Artemether IP 40 mg Lumefantrine IP 240 mg Excipients q.s. |
| Artemether With Lumefantrine Tablets | General / Unclassified | Each uncoated tablet contains: Artemether IP 80 mg Lumefantrine IP 480 mg Excipients q.s. |
| Artesunate Tablets | General / Unclassified | Each uncoated tablet contains Artesunate IP 100 mg |
| Ascorbic Acid Tablets | General / Unclassified | Each uncoated chewable tablet contains : Ascorbic acid IP 50 mg Approved colour to be used |
| Ascorbic Acid Tablets IP | General / Unclassified | Each uncoated tablet contains : Ascorbic Acid IP 100 mg Excipients q.s. |
| Atenolol Tablets IP 25 mg | General / Unclassified | Each uncoated tablet contains : Atenolol IP 25 mg |
| Atenolol Tablets IP 50 mg | General / Unclassified | Each uncoated tablet contains : Atenolol IP 50 mg |
| Atomoxetine Tablets 10 mg | General / Unclassified | Each film coated tablet contains: Atomoxetine Hydrochloride IP Equivalent to Atomoxetine 10 mg Approved colour to be used |
| Avanafil Tablets | General / Unclassified | Each film coated tablet contains : Avanafil 50 mg Approved colour to used |
| Avanafil Tablets | General / Unclassified | Each filmcoated tablet contains : Avanafil 100 mg Approved colour to used |
| Avanafil Tablets | General / Unclassified | Each filmcoated tablet contains : Avanafil 200 mg Approved colour to used |
| Azilsartan Medoxomil Tablets | General / Unclassified | Each film coated tablet contains : Azilsartan Kamedoxomil Eq. Azilsartan Medoxomil 10 mg Approved coloured used |
| Azilsartan Medoxomil Tablets | General / Unclassified | Each film coated tablet contains : Azilsartan Kamedoxomil Eq. Azilsartan Medoxomil 20 mg Approved coloured used |
| Azilsartan Medoxomil Tablets | General / Unclassified | Each uncoated tablet contains: Azilsartan Kamedoxomil Eq. to Azilsartan Medoxomil 40 mg Approved colour to used |
| Azilsartan Medoxomil Tablets | General / Unclassified | Each uncoated tablet contains: Azilsartan Kamedoxomil Eq. to Azilsartan Medoxomil 80 mg Approved colour to used |
| Benidipine Hydrochloride Tablets | General / Unclassified | Each film coated tablet contains Benidipine Hydrochloride JP 4 mg Excipients q.s. Approved color to be use |
| Benidipine Hydrochloride Tablets | General / Unclassified | Each film coated tablet contains Benidipine Hydrochloride JP 8 mg Excipients q.s. Approved color to be use |
| Betahistine Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains : Betahistine Hydrochloride IP 16 mg |
| Betahistine Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains : Betahistine Hydrochloride IP 24 mg |
| Betahistine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains Betahistine Hydrochloride IP 8 mg |
| Betahistine Hydrochloride tablet IP | General / Unclassified | Each uncoated tablet contains : Betahistine Hydrochloride IP 8 mg |
| Betamethasone Sodium Phosphate Tablets IP | General / Unclassified | Each uncoated tablet contains : Betamethasone Sodium Phosphate IP Equivalent to Betamethasone 0.50 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Betamethasone Tablets IP | General / Unclassified | Each uncoated tablet contains : Betamethasone IP 0.50 mg Excipients q.s. |
| Bilastine Tablets | General / Unclassified | Each uncoated tablet contains: Bilastine 20mg Approved colour to used |
| Bilastine Tablets | General / Unclassified | Each uncoated tablet contains: Bilastine 40 mg Approved colour to used |
| Bisacodyl Tablets IP | General / Unclassified | Each film coated tablet contains : Bisacodyl IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Bisacodyl Tablets IP | General / Unclassified | Each enteric-coated tablet contains Bisacodyl IP 5 mg Colour: Brilliant Blue l Erythrosine / Tartraz ine /Quinoline Yellow/ Sunset yellow or Titaniuin Dioxide IP IApple Green / Iron oxide red,Iron oxide Yeld |
| Brivaracetam Tablets IP 100mg | General / Unclassified | Each film coated tablets contains : Brivaracetam IP 100 mg Approved colour to be used |
| Brivaracetam Tablets IP 50mg | General / Unclassified | Each film coated tablets contains : Brivaracetam IP 50 mg Approved colour to be used |
| Brivaracetam Tablets IP 75mg | General / Unclassified | Each film coated tablets contains : Brivaracetam IP 75 mg Approved colour to be used |
| Bromazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Bromazepam BP 1.5 mg Excipients q.s. |
| Bromazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Bromazepam BP 3 mg Excipients q.s. |
| Bromazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Bromazepam BP 6 mg Excipients q.s. |
| Bromhexine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains Bromhexine Hydrochloride IP 4 mg Colour : Erythrosine /Sunset Yellow /Quinoline Yellow |
| Bromhexine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Bromhexine Hydrochloride IP 8 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Buprenorphine Hydrochloride & Naloxone Sublingual Tablets IP | General / Unclassified | Each uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Eq. to Buprenorphine 0.4 mg Naloxone Hydrochloride IP Eq. to Naloxone 0.1 mg Approved colour to be use |
| Buprenorphine Hydrochloride & Naloxone Sublingual Tablets IP | General / Unclassified | Each uncoated sublingual tablet contains Buprenorphine Hydrochloride IP Eq. to Buprenorphine 2 mg Naloxone Hydrochloride IP Eq. to Naloxone 0.5 mg Approved colour to be use |
| Buprenorphine Hydrochloride & Naloxone Tablets | General / Unclassified | Each uncoated tablet contains : Buprenorphine Hydrochloride IP Eq. to Buprenorphine 2 mg Naloxone Hydrochloride IP Eq. to Naloxone 0.4 mg Approved colour to be use |
| Buprenorphine Hydrochloride & Naloxone Tablets | General / Unclassified | Each uncoated tablet contains : Buprenorphine Hydrochloride IP Eq. to Buprenorphine 0.5 mg Naloxone Hydrochloride IP Eq. to Naloxone 0.1 mg Approved colour to be use |
| Buprenorphine Hydrochloride & Sublingual Tablets IP | General / Unclassified | Each uncoated sublingul tablet contains: Buprenorphine Hydrochloride IP Eq. to Buprenorphine 200 ug Approved colour to be use |
| Buprenorphine Hydrochloride & Sublingual Tablets IP | General / Unclassified | Each uncoated sublingul tablet contains: Buprenorphine Hydrochloride IP Eq. to Buprenorphine 400 ug Approved colour to be use |
| Cabergoline Tablets IP 0.5 mg | General / Unclassified | Each Uncoated tablet contains: Cabergoline IP 0.5 mg Excipients q.s. |
| Cabergoline Tablets IP 1 mg | General / Unclassified | Each Uncoated tablet contains: Cabergoline IP 1 mg Excipients q.s. |
| Captopril Tablets IP | General / Unclassified | Each film coated tablet contains: Captopril IP 25 mg |
| Carisoprodol Tablets IP | General / Unclassified | Each uncoated tablet contains: Carisoprodol IP 350 mg Approved colour to be used |
| Carisoprodol Tablets IP | General / Unclassified | Each uncoated tablet contains: Carisoprodol IP 500 mg Approved colour to be used |
| Carvedilol Tablets IP | General / Unclassified | Each uncoated tablet contains Carvedilol IP 3.125 mg |
| Carvedilol Tablets IP | General / Unclassified | Each uncoated tablet contains Carvedilol IP 6.25 mg |
| Carvedilol Tablets IP | General / Unclassified | Each uncoated tablet contains Carvedilol IP 12.5 mg |
| Cefdinir Tablets 300 mg | General / Unclassified | Each film coated tablet contains : Cefdinir IP 300 mg Excipients q.s. Approved color to be use |
| Cefdinir dispersible Tablets 125 mg | General / Unclassified | Each dispersible uncoated tablet contains Cefdinir IP 125 mg Excipients q.s. Approved color to be use |
| Cetrizine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains Cetirizine Hydrochloride IP 5 mg Excipients q.s. |
| Chloramphenicol Tablets | General / Unclassified | Each sugar coated tablet contains : Chloramphenicol IP 250 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iror oxide Yellow |
| Chlordiazepoxide & Trifluoperazine Tablets | General / Unclassified | Each film coated tablet contains : Chlordiazepoxide IP 10 mg Trifluoperazine Hydrochloride IP eq. to Trifluoperazine 1 mg Approved colour to be used |
| Chlordiazepoxide Tablets IP | General / Unclassified | Each film coated tablet contains : Chlordiazepoxide IP 5 mg Approved colour to be used |
| Chloroquine Phosphate Tablets IP | General / Unclassified | Each film coated tablet contains : Chloroquine Phosphate IP 250 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Chloroquine Tablets IP | General / Unclassified | Each film coated tablet contains : Chloroquine Sulphate IP 100 mg Approved colour to be use |
| Chloroquine Tablets IP | General / Unclassified | Each film coated tablet contains : Chloroquine Sulphate IP 500 mg Approved colour to be use |
| Chlorpromazine Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Chlorpromazine Hydrochloride IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Chlorthalidone Tablets | General / Unclassified | Each uncoated tablet contains Chlorthalidone IP 6.25 mg |
| Chlorthalidone Tablets | General / Unclassified | Each uncoated tablet contains Chlorthalidone IP 12.50 mg |
| Chlorthalidone Tablets IP | General / Unclassified | Each uncoated tablet contains : Chlorthalidone IP 50 mg Permitted Color Used |
| Cinitapride Tablets | General / Unclassified | Each uncoated tablet contains : Cinitapride Hydrogen Tartrate Eq. to Cinitapride 1 mg Approved colour to be used |
| Cinitapride Tablets | General / Unclassified | Each uncoated tablet contains : Cinitapride Hydrogen Tartrate Eq. to Cinitapride 3 mg Approved colour to be used |
| Cinnarizine & Dimenhydrinate Tablets | General / Unclassified | Each uncoated tablet contains : Cinnarizine IP 20 mg Dimenhydrinate BP 40 mg Excipients q.s. Approved colour to be used |
| Cinnarizine Tablets | General / Unclassified | Each uncoated tablets contains Cinnarizine IP 15 mg Excipients q.s. Approved colour to be used |
| Cinnarizine Tablets IP | General / Unclassified | Each film coated tablet contains Cinnarizine Hydrochloride IP 25 mg Colour: Brilliant Blue / Erythrosine /Tartrazine |
| Cinnarizine and Dimenhydrinate Mouth dissolving Tablets | General / Unclassified | Each orally disintegrating tablets contains Cinnarizine IP 20 mg Dimenhydrinate IP 40 mg Excipients q.s. Approved color to be use |
| Citalopram Tablets IP | General / Unclassified | Each uncoated tablet contains: Citalopram Hydrobromide IP Eq. to Citalopram 10 mg Approved colour to be used |
| Citalopram Tablets IP | General / Unclassified | Each uncoated tablet contains: Citalopram Hydrobromide IP Eq. to Citalopram 20 mg Approved colour to be used |
| Citalopram Tablets IP | General / Unclassified | Each uncoated tablet contains: Citalopram Hydrobromide IP Eq. to Citalopram 40 mg Approved colour to be used |
| Clarithromycin Tablets IP | General / Unclassified | Each film coated tablet contains : Clarithromycin IP 250 mg Approved colour to used |
| Clarithromycin Tablets IP | General / Unclassified | Each film coated tablet contains : Clarithromycin IP 500 mg Approved colour to used |
| Clenbuterol Hydrochioride Tablets | General / Unclassified | Each uncoated tabiets contains Clenbuterol Hydrochloride BP 0.02 mg Approved colour to be used |
| Clidinium Bromide and Chlordiazepoxide Tablets | General / Unclassified | Each film coated tablet contains: Clidinium Bromide USP 2.5 mg Chlordiazepoxide IP 5 mg Excipients q.s. Approved colour to be used |
| Clindamycin Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Clindamycin Hydrochloride IP Eq. to Clindamycin 150 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Clindamycin Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Clindamycin Hydrochloride IP Eq. to Clindamycin 300 mg Colour: Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Clobazam Tablets IP | General / Unclassified | Each uncoated tablet contains : Clonazepam IP 5 mg Excipients q.s. |
| Clobazam Tablets IP | General / Unclassified | Each uncoated tablet contains : Clonazepam IP 10 mg Excipients q.s. |
| Clobazam Tablets IP | General / Unclassified | Each uncoated tablet contains : Clonazepam IP 20 mg Excipients q.s. |
| Clomipramine Hydrochloride (sustained relesed) Tablets | General / Unclassified | Each uncoated tablet contains Clomipramine Hydrochloride IP 75 mg (As sustained release) Excipients q.s. Approved coloured to be used |
| Clomipramine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains Clomipramine Hydrochloric IP 50 mg |
| Clozapine Tablets IP | General / Unclassified | Each uncoated tablet contains : Clozapine IP 25 mg Excipients q.s. |
| Clozapine Tablets IP | General / Unclassified | Each uncoated tablet contains : Clozapine IP 50 mg Excipients q.s. |
| Clozapine Tablets IP | General / Unclassified | Each uncoated tablet contains : Clozapine IP 100 mg Excipients q.s. |
| Co-Trimoxazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Trimethoprim IP 80 mg Sulphamethoxazole IP 400 mg |
| Co-Trimoxazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Trimethoprim IP 160 mg Sulphamethoxazole IP 800 mg |
| Co-Trimoxazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Trimethoprim IP 40 mg Sulphamethoxazole IP 200 mg |
| Cyanocobalamin Tablets IP | General / Unclassified | Each uncoated tablet contains : Cyanocobalamin IP 10 mcg Excipients q.s. Colour – Tartrazine & Sunset Yellow FCF. |
| Cyclobenzaprine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains: Cyclobenzaprine Hydrochloride IP 10 mg Excipients q.s. |
| Cyclobenzaprine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains: Cyclobenzaprine Hydrochloride IP 5 mg Excipients q.s. |
| Cynocobalamin Tablets IP | General / Unclassified | Each uncoated tablets contains Cynocobalamin IP 1500 mcg Excipients q.s. Approved colour to be used |
| Cyproterone Acetate Tablets IP | General / Unclassified | Each uncoated tablets contains Cyproterone Acetate IP 50 mg Approved colour to be used |
| Cyproterone Acetate and Ethinylestradiol Tablets | General / Unclassified | Each uncoated tablets contains Cyproterone Acetate IP 2 mg Ethinylestradiol IP 0.035 mg Approved colour to be used |
| Deltiazem Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains Deltiazem Hydrochloride IP 30.00 mg |
| Desvenlafaxine Extended Release Tablets | General / Unclassified | Each uncoated Extended Release tablet contains: Desvenlafaxine Succinate IP Eq. to Desvenlafaxine 50 mg Approved colour to used |
| Desvenlafaxine Extended Release Tablets | General / Unclassified | Each uncoated Extended Release tablet contains: Desvenlafaxine Succinate IP Eq. to Desvenlafaxine 100 mg Approved colour to used |
| Dexchlorphenramine Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains Dexchlorphenramine Maleate IP 2 mg Colour : Tartrazine / Sunset Yellow / Ponceau 4R |
| Diacerein with Glucosamine Tablets | General / Unclassified | Each film coated tablet contains : Diacerein IP 50 mg Glucosamine Sulphate Potassium Chloride USP 500 mg Approved colour to be use |
| Diacerein with Glucosamine Tablets | General / Unclassified | Each film coated tablet contains : Diacerein IP 50 mg Glucosamine Sulphate Potassium Chloride USP 750 mg Approved colour to be use |
| Diacerein, Glucosamine, Methylsulphonyl Methane | General / Unclassified | Each film coated tablet contains Diacerein IP 50 mg Glucosamine Sulphate Potassium IP 750 mg Methyl sulphonyl Methane USP 250 mg Excipients q.s. Approved colour to be used |
| Dicyclomine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Dicyclomine Hydrochloride IP 20 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Diethylcarbamazine Citrate Tablets IP 100 mg | General / Unclassified | Each uncoated tablet contains : Diethylcarbamazine Citrate IP 100 mg |
| Diethylcarbamazine Citrate Tablets IP 50 mg | General / Unclassified | Each uncoated tablet contains : Diethylcarbamazine Citrate IP 50 mg |
| Diiodohydroxyquinoline Tablets IP 300 mg | General / Unclassified | Each uncoated tablet contains : Diiodohydroxyquinoline IP 300 mg Approved colour to used |
| Diiodohydroxyquinoline Tablets IP 600 mg | General / Unclassified | Each uncoated tablet contains : Diiodohydroxyquinoline IP 600 mg Approved colour to used |
| Diloxanide Furoate Tablets IP 500 mg | General / Unclassified | Each uncoated tablet contains : Diloxanide Furoate IP 500 mg Approved colour to used |
| Diloxanide Furoate and Metronidazole Tablets | General / Unclassified | Each uncoated tablet contains : Diloxanide Furoate IP 500 mg Metronidazole IP 400 mg Approved colour to used |
| Diloxanide Furoate and Tinidazole Tablets | General / Unclassified | Each uncoated tablet contains : Diloxanide Furoate IP 150 mg Tinidazole IP 250 mg Approved colour to used |
| Diltiazem (SR) Tablets | General / Unclassified | Each sustain release tablet contains Diltiazem IP 90 mg |
| Diltiazem Modified Release Tablets IP | General / Unclassified | Each modified release film coated tablet contains : Diltiazem Hydrochloride IP 30 mg Approved coloured used |
| Diltiazem Modified Release Tablets IP | General / Unclassified | Each modified release film coated tablet contains : Diltiazem Hydrochloride IP 60 mg Approved coloured used |
| Diltiazem Modified Release Tablets IP | General / Unclassified | Each modified release film coated tablet contains : Diltiazem Hydrochloride IP 90 mg Approved coloured used |
| Diltiazem Sustained Release Tablets | General / Unclassified | Each film coated Sustained Release tablet contains Diltiazem Hydrochloride IP 90 mg Approved colour to be used |
| Diltiazem Sustained Release Tablets | General / Unclassified | Each film coated Sustained Release tablet contains Diltiazem Hydrochloride IP 120 mg Approved colour to be used |
| Dimenhydrinate TabletsBP 50 mg | General / Unclassified | Each Uncoated tablet contains: Dimenhydrinate BP 50 mg Excipients q.s. |
| Diosmin Tablets | General / Unclassified | Each film coated lablet contains : Diosmin (Micronised) BP 150 mg Approved colour to be use q.s. |
| Diosmin Tablets | General / Unclassified | Each film coated lablet contains : Diosmin (Micronised) BP 300 mg Approved colour to be use q.s. |
| Diphenoxylate Hydrochloride & Atropine Tablets IP | General / Unclassified | Each uncoated tablet contains : Diphenoxylate Hydrochloride IP 2.50 mg Atropine Sulphate IP 0.0250 mg Approved colour to used |
| Disulfiram Tablets IP | General / Unclassified | Each uncoated tablet contains Disulfiram IP 250 mg |
| Disulfiram Tablets IP | General / Unclassified | Each uncoated tablet contains Disulfiram IP 500 mg |
| Divalproex Sodium Extended-release Tablets IP | General / Unclassified | Each film coated Extende-release tablet contains: Divalproex sodium IP Eq. to Valproic acid 125 mg Approved colour to be used |
| Divalproex Sodium Extended-release Tablets IP | General / Unclassified | Each film coated Extende-release tablet contains: Divalproex sodium IP Eq. to Valproic acid 250 mg Approved colour to be used |
| Divalproex Sodium Extended-release Tablets IP | General / Unclassified | Each film coated Extende-release tablet contains: Divalproex sodium IP Eq. to Valproic acid 500 mg Approved colour to be used |
| Divalproex Sodium Extended-release Tablets IP | General / Unclassified | Each film coated Extende-release tablet contains: Divalproex sodium IP Eq. to Valproic acid 750 mg Approved colour to be used |
| Divalproex Sodium Extended-release Tablets IP | General / Unclassified | Each film coated Extende-release tablet contains: Divalproex sodium IP Eq. to Valproic acid 1000 mg Approved colour to be used |
| Divalproex Sodium Gastro-resistant | General / Unclassified | Each Enteric coated tablet contains: Divalproex sodium IP Eq. to Valproic acid 125 mg Approved colour to be used |
| Divalproex Sodium Gastro-resistant | General / Unclassified | Each Enteric coated tablet contains: Divalproex sodium IP Eq. to Valproic acid 250 mg Approved colour to be used |
| Divalproex Sodium Gastro-resistant | General / Unclassified | Each Enteric coated tablet contains: Divalproex sodium IP Eq. to Valproic acid 500 mg Approved colour to be used |
| Doxycyline Dispersible Tablets IP | General / Unclassified | Each uncoated dispersible tablet contains : Doxycycline Hyclate IP eq. to Doxycycline 100 mg Approved colour to be used |
| Drospirenone and Ethinylestradiol Tablets | General / Unclassified | Each uncoated tablets contains Drospirenone IP 3 mg Ethinylestradiol IP 0.035 mg Approved colour to be used |
| Drospirenone and Ethinylestradiol Tablets IP | General / Unclassified | Each uncoated tablets contains Drospirenone IP 3 mg Ethinylestradiol IP 0.03 mg Approved colour to be used |
| Drospirenone and Ethinylestradiol Tablets IP | General / Unclassified | Each uncoated tablets contains Drospirenone IP 3 mg Ethinylestradiol IP 0.02 mg Approved colour to be used |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets | General / Unclassified | Each film coated tablet contains : Drotaverine Hydrochloride IP 80 mg Mefenamic Acid IP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Drotaverine Tablets IP | General / Unclassified | Each film coated tablet contains : Drotaverine Hydrochloride IP 80 mg Approved coloured used |
| Drotaverine Tablets IP | General / Unclassified | Each film coated tablet contains : Drotaverine Hydrochloride IP 40 mg Approved coloured used |
| Drotaverine Tablets IP | General / Unclassified | Each film coated tablet contains : Drotaverine Hydrochloride IP 40 mg Approved coloured used |
| Dydrogesterone Tablets IP 10mg | General / Unclassified | Each film coated tablet conains: Dydrogesterone IP 10 mg Approved colour to be used |
| Ebastine & Phenylephrine Tablets | General / Unclassified | Each film coated tablets contains : Ebastine IP 10 mg Phenylephrine Hydrochloride IP 10 mg Excipients q.s. Approved colour to be used |
| Ebastine Tablets IP 10 mg | General / Unclassified | Each film coated tablet contains : Ebastine IP 10 mg Approved colour to used |
| Ebastine Tablets IP 20 mg | General / Unclassified | Each film coated tablet contains : Ebastine IP 20 mg Approved colour to used |
| Empagliflozin Tablets | General / Unclassified | Each film coated tablet contains Empagliflozin 10 mg Approved colour to be used |
| Empagliflozin Tablets | General / Unclassified | Each film coated tablet contains Empagliflozin 25 mg Approved colour to be used |
| Enalapril Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains: Enalapril Maleate IP 2.5 mg |
| Enalapril Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains: Enalapril Maleate IP 5 mg |
| Enalapril Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains: Enalapril Maleate IP 10 mg |
| Enalapril Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains: Enalapril Maleate IP 20 mg |
| Ephedrine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Ephedrine Hydrochloride IP 15 mg |
| Erythromycin Estolate Tablets IP | General / Unclassified | Each film coated tablet contains : Erythromycin Estolate Equivalent to Erythromycin Base IP 500 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| Erythromycin Estolate Tablets IP 500 mg. | General / Unclassified | Each uncoated tablet contains : Erythromycin Estolate Eq. to Erythromycin Base IP 500 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Erythromycin Stearate Tablets IP | General / Unclassified | Each uncoated tablet contains : Erythromycin Stearate Equivalent to Erythromycin IP 250 mg Excipients q.s. |
| Erythromycin Stearate Tablets IP | General / Unclassified | Each film coated tablet contains : Erythromycin Stearate IP Eq. to Erythromycin 500 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Erythromycin Tablets IP | General / Unclassified | Each film coated tablet contains : Erythromycin Estolate Equivalent to Erythromycin Base IP 333 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine/ uinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Erythromycin Tablets IP 250 mg. | General / Unclassified | Each uncoated tablet contains: Erythromycin Estolate Equivalent to Erythromycin Base IP 250 mg Excipients q.s. |
| Eszopiclone Tablets | General / Unclassified | Each film coated tablet contains : Eszopiclone IP 1 mg Approved colour to be used |
| Eszopiclone Tablets | General / Unclassified | Each film coated tablet contains : Eszopiclone IP 2 mg Approved colour to be used |
| Eszopiclone Tablets | General / Unclassified | Each film coated tablet contains : Eszopiclone IP 3 mg Approved colour to be used |
| Etamsylate Tablets 250 mg | General / Unclassified | Each uncoated tablet contains : Etamsylate BP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Etamsylate Tablets 250 mg | General / Unclassified | Each uncoated tablet contains : Etamsylate BP 500 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ethambutol Hydrochloride Tablets IP 200 mg | General / Unclassified | Each uncoated tablet contains : Ethambutol Hydrochloride IP 200 mg |
| Ethambutol Hydrochloride Tablets IP 400 mg | General / Unclassified | Each uncoated tablet contains : Ethambutol Hydrochloride IP 400 mg |
| Ethambutol Hydrochloride Tablets IP 800 mg | General / Unclassified | Each uncoated tablet contains : Ethambutol Hydrochloride IP 800 mg |
| Ethinylestradiol Tablets IP | General / Unclassified | Each uncoated tablet contains : Ethinylestradiol IP 10 ug Excipients q.s. |
| Ethinylestradiol Tablets IP | General / Unclassified | Each uncoated tablet contains : Ethinylestradiol IP 20 ug Excipients q.s. |
| Ethinylestradiol Tablets IP | General / Unclassified | Each uncoated tablet contains : Ethinylestradiol IP 50 ug Excipients q.s. |
| Ethionamide Tablets IP | General / Unclassified | Each film coated tablets contains : Ethionamide IP 125 mg Approved colour to be used |
| Ethionamide Tablets IP | General / Unclassified | Each film coated tablets contains : Ethionamide IP 250 mg Approved colour to be used |
| Etizolam & Propranolol Hydrochloride Tablets | General / Unclassified | Each Uncoated tablet contains: Etizolam 0.25 mg Propranolol Hydrochloride IP 20 mg Excipients q.s. Approved colour to be used |
| Etizolam Mouth Dissoving Tablets | General / Unclassified | Each uncoated tablets contains Etizolam IP 0.25 mg Approved color to be use |
| Etizolam Mouth Dissoving Tablets | General / Unclassified | Each uncoated tablets contains Etizolam IP 0.5 mg Approved color to be use |
| Etizolam Mouth Dissoving Tablets | General / Unclassified | Each uncoated tablets contains Etizolam IP 1 mg Approved color to be use |
| Etizolam Tablets | General / Unclassified | Each uncoated tablet contains Etizolam IР 0.25 mg Colour: Brilliant Blue /Tartrazine / Sunset yellow or Apple Green |
| Etizolam Tablets | General / Unclassified | Each uncoated tablet contains Etizolam IР 0.50 mg Colour: Brilliant Blue /Tartrazine / Sunset yellow or Apple Green |
| Etizolam Tablets | General / Unclassified | Each uncoated tablet contains Etizolam IP 1 mg Colour: Erythrosine /Tartrazine / Sunset yellow / Titanium Dioxide IP |
| Etizolam Tablets | General / Unclassified | Each film coated tablets contains Etizolam IP 0.25 mg Excipients q.s. Approved color to be use |
| Etizolam Tablets IP | General / Unclassified | Each film coated tablets contains Etizolam IP 0.5 mg Excipients q.s. Approved color to be use |
| Etodolac Prolonged Relesed Tablets IP | General / Unclassified | Each film coated (PR) tablet contains : Etodolac IP 200 mg Approved coloured used |
| Etodolac Prolonged Relesed Tablets IP | General / Unclassified | Each film coated (PR) tablet contains : Etodolac IP 600 mg Approved coloured used |
| Etodolac Tablets IP | General / Unclassified | Each film coated tablet contains : Etodolac IP 150 mg Approved coloured used |
| Etodolac Tablets IP | General / Unclassified | Each film coated tablet contains : Etodolac IP 200 mg Approved coloured used |
| Etodolac Tablets IP | General / Unclassified | Each film coated tablet contains : Etodolac IP 300 mg Approved coloured used |
| Etodolac Tablets IP | General / Unclassified | Each film coated tablet contains : Etodolac IP 400 mg Approved coloured used |
| Etodolac and Thiocolchicoside Tablels | General / Unclassified | Each film coated tablets conlains Etodolac IP 300 mg Thiocolchicoside IP 8 mg Approved color to be use |
| Etodolac and Tolperisone Hydrochloride Tablets | General / Unclassified | Each film coated tablets contains : Etodolac IP 400 mg Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Etofylline & Theophylline Tablets | General / Unclassified | Each uncoated tablet contains : Etofylline IP 85 77 mg Theophylline (Anhydrous) IP 2.3 mg |
| Ezetimibe Tablets IP | General / Unclassified | Each flimcoated tablet contains Ezetimibe 10 mg Permitted Color Used |
| Faropenem Sodium (ER) Tablets | General / Unclassified | Each film coated Extended Release tablet contains : Faropenem Sodium JP Eq. to Faropenem 300 mg Approved coloured used |
| Faropenem Sodium Tablets JP | General / Unclassified | Each film coated tablet contains : Faropenem Sodium JP Eq. to Faropenem 200 mg Approved coloured used |
| Febuxostat Tablets IP | General / Unclassified | Each filmcoated tablet contains : Febuxostat IP 80 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP Apple Green/Iron oxide red, Iron oxide Yellow |
| Febuxostate Tablets | General / Unclassified | Each filmcoated tablet contains : Febuxostate IP 40 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red,Iron oxide Yellow |
| Fenofibrate Tablets IP 160 mg | General / Unclassified | Each film coated tablets contains : Fenofibrate IP 160 mg Excipients q.s. Approved colour to be used |
| Fenofibrate Tablets IP 200 mg | General / Unclassified | Each film coated tablets contains : Fenofibrate IP 200 mg Excipients q.s. Approved colour to be used |
| Flavoxate Hydrochloride 100 mg | General / Unclassified | Each film coated tablets contains : Flavoxate Hydrochloride IP 100 mg Excipients q.s. Approved colour to be used |
| Flibanserin Tablets 100 mg | General / Unclassified | Each film coated tablet contains Flibanserin 100 mg Excipients q.s. Approved colour to be used |
| Flunarizine Dihydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains Flunarizine Dihydrochloride IP 10 mg |
| Flunarizine Tablets IP | General / Unclassified | Each uncoated tablet contains : Flunarizine Dihydrochloride IP Eq. to Flunarizine 5 mg |
| Flupentixol Dihydrochloride Tablets | General / Unclassified | Each film coated tablet contains Flupentixol Dihydrochloride BP eq. to Flupentixol 0.5 mg Colour: Brilliant Blue / Erythrosine /Tartrazine or Titanium Dioxide IP / Ferric Oxide Yellow |
| Flupentixol and Melitracen Tablets | General / Unclassified | Each film coated tablets contains: Flupentixol Hydrochloride BP Eq. to Flupentixol 0.5 mg Melitracen Hydrochloride Eq. to Melitracen 10 mg Approved colour to be used |
| Fluvoxamine Maleate Tablets IP | General / Unclassified | Each film coated tablet contains: Fluvoxamine Maleate IP 50 mg Approved colour to used |
| Fluvoxamine Maleate Tablets IP | General / Unclassified | Each film coated tablet contains: Fluvoxamine Maleate IP 100 mg Approved colour to used |
| Frusemide Tablets IP 40 mg | General / Unclassified | Each uncoated tablet contains : Frusemide IP 40 mg |
| Fungal Diastase, Papain , Simethicone & Niacinamide | General / Unclassified | Each film coated tablet contains : Fungal Diastase (1:800) IP 50 mg Papain IP 40 mg Simethicone IP 50 mg Niacinamide 25 mg Thiamine Mononitrate IP 2.5 mg Vitamin B2 IP 2.5 mg Excipients q.s. Colour – Black Oxide of Iron |
| Fungal Diastase, Papain With Activated Charcoal Tablets | General / Unclassified | Each film coated tablet contains : Fungal Diastase (1:800) IP 50 mg Papain IP 40 mg Activated Charcoal IP 75 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Furazolidone , Metronidazole & Dicyclomine Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains : Furazolidone IP 50 mg Metronidazole IP 200 mg Dicyclomine Hydrochloride IP 10 mg |
| Furazolidone Tablets IP | General / Unclassified | Each uncoated tablet contains : Furazolidone IP 100 mg |
| Furazolidone and Metronidazole Tablets | General / Unclassified | Each uncoated tablet contains Furazolidone IP 50 mg Metronidazole IP 100 mg Excipients q.s. |
| Gatifloxacin Tablets | General / Unclassified | Each film coated tablet contains Gatifloxacin 400 mg Approved colour to used |
| Glibenclamide Tablets IP | General / Unclassified | Each uncoated tablet contains Glibenclamide IP 5 mg |
| Glicazide Extended Release Tablets | General / Unclassified | Each uncoated extend release tablet contains Glicazide IP 30 mg |
| Glicazide Tablets IP | General / Unclassified | Each uncoated tablet contains Glicazide IP 80 mg |
| Glimepride Tablets IP | General / Unclassified | Each uncoated tablet contains Glimepride IP 1 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Glimepride Tablets IP | General / Unclassified | Each uncoated tablet contains Glimepride IP 2 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Glimepride Tablets IP | General / Unclassified | Each uncoated tablet contains Glimepride IP 3 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Glimepride Tablets IP | General / Unclassified | Each uncoated tablet contains Glimepride IP 4 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Glipizide Tablets 10 mg | General / Unclassified | Each uncoated tablet contains : Glipizide IP 10 mg |
| Glipizide Tablets IP 5 mg | General / Unclassified | Each uncoated tablet contains : Glipizide IP 5 mg |
| Glutathione Tablets | General / Unclassified | Each uncoated tablet contains : Glutathione 600 mg Exciplents q.s. |
| Glyceryl Trinitrate Tablets IP | General / Unclassified | Each uncoated tablet contains Glyceryl Trinitrate IP 500 mcg |
| Griseofulvin Tablets IP | General / Unclassified | Each uncoated tablet contains : Griseofulvin IP 125 mg Excipients q.s. |
| Griseofulvin Tablets IP | General / Unclassified | Each uncoated tablet contains : Griseofulvin IP 250 mg Excipients q.s. |
| Haloperidol Tablet IP | General / Unclassified | Each uncoated tablet contains Haloperidol IP 0.5 mg Excipients q.s. |
| Haloperidol Tablet IP | General / Unclassified | Each uncoated tablet contains Haloperidol IP 1 mg Excipients q.s. |
| Haloperidol Tablet IP | General / Unclassified | Each uncoated tablet contains Haloperidol IP 1.5 mg Excipients q.s. |
| Haloperidol Tablet IP | General / Unclassified | Each uncoated tablet contains Haloperidol IP 2 mg Excipients q.s. |
| Haloperidol Tablet IP | General / Unclassified | Each uncoated tablet contains Haloperidol IP 5 mg Excipients q.s. |
| Haloperidol Tablet IP | General / Unclassified | Each uncoated tablet contains Haloperidol IP 10 mg Excipients q.s. |
| Haloperidol Tablets | General / Unclassified | Each uncoated tablet contains : Haloperidol IP 0.5 mg Approved colour to used |
| Haloperidol Tablets IP | General / Unclassified | Each uncoated tablet contains : Haloperidol IP 1.5 mg Approved colour to used |
| Haloperidol Tablets IP | General / Unclassified | Each uncoated tablet contains : Haloperidol IP 5 mg Approved colour to used |
| Haloperidol Tablets IP | General / Unclassified | Each uncoated tablet contains : Haloperidol IP 10 mg Approved colour to used |
| Hydralazine Hydrochloride Tablets 25 mg | General / Unclassified | Each uncoated tablets contains : Hydralazine Hydrochloride BP 25 mg Approved colour to be used |
| Hydralazine Hydrochloride Tablets 50 mg | General / Unclassified | Each uncoated tablets contains : Hydralazine Hydrochloride BP 50 mg Approved colour to be used |
| Hydrochlorothiazide Tablets IP | General / Unclassified | Each uncoated tablet contains : Hydrochlorothiazide IP 12.5 mg |
| Hydrochlorothiazide Tablets IP | General / Unclassified | Each uncoated tablet contains : Hydrochlorothiazide IP 25 mg |
| Hydroxychloroquine Tablets IP | General / Unclassified | Each film coated tablet contains : Hydroxychloroquine Sulphate IP 100 mg Approved colour to be use |
| Hydroxychloroquine Tablets IP | General / Unclassified | Each film coated tablet contains : Hydroxychloroquine Sulphate IP 200 mg Approved colour to be use |
| Hydroxychloroquine Tablets IP | General / Unclassified | Each film coated tablet contains : Hydroxychloroquine Sulphate IP 300 mg Approved colour to be use |
| Hydroxychloroquine Tablets IP | General / Unclassified | Each film coated tablet contains : Hydroxychloroquine Sulphate IP 400 mg Approved colour to be use |
| Hydroxyzine Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Hydroxyzine Hydrochloride IP 25 mg Approved colour to used |
| Hydroxyzine Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Hydroxyzine Hydrochloride IP 10 mg Excipients q.s. Approved colour to used |
| Imipramine Hydrochloride Tablets IP 10 mg | General / Unclassified | Each film coated tablet contains : Imipramine Hydrochloride IP 10 mg Approved colour to used |
| Imipramine Hydrochloride Tablets IP 25 mg | General / Unclassified | Each film coated tablet contains : Imipramine Hydrochloride IP 25 mg Approved colour to used |
| Irbesartan Tablets 75 mg | General / Unclassified | Each uncoated tablet contains : Irbesartan IP 75 mg Approved colour to used |
| Irbesartan Tablets IP 150 mg | General / Unclassified | Each uncoated tablet contains : Irbesartan IP 150 mg Approved colour to used |
| Irbesartan Tablets IP 300 mg | General / Unclassified | Each uncoated tablet contains : Irbesartan IP 300 mg Approved colour to used |
| Irbesartan and Hydrochlorothiazide Tablets IP | General / Unclassified | Each uncoated tablet contains : Irbesartan IP 150 mg Hydrochlorothiazide IP 12.5 mg Approved colour to used |
| Irbesartan and Hydrochlorothiazide Tablets IP | General / Unclassified | Each uncoated tablet contains : Irbesartan IP 300 mg Hydrochlorothiazide IP 12.5 mg Approved colour to used |
| Isoniazid Tablets IP 100 mg | General / Unclassified | Each filmcoated tablet contains : Isoniazid IP 100 mg Approved colour to used |
| Isoniazid Tablets IP 300 mg | General / Unclassified | Each filmcoated tablet contains : Isoniazid IP 300 mg Approved colour to used |
| Isoniazid Tablets IP 50 mg | General / Unclassified | Each filmcoated tablet contains : Isoniazid IP 50 mg Approved colour to used |
| Isosorbibe Dinitrate and Hydralazine Hydrochloride Tablets | General / Unclassified | Each film coated tablets contains : Diluted Isosorbibe Dinitrate IP Eq. to Isosorbibedrinate 20 mg Hydralazine Hydrochloride IP 37.5 mg Excipients q.s. Approved colour to be used |
| Isosorbide Mononitrate Tablets IP | General / Unclassified | Each uncoated tablet contains Isosorbide Mononitrate IP 10 mg |
| Isosorbide Mononitrate Tablets IP | General / Unclassified | Each uncoated tablet contains Isosorbide Mononitrate IP 20 mg |
| Isosorbide Mononitrate Tablets IP | General / Unclassified | Each uncoated tablet contains Isosorbide Mononitrate IP 30 mg |
| Isotretinoin Tablets | General / Unclassified | Each Uncoated tablet contains: Isotretinoin IP 10 mg Excipients q.s. Approved colour to be used |
| Isotretinoin Tablets | General / Unclassified | Each Uncoated tablet contains: Isotretinoin IP 20 mg Excipients q.s. Approved colour to be used |
| Itopride Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains: Itopride Hydrochloride IP 50mg Approved colour use |
| Ketoprofen & Thiocolchicoside Tablets | General / Unclassified | Each uncoated tablet contains Ketoprofen 50 mg Thiocolchicoside 4 mg |
| Lacosamide Tablets | General / Unclassified | Each film coated tablet contains : Lacosamide 50 mg Excipients q.s. Approved colour used |
| Lacosamide Tablets | General / Unclassified | Each film coated tablet contains : Lacosamide 100 mg Excipients q.s. Approved colour used |
| Lacosamide Tablets | General / Unclassified | Each film coated tablet contains : Lacosamide 150 mg Excipients q.s. Approved colour used |
| Lacosamide Tablets | General / Unclassified | Each film coated tablet contains : Lacosamide 200 mg Excipients q.s. Approved colour used |
| Lactic acid Bacillus tablet | General / Unclassified | Each uncoated tablet contains : Lactic acid Bacillus 60 mil. spo. Approved colour to be use |
| Lactic acid Bacillus tablet | General / Unclassified | Each uncoated tablet contains : Lactic acid Bacillus 120 mil. spo. Approved colour to be use |
| Lamotrigine Dispersible Tablets IP | General / Unclassified | Each uncoated dispersible tablet contains: Lamotrigine IP 25 mg Approved colour to be used |
| Lamotrigine Dispersible Tablets IP | General / Unclassified | Each uncoated dispersible tablet contains: Lamotrigine IP 50 mg Approved colour to be used |
| Lamotrigine Dispersible Tablets IP | General / Unclassified | Each uncoated dispersible tablet contains: Lamotrigine IP 100 mg Approved colour to be used |
| Lamotrigine Sustained-release Tablets IP | General / Unclassified | Each uncoated sustained release tablet contains: Lamotrigine IP 50 mg Approved colour to be used |
| Lamotrigine Sustained-release Tablets IP | General / Unclassified | Each uncoated sustained release tablet contains: Lamotrigine IP 100 mg Approved colour to be used |
| Lamotrigine Sustained-release Tablets IP | General / Unclassified | Each uncoated sustained release tablet contains: Lamotrigine IP 200 mg Approved colour to be used |
| Lansoprazole Orally Disintegrating Tablets | General / Unclassified | Each orally disintegrating tablet contains Lansoprazole IP 15 mg Approved coloured used |
| Letrozole Tablets IP | General / Unclassified | Each film coated tablets contains : Letrozole IP 2.5 mg Approved colour to be used |
| Levamisole Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablets contains Levamisole Hydrochloride IP Eq. to Levamisole 50 mg Approved colour to be used |
| Levamisole Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablets contains Levamisole Hydrochloride IP Eq. to Levamisole 150 mg Approved colour to be used |
| Levetiracetam (PR) Tablets IP | General / Unclassified | Each uncoated tablet contains : Levetiractam IP 500 mg (Prolonged released) Excipients q.s. |
| Levetiracetam Tablets IP | General / Unclassified | Each uncoated tablet contains Levetiracetam 250 mg |
| Levetiracetam Tablets IP | General / Unclassified | Each uncoated tablet contains Levetiracetam 500 mg |
| Levetiracetam Tablets IP | General / Unclassified | Each uncoated tablet contains Levetiracetam 750 mg |
| Levetiracetam Tablets IP | General / Unclassified | Each uncoated tablet contains : Levetiractam IP 1000 mg Excipients q.s. |
| Levetiracetam Tablets IP | General / Unclassified | Each film coated tablet contains : Levetiractam IP 500 mg Excipients q.s. Approved colour to be use |
| Levodopa Tablets IP | General / Unclassified | Each uncoated tablet contains : Levodopa IP 250 mg Excipients |
| Levodopa Tablets IP | General / Unclassified | Each uncoated tablet contains : Levodopa IP 500 mg Excipients |
| Levodopa and Carbidopa Tablets IP | General / Unclassified | Each uncoated tablet contains: Levodopa IP 100 mg Carbidopa IP Eq. to Anhydrous Carbidopa 10 mg Excipients q.s. |
| Levodopa and Carbidopa Tablets IP | General / Unclassified | Each uncoated tablet contains: Levodopa IP 100 mg Carbidopa IP Eq. to Anhydrous Carbidopa 25 mg Excipients q.s. |
| Levodopa and Carbidopa Tablets IP | General / Unclassified | Each uncoated tablet contains: Levodopa IP 250 mg Carbidopa IP Eq. to Anhydrous Carbidopa 25 mg Excipients q.s. |
| Levosulpiride Sustained Released Tablets | General / Unclassified | Each uncoated Sustained Released tablet contains : Levosulpiride 75 mg |
| Levosulpiride Sustained Released Tablets | General / Unclassified | Each uncoated Sustained Released tablet contains : Levosulpiride 150 mg |
| Levosulpiride Sustained Released Tablets | General / Unclassified | Each uncoated Sustained Released tablet contains : Levosulpiride 200 mg |
| Levosulpiride Tablets | General / Unclassified | Each uncoated tablet contains : Levosulpiride 25 mg |
| Lisinopril Tablets IP | General / Unclassified | Each uncoated tablet contains : Lisinopril IP 5 mg |
| Lithium Carbonate Prolonged-release | General / Unclassified | Each uncoated Prolonged released tablet contains Lithium Carbonate IP 300 mg (As Prolonged release) |
| Lithium Carbonate Prolonged-release | General / Unclassified | Each uncoated Prolonged released tablet contains Lithium Carbonate IP 400 mg (As Prolonged release) |
| Lithium Carbonate Prolonged-release | General / Unclassified | Each uncoated Prolonged released tablet contains Lithium Carbonate IP 450 mg (As Prolonged release) Excipients q.s. |
| Lithium Carbonate Tablets IP 300 mg | General / Unclassified | Each uncoated tablet contains Lithium Carbonate IP 300 mg |
| Loperamide Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Loperamide Hydrochloride IP 2 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Loratadine Tablets IP | General / Unclassified | Each uncoated tablet contains : Loratadine IP 5 mg |
| Loratadine Tablets IP | General / Unclassified | Each uncoated tablet contains : Loratadine IP 10 mg |
| Lornoxicam & Paracetmol Tablets | General / Unclassified | Each film coated tablet contains : Lornoxicam IP 8 mg Paracetmol IP 325 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Lornoxicam & Thiocolchicoside Tablets | General / Unclassified | Each film coated tablet contains : Lornoxicam IP 4 mg Thiocolchicoside 4 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Lornoxicam & Thiocolchicoside Tablets | General / Unclassified | Each film coated tablet contains : Lornoxicam IP 8 mg Thiocolchicoside 4 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP |
| Lornoxicam Tablets IP 8mg | General / Unclassified | Each film coated tablet contains: Lornoxicam 8mg Excipients q.s. Approved colour to be used |
| Lurasidone Hydrochloride Tablets | General / Unclassified | Each film coated tablet contains : Lurasidone Hydrochloride 40 mg Approved colour to used |
| Lurasidone Hydrochloride Tablets | General / Unclassified | Each film coated tablet contains : Lurasidone Hydrochloride 80 mg Approved colour to used |
| METRONIDAZOLE & FURAZOLIDONE Tablets | General / Unclassified | Each uncoated tablet contains : Metronidazole IP 200 mg Furazolidone IP 100 mg |
| Magnesium Trisilicate Chewable Tablets | General / Unclassified | Each uncoated chewable tablet contains : Magnesium Trisilicate IP 250 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Mebendazole Tablets IP | General / Unclassified | Each uncoated tablet contains : Mebendazole IP 100 mg |
| Mebeverine Hydrochloride and Chlordiazepoxide Tablets | General / Unclassified | Each uncoated tablet contains : Mebeverine Hydrochloride IP 135 mg Chlordiazepoxide IP 5 mg Excipients q.s Approved colour to be used |
| Mebeverine Hydrochloride and Chlordiazepoxide Tablets | General / Unclassified | Each film coated tablet contains: Mebeverine Hydrochloride IP 135 mg Chlordiazepoxide IP 5 mg Excipients q.s. Approved colour to be used |
| Mefenamic Acid & Dicyclomine Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains : Mefenamic Acid IP 250 mg Dicyclomine Hydrochloride IP 10 mg |
| Mefenamic Acid & Dicyclomine Hydrocloride Tablets | General / Unclassified | Each uncoated tablet contains Mefenamic Acid IP 250 mg Dicyclomine Hydrochloride IP 20 mg |
| Mefenamic Acid Dispersible Tablets | General / Unclassified | Each Uncoated Dispersible tablet contains: Mefenamic Acid IP 100 mg Excipients q.s. Approved colour to be used |
| Mefenamic Acid Tablets IP | General / Unclassified | Each uncoated tablet contains : Mefenamic Acid IP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Mefenamic Acid and Dicyclomine HCI Tablets | General / Unclassified | Each uncoated tablet contains : Mefenamic acid IP 125 mg Dicyclomine Hydrochloride IP 10 mg Excipients q.s. Approved coloured to be used |
| Mefenamic acid and Tizanidine Tablets | General / Unclassified | Each unCoated tablet contains : Mefenamic acid IP 500 mg Tizanidine Hydrochloride IP Equivalent to Tizanidine 6 mg Excipients q.s. Approved color to be use |
| Meloxicam Tablets | General / Unclassified | Each uncoated tablet contains : Meloxicam IP 7.5 mg Approved colour to used |
| Meloxicam Tablets | General / Unclassified | Each uncoated tablet contains : Meloxicam IP 15 mg Approved colour to used |
| Memantine HCI Tablets IP | General / Unclassified | Each film coated tablet contains : Memantine Hydrochloride IP 10 mg Excipients q.s. Approved coloured used |
| Memantine HCI Tablets IP | General / Unclassified | Each film coated tablet contains : Memantine Hydrochloride IP 5 mg Approved coloured used |
| Methyldopa Tablets IP | General / Unclassified | Each film coated tablet contains : Methyldopa IP Eq. to Anhydrous Methyldopa 125 mg Approved coloured used |
| Methyldopa Tablets IP | General / Unclassified | Each film coated tablet contains : Methyldopa IP Eq. to Anhydrous Methyldopa 250 mg Approved coloured used |
| Methylergomatrine Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains : Methylergomatrine Maleate IP 0.125 mg |
| Metoclopramide Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Metoclopramide Hydrochloride IP 10 mg Eq. to Anhydrous Metoclopramide Hydrochloride Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunsel yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Metronidazole Tablets IP 200 MG. | General / Unclassified | Each film coated tablet contains : Metronidazole IP 200 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Metronidazole Tablets IP 400 MG. | General / Unclassified | Each film coated tablet contains : Metronidazole IP 400 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Midodrine Hydrochloride Tablets USP 2.5 mg | General / Unclassified | Each film coated tablets contains : Midodrine Hydrochloride USP 2.5 mg Excipients q.s. Approved colour to be used |
| Midodrine Hydrochloride Tablets USP 5 mg | General / Unclassified | Each film coated tablets contains : Midodrine Hydrochloride USP 5 mg Excipients q.s. Approved colour to be used |
| Mirtazipine Tablets | General / Unclassified | Each uncoated tablet contains Mirtazipine IP 15 mg Colour: Tartrazine / Sunset Yellow |
| Mirtazipine Tablets | General / Unclassified | Each uncoated tablet contains Mirtazipine IP 30 mg Colour: Tartrazine / Sunset Yellow |
| Misoprostol Tablets IP | General / Unclassified | Each uncoated tablet contains : Misoprostol IP 200 mcg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide P /Apple Green/Iron oxide red Iron oxide Yellow |
| Modafinil Tablets IP | General / Unclassified | Each uncoated tablet contains : Modafinil IP 100 mg Approved colour to be used |
| Modafinil Tablets IP | General / Unclassified | Each uncoated tablet contains : Modafinil IP 200 mg Approved colour to be used |
| Moxifloxacin Tablets | General / Unclassified | Each film coated tablet contains Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 400 mg Colour: Brilliant Blue / Erythrosine /Tartrazine / Sunset yellow or Apple Green / Titanium Dioxide IP |
| Moxonidine Tablets | General / Unclassified | Each film coated tablet contains : Moxonidine BP 0.2 mg Excipients q.s. Approved colour used |
| Moxonidine Tablets | General / Unclassified | Each film coated tablet contains : Moxonidine BP 0.3 mg Excipients q.s. Approved colour used |
| Moxonidine Tablets | General / Unclassified | Each film coated tablet contains : Moxonidine BP 0.4 mg Excipients q.s. Approved colour used |
| Mycophenolate Mofetil Tablets IP 250 mg | General / Unclassified | Each film coated tablets contains Mycophenolate Mofetil IP 250 mg Approved colour to be used |
| Mycophenolate Mofetil Tablets IP 360 mg | General / Unclassified | Each film coated tablets contains Mycophenolate Mofetil IP 360 mg Approved colour to be used |
| Mycophenolate Mofetil Tablets IP 500 mg | General / Unclassified | Each film coated tablets contains Mycophenolate Mofetil IP 500 mg Approved colour to be used |
| Mycophenolate Mofetil Tablets IP 750 mg | General / Unclassified | Each film coated tablets contains Mycophenolate Mofetil IP 750 mg Approved colour to be used |
| N-Acetylsteine Tablet | General / Unclassified | Each Film coated tablet contains : N-Acetylsteine USP 600 mg Excipients q.s. Approved coloured used |
| Naltrexone Hydrochloride Tablets IP 50 mg | General / Unclassified | Each uncoated tablets contains: Naltrexone Hydrochloride IP 50 mg Approved colour to be use |
| Nicorandil Prolonged Release Tablets IP 10 mg | General / Unclassified | Each uncoated Prolonged-release tablet contains : Nicorandil IP 10 mg Excipient q.s |
| Nicorandil Prolonged Release Tablets IP 20 mg | General / Unclassified | Each uncoated Prolonged-release tablet contains : Nicorandil IP 20 mg Excipient q.s |
| Nicorandil Tablets 5 mg | General / Unclassified | Each uncoated tablet contains : Nicorandil IP 5 mg Approved colour to used |
| Nicorandil Tablets IP 10 mg | General / Unclassified | Each uncoated tablet contains : Nicorandil IP 10 mg Approved colour to used |
| Nicorandil Tablets IP 20 mg | General / Unclassified | Each uncoated tablet contains : Nicorandil IP 20 mg Approved colour to used |
| Nicoumalone Tablets IP | General / Unclassified | Each uncoated tablet corntains Nicoumalone IP 0.5 mg Excipients q.s. |
| Nicoumalone Tablets IP | General / Unclassified | Each uncoated tablet corntains Nicoumalone IP 5 mg Excipients q.s. |
| Nicoumalone Tablets IP | General / Unclassified | Each uncoated tablet corntains Nicoumalone IP 6 mg Excipients q.s. |
| Nicoumalone Tablets IP 1 mg | General / Unclassified | Each uncoated tablet contains : Nicoumalone IP 1 mg Approved colour to used |
| Nicoumalone Tablets IP 2 mg | General / Unclassified | Each uncoated tablet contains : Nicoumalone IP 2 mg Approved colour to used |
| Nicoumalone Tablets IP 2 mg. | General / Unclassified | Each Uncoated tablet contains : Nicoumalone BP 2 mg |
| Nicoumalone Tablets IP 3 mg | General / Unclassified | Each uncoated tablet contains : Nicoumalone IP 3 mg Approved colour to used |
| Nicoumalone Tablets IP 4 mg | General / Unclassified | Each uncoated tablet contains : Nicoumalone IP 4 mg Approved colour to used |
| Nifedipine Prolonged-release Tablets IP | General / Unclassified | Each prolonged-release tablet contains Nifedipin IP 20 mg |
| Nimetazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Nimetazepam 5.0 mg Excipients q.s. |
| Nitazoxanide Tablets | General / Unclassified | Each film coated tablet contains Nitazoxanide 500 mg Excipients q.s. Approved colour to be used |
| Nitrazepam Tablets IP | General / Unclassified | Each uncoated tablet contains : Nitrazepam IP 10 mg |
| Nitroglycerin Controlled Release Tablets IP | General / Unclassified | Each uncoated CR tablet contains : Diluted Nitroglycerin IP eq. to Nitroglycerin 2.6 mg Colour: Sunset yellow FCF |
| Nitroglycerin Controlled Release Tablets IP | General / Unclassified | Each uncoated CR tablet contains : Diluted Nitroglycerin IP eq. to Nitroglycerin 6.4 mg Colour: Sunset yellow FCF |
| Norethisterone Acetate Controlled released Tablets | General / Unclassified | Each film coated controlled released tablet contains : Norethisterone Acetate BP 10 mg Approved colour to be use |
| Norethisterone Tablets IP | General / Unclassified | Each uncoated tablet contains : Norethisterone IP 5 mg Excipients q.s. |
| Norfloxacin & Ornidazole Tablets | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 400 mg Ornidazole IP 500 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Norfloxacin & Tinidazole (With Betacyclodextrin) Tablets | General / Unclassified | Each uncoated tablet contains : Norfloxacin IP 400 mg Tinidazole IP 600 mg ( With Betacyclodextrin) Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Norfloxacin , Tinidazole With Betacyclodextrin Tablets | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 400 mg Tinidazole IP 600 mg Betacyclodextrin USP 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Norfloxacin , Tinidazole With Betadex Tablets | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 400 mg Tinidazole IP 600 mg Betadex (Anhydrous) USP 10 mg Approved colour to used |
| Norfloxacin Tablets IP | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 400 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Norfloxacin With Betacyclodextrin Tablets | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 400 mg Betacyclodextrin USP 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Norfloxacin With Lactic Acid Bacillus Tablets | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 400 mg Lactic Acid Bacillus 90 ms. Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Norfloxacin and Tinidazole Tablets | General / Unclassified | Each film coated tablet contains : Norfloxacin IP 200 mg Tinidazole IP 300 mg Approved colour to used |
| Nortriptyline Tablets IP | General / Unclassified | Each film coated tablet contains : Nortriptyline IP 10 mg Permitted Color Used |
| Nortriptyline Tablets IP | General / Unclassified | Each film coated tablet contains : Nortriptyline IP 25 mg Permitted Color Used |
| Olanzapine Tablets | General / Unclassified | Each film coated tablet contains: Olanzapine IP 15 mg Approved colour to used |
| Olanzapine Tablets IP | General / Unclassified | Each film coated tablet contains: Olanzapine IP 2.5 mg Approved colour to used |
| Olanzapine Tablets IP | General / Unclassified | Each film coated tablet contains: Olanzapine IP 5 mg Approved colour to used |
| Olanzapine Tablets IP | General / Unclassified | Each film coated tablet contains: Olanzapine IP 7.5 mg Approved colour to used |
| Olanzapine Tablets IP | General / Unclassified | Each film coated tablet contains: Olanzapine IP 10 mg Approved colour to used |
| Orinidazole Tablets | General / Unclassified | Each Film coated tablet contains : Orinidazole IP 500 mg Excipients q.s. Approved coloured used |
| Oxazepam Tablets IP | General / Unclassified | Each Uncoated tablet contains : Oxezepam IP 10.0 mg Excipients q.s. |
| Oxazepam Tablets IP | General / Unclassified | Each Uncoated tablet contains : Oxezepam IP 15.0 mg Excipients q.s. |
| Oxazepam Tablets IP | General / Unclassified | Each Uncoated tablet contains : Oxezepam IP 30.0 mg Excipients q.s. |
| Oxcarbazepine Extended Release Tablets | General / Unclassified | Each film coated extended release tablet contains: Oxcarbazepine IP 300 mg Approved colour to be used |
| Oxcarbazepine Extended Release Tablets | General / Unclassified | Each film coated extended release tablet contains: Oxcarbazepine IP 600 mg Approved colour to be used |
| Oxcarbazepine Tablets IP 150 mg | General / Unclassified | Each film coated tablet contains : Oxcarbazepine IP 150 mg Excipients q.s Approved colour to used |
| Oxcarbazepine Tablets IP 300 mg | General / Unclassified | Each film coated tablet contains : Oxcarbazepine IP 300 mg Excipients q.s Approved colour to used |
| Oxcarbazepine Tablets IP 450 mg | General / Unclassified | Each film coated tablet contains : Oxcarbazepine IP 450 mg Excipients q.s Approved colour to used |
| Oxcarbazepine Tablets IP 600 mg | General / Unclassified | Each film coated tablet contains : Oxcarbazepine IP 600 mg Excipients q.s Approved colour to used |
| Oxyphenbutazone Tablets IP | General / Unclassified | Each film coated tablet contains : Oxyphenbutazone IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Paroxetine Hydrochloride Tablets | General / Unclassified | Each film coated tablet contains : Paroxetine Hydrochloride IP Eq. to Paroxetine 40 mg Approved colour to be use |
| Paroxetine Prolonged Release Tablets | General / Unclassified | Each Enteric coated tablet contains : Paroxetine Hydrochloride IP Eq. to Paroxetine 12.5 mg Approved colour to be use |
| Paroxetine Prolonged Release Tablets | General / Unclassified | Each Enteric coated tablet contains : Paroxetine Hydrochloride IP Eq. to Paroxetine 25 mg Approved colour to be use |
| Paroxetine Prolonged Release Tablets | General / Unclassified | Each Enteric coated tablet contains : Paroxetine Hydrochloride IP Eq. to Paroxetine 37.5 mg Approved colour to be use |
| Paroxetine Tablets IP 10 mg | General / Unclassified | Each film coated tablet contains : Paroxetine Hydrochloride IP eq. to Paroxetine 10 mg Approved colour to used |
| Paroxetine Tablets IP 20 mg | General / Unclassified | Each film coated tablet contains : Paroxetine Hydrochloride IP eq. to Paroxetine 20 mg Approved colour to used |
| Paroxetine Tablets IP 30 mg | General / Unclassified | Each film coated tablet contains : Paroxetine Hydrochloride IP eq. to Paroxetine 30 mg Approved colour to used |
| Pentoxifylline Extended release Tablets IP 400 mg | General / Unclassified | Each film coated Extended release tablets contains : pentoxifylline IP 400 mg Excipients q.s. Approved colour to be used |
| Pheniramine Maleate Tablets IP 25 mg | General / Unclassified | Each uncoated tablet contains : Pheniramine Maleate IP 25 mg |
| Phenobarbitone Tablets IP 30 mg | General / Unclassified | Each uncoated tablet contains : Phenobarbitone IP 30 mg Approved colour to used |
| Phenobarbitone Tablets IP 60 mg | General / Unclassified | Each uncoated tablet contains : Phenobarbitone IP 60 mg Approved colour to used |
| Phenolphthaleine, Senna Powder & Myrobalan With Lactose Tablets | General / Unclassified | Each uncoated tablet contains : Phenolphthaleine IP 85 IP 129.60 mg Senna Powder IP 66 IP 16.20 mg Myrobalan Powder IP 66 IP 16.20 mg Lactose IP qs. Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| Phenylbutazone Tablets IP | General / Unclassified | Each sugar coated tablet contains : Phenylbutazone IP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunser yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Phenylbutazone Tablets IP | General / Unclassified | Each film coated tablets contains : Phenylbutazone IP07 100 mg Excipients q.s. Approved colour to be used |
| Phenylbutazone Tablets IP | General / Unclassified | Each film coated tablets contains : Phenylbutazone IP07 200 mg Excipients q.s. Approved colour to be used |
| Phenylbutazone Tablets IP 07 | General / Unclassified | Each sugar coated tablet contains : Phenylbutazone IP07 200 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunser yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Phenytoin Sodium Tablets IP | General / Unclassified | Each film coated contains Phenytoin Sodium IP 50 mg Approved coloured used |
| Phenytoin Sodium Tablets IP | General / Unclassified | Each film coated contains Phenytoin Sodium IP 100 mg Approved coloured used Flunarizine Tablets IP |
| Pirfenidone Tablets IP 400 mg | General / Unclassified | Each film coated tablet contains : Pirfenidone IP 400 mg Excipients q.s. Approved colour to be used |
| Pirfonidone Tablets IP | General / Unclassified | Each film coated tablet contains Pirfenidone IP 200 mg Approved colour to used |
| Ploglitazone & Glimepride Tablets | General / Unclassified | Each uncoated tablet contains Ploglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Glimepride IP 1 mg |
| Ploglitazone & Glimepride Tablets | General / Unclassified | Each uncoated tablet contains Ploglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg Glimepride IP 2 mg |
| Prasugrel Tablets IP 10 mg | General / Unclassified | Each film coated tablet contains : Prasugrel Hydrochloride IP Eq. to Prasugrel 10 mg Approved colour to used |
| Prasugrel Tablets IP 5 mg | General / Unclassified | Each film coated tablet contains : Prasugrel Hydrochloride IP Eq. to Prasugrel 5 mg Approved colour to used |
| Praziquantel Tablets IP 600mg | General / Unclassified | Each film coated tablets contains : Praziquantel IP 600 mg Approved colour to be used |
| Primaquine Tablets IP 15 mg | General / Unclassified | Each film coated tablets contains : Primaquine Phosphate IP 26 mg Eq. to Primaquine 15mg Excipients q.s. Approved colour to be used |
| Primaquine Tablets IP 7.5 mg | General / Unclassified | Each film coated tablets contains : Primaquine Phosphate IP 13 mg Eq. to Primaquine 7.5 mg Excipients q.s. Approved colour to be used |
| Prochlorperazine Maleate Orally Disintegrating Tablets | General / Unclassified | Each orally disintegrating tablet contains : Prochlorperazine Maleate IP 5 mg Excipients q.s. |
| Prochlorperazine Maleate Orally Disintegrating Tablets | General / Unclassified | Each orally disintegrating tablet contains : Prochlorperazine Maleate IP 10 mg Excipients q.s. |
| Prochlorperazine Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains : Prochlorperazine Maleate IP 10 mg |
| Prochlorperazine Maleate Tablets IP | General / Unclassified | Each uncoated tablet contains : Prochlorperazine Maleate IP 5 mg |
| Procyclidine Tablets IP | General / Unclassified | Each uncoated tablet contains: Procyclidine Hydrochloride IP 2.5 mg Approved colour to used |
| Procyclidine Tablets IP | General / Unclassified | Each uncoated tablet contains: Procyclidine Hydrochloride IP 5 mg Approved colour to used |
| Promethazine Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Promethazine Hydrochloride IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron Oxide red iron oxide Yellow |
| Propranolol HCl and Flunarizine Tablets | General / Unclassified | Each uncoated tablet contains : Propranolol HCI IP 40 mg Flunarizine Dlhydrochloride IP Eq. to Flunarizine 10 mg Approved colour to used |
| Propranolol HCl and Flunarizine Tablets | General / Unclassified | Each uncoated tablet contains : Propranolol HCI IP 40 mg Flunarizine Dihydrochloride IP Eq. to Flunarizine 5 mg Approved colour to be used |
| Propranolol HCl and Flunarizine Tablets | General / Unclassified | Each uncoated tablet contains : Propranolol HCI IP 40 mg Flunarizine Dlhydrochloride IP Eq. to Flunarizine 5 mg Approved colour to used |
| Propranolol Hydrochloride & Etizolam Tablets | General / Unclassified | Each uncoated tablet contains Propranolol Hydrochloride IP 10 mg Etizolam 0.25 mg Colour: Brilliant Blue / Erythrosine /Tartrazine or Titanium Dioxide IP |
| Propranolol Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains Propranolol Hydrochloride IP 10 mg |
| Propranolol Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains Propranolol Hydrochloride IP 20 mg |
| Propranolol Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Propranolol Hydrochloride IP 40 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green /tron oxide red, Iron Oxide Yellow |
| Propranolol Sustained Release Tabiets 160 mg | General / Unclassified | Each uncoated sustained release tablet contains : Propranolol Hydrochloride IP 160 mg Approved colour to be used |
| Propranolol Sustained Release Tabiets 20 mg | General / Unclassified | Each uncoated sustained release tablet contains : Propranolol Hydrochloride IP 20 mg Approved colour to be used |
| Propranolol Sustained Release Tabiets 80 mg | General / Unclassified | Each uncoated sustained release tablet contains : Propranolol Hydrochloride IP 80 mg Approved colour to be used |
| Prulifloxacin Tablets | General / Unclassified | Each film coated tablet contains Prulifloxacin Hydrochloride IP eq. to Prulifloxacin 600 mg |
| Prulifloxacin Tablets | General / Unclassified | Each film coated tablets contains: Prulifloxacin HCl 600 mg Approved color to be use |
| Pyrazinamide Tablets | General / Unclassified | Each uncoated tablet contains : Pyrazinamide IP 750 mg |
| Pyridoxine Hydrochloride Tablets IP | General / Unclassified | Each uncoated tablet contains : Pyridoxine Hydrochloride IP 10 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Quetiapine Fumarate Tablets IP | General / Unclassified | Each film coated tablet contains: Quetiapine Fumarate IP 25 mg Eq. to Quetiapine Approved colour to used |
| Quetiapine Fumarate Tablets IP | General / Unclassified | Each film coated tablet contains: Quetiapine Fumarate IP 50 mg Eq. to Quetiapine Approved colour to used |
| Quetiapine Fumarate Tablets IP | General / Unclassified | Each film coated tablet contains: Quetiapine Fumarate IP 100 mg Eq. to Quetiapine Approved colour to used |
| Quetiapine Fumarate Tablets IP | General / Unclassified | Each film coated tablet contains: Quetiapine Fumarate IP 200 mg Eq. to Quetiapine Approved colour to used |
| Quetiapine Fumarate Tablets IP | General / Unclassified | Each film coated tablet contains: Quetiapine Fumarate IP 300 mg Eq. to Quetiapine Approved colour to used |
| Quetiapine Sustained release Tablets | General / Unclassified | Each film coated Sustained released tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 50 mg Approved colour to be used |
| Quetiapine Sustained release Tablets | General / Unclassified | Each film coated Sustained released tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 200 mg Approved colour to be used |
| Quetiapine Sustained release Tablets | General / Unclassified | Each film coated Sustained released tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 300 mg Approved colour to be used |
| Quetiapine Sustained release Tablets | General / Unclassified | Each film coated Sustained released tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 400 mg Approved colour to be used |
| Quiniodochlor Tablets IP | General / Unclassified | Each uncoated tablet contains : Quiniodochlor IP 250 mg |
| Racecadotril Dispersible Tablets | General / Unclassified | Each uncoated dispersible tablet contains : Racecadotril IP 10 mg Excipients q.s. Approved colour to be used |
| Racecadotril Dispersible Tablets | General / Unclassified | Each uncoated dispersible tablet contains : Racecadotril IP 30 mg Excipients q.s. Approved colour to be used |
| Ramipril Tablets IP | General / Unclassified | Each filmcoated tablet contains : Ramipril IP 2.5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ramipril Tablets IP | General / Unclassified | Each filmcoated tablet contains : Ramipril IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ramipril Tablets IP | General / Unclassified | Each filmcoated tablet contains : Ramipril IP 10 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Ramipril Tablets IP | General / Unclassified | Each uncoated tablets contains : Ramipril IP 5 mg |
| Ramipril With Hydrochlorothiazide Tablets | General / Unclassified | Each filmcoated tablet contains : Ramipril IP 2.5 mg Hydrochlorothiazide IP 12.5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP/ Apple Green / Iron oxide red, Iron oxide Yellow |
| Ramosetron Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains: Ramosetron Hydrochloride 2.5 mcg Approved colour to used |
| Ramosetron Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains: Ramosetron Hydrochloride 5 mcg Approved colour to used |
| Ramosetron Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains: Ramosetron Hydrochloride 0.1 mg Approved colour to used |
| Ramosetron Hydrochloride Tablets | General / Unclassified | Each uncoated tablets contains Ramosetron Hydrochloride 100 mcg Approved colour to be used |
| Ranolazine Extend Release Tablets | General / Unclassified | Each film coated Sustained release tablets contains : Ranolazine 500 mg Excipients q.s. Approved colour to be used |
| Ranolazine Sustained Release Tablets | General / Unclassified | Each uncoated Sustained Release tablet contains Ranolazine 750 mg Excipients q.s. |
| Ranolazine Sustained Release Tablets | General / Unclassified | Each uncoated Sustained Release tablet contains Ranolazine 500 mg Excipients q.s. |
| Ranolazine Sustained Release Tablets | General / Unclassified | Each uncoated Sustained Release tablet contains Ranolazine 1000 mg Excipients q.s. |
| Ranolazine Sustained Release Tablets | General / Unclassified | Each film coated Extended release tablets contains : Ranolazine 500 mg Excipients q.s. Approved colour to be used |
| Rebamipide Tablets | General / Unclassified | Each film coated tablet contains Rebamipide IP 100 mg Excipients q.s. |
| Rececadotril Tablets | General / Unclassified | Each uncoated tablet contains : Rececadotril IP 100 mg Excipients q.s. |
| Riboflavin Tablets IP For Therapeutic Use | General / Unclassified | Each uncoated tablet contains : Riboflavin IP 10 mg Excipients q.s. |
| Rifampicin & Isoniazid Tablets | General / Unclassified | Each filmcoated tablet contains : Rifampicin IP 450 mg Isoniazid IP 300 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow/Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Rifaximin Dispersible Tablets | General / Unclassified | Each uncoated dispersible tablets contains Rafaximin BP 200 mg Excipients q.s. Approved colour to be used |
| Rifaximin Tablets | General / Unclassified | Each Film coated tablet contains : Rifaximin Eur. 200 mg Excipients q.s. Approved coloured used |
| Rifaximin Tablets | General / Unclassified | Each Film coated tablet contains : Rifaximin Eur. 400 mg Excipients q.s. Approved coloured used |
| Rifaximin Tablets | General / Unclassified | Each Film coated tablet contains : Rifaximin Eur. 550 mg Excipients q.s. Approved coloured used |
| Risperidone Tablets IP | General / Unclassified | Each uncoated tablet contains : Risperidone IP 2 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Risperidone Tablets IP | General / Unclassified | Each uncoated tablets contains Risperidone IP 0.5 mg Approved color to be use |
| Risperidone Tablets IP | General / Unclassified | Each uncoated tablets contains Risperidone IP 1 mg Approved color to be use |
| Risperidone Tablets IP | General / Unclassified | Each uncoated tablets contains Risperidone IP 3 mg Approved color to be use |
| Risperidone Tablets IP | General / Unclassified | Each uncoated tablets contains Risperidone IP 4 mg Approved color to be use |
| Risperidone and Trihexyphenidyl Tablets | General / Unclassified | Each uncoated tablet contains : Risperidone IP 2 mg Trihexyphenidyl Hydrochloride IP 2 mg Approved colour to be used |
| Risperidone and Trihexyphenidyl Tablets | General / Unclassified | Each uncoated tablet contains : Risperidone IP 4 mg Trihexyphenidyl Hydrochloride IP 2 mg Approved colour to be used |
| Rivaroxaban Tablets | General / Unclassified | Each film coated tablet contains : Rivaroxaban 10 mg Approved colour to used |
| Rivaroxaban Tablets | General / Unclassified | Each film coated tablet contains : Rivaroxaban 20 mg Approved colour to used |
| Rivaroxaban Tablets | General / Unclassified | Each film coated tablet contains : Rivaroxaban 15 mg Approved colour to used |
| Roflumilast Tablets 500 mcg | General / Unclassified | Each uncoated tablet contains : Roflumilast IP 500 mcg |
| Rosiglitazone Maleate Tablets | General / Unclassified | Each uncoated tablet contains : Rosiglitazone Maleate Eq. to Rosiglitazone 1 mg Approved colour to used |
| Rosiglitazone Maleate Tablets | General / Unclassified | Each uncoated tablet contains : Rosiglitazone Maleate Eq. to Rosiglitazone 2 mg Approved colour to used |
| Rosiglitazone Maleate Tablets | General / Unclassified | Each uncoated tablet contains : Rosiglitazone Maleate Eq. to Rosiglitazone 4 mg Approved colour to used |
| Rosiglitazone Maleate Tablets | General / Unclassified | Each uncoated tablet contains : Rosiglitazone Maleate Eq. to Rosiglitazone 8 mg Approved colour to used |
| Roxithromycin Dispersible Tablets IP | General / Unclassified | Each ucoated dispersible tablet contains : Roxithromycin IP 50 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| Roxithromycin Tablets IP | General / Unclassified | Each film coated tablet contains : Roxithromycin IP 150 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Sacubitril and Valsartan Tablets | General / Unclassified | Each film coated tablets contains Sacubutril 24 mg Valsartan IP 26 mg Approved colour to be used |
| Sacubitril and Valsartan Tablets | General / Unclassified | Each film coated tablets contains Sacubutril 49 mg Valsartan IP 51 mg Approved colour to be used |
| Sacubutril and Valsartan Tablets | General / Unclassified | Each film coated tablets contains Sacubutril 97 mg Valsartan IP 103 mg Approved colour to be used |
| Sartraline Tablets IP | General / Unclassified | Each film coated tablet contains : Sartraline Hydrochloride IP Eg. to Sartraline 25 mg Approved colour to be used |
| Sartraline Tablets IP | General / Unclassified | Each film coated tablet contains : Sartraline Hydrochloride IP Eg. to Sartraline 50 mg Approved colour to be used |
| Sartraline Tablets IP | General / Unclassified | Each film coated tablet contains : Sartraline Hydrochloride IP Eg. to Sartraline 100 mg Approved colour to be used |
| Serratiopeptidase Tablets | General / Unclassified | Each enteric coated tablet contains : Serratiopeptidase (20,000 Serratiopeptidase Units) IP 10 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Sodium Valproate Tablets IP | General / Unclassified | Each uncoated tablet contains Sodium Valproate IP 100 mg |
| Sodium Valproate Tablets IP | General / Unclassified | Each uncoated tablet contains Sodium Valproate IP 200 mg |
| Sodium Valproate Tablets IP | General / Unclassified | Each uncoated tablet contains Sodium Valproate IP 300 mg |
| Sodium Valproate Tablets IP | General / Unclassified | Each uncoated tablet contains Sodium Valproate IP 500 mg |
| Sodium Valproate and Valproic Acid Controlled release Tablets | General / Unclassified | Each film coated controlled release tablets contains : Sodium Valproate IP 133.5 mg Valproic Acid IP 58 mg ( Both together corresponds to sodium Valproate IP 200 mg ) Excipients q.s. Approved colour to be used |
| Sparfloxacin Tablets | General / Unclassified | Each film coated tablet contains : Sparfloxacin 200 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / tron oxide red, Iron Oxide Yellow |
| Spiramycin Tablets | General / Unclassified | Each film coated tablets contains Spiramycin IP 8000000 IU Excipients q.s. Approved colour to be used |
| Sulphaguanidine Tablets IP | General / Unclassified | Each uncoated tablet contains : Sulphaguanidine IP66 500 mg |
| Sulpiride Tablets IP 100 mg | General / Unclassified | Each uncoated tablet contains : Sulpiride IP 100 mg Approved colour to used |
| Sulpiride Tablets IP 200 mg | General / Unclassified | Each uncoated tablet contains : Sulpiride IP 200 mg Approved colour to used |
| Sulpiride Tablets IP 400 mg | General / Unclassified | Each uncoated tablet contains : Sulpiride IP 400 mg Approved colour to used |
| THIAMINE (Mono), Riboflavin With Cyanocobalamin Tablets | General / Unclassified | Each film coated tablet contains : Thiamine Mononitrate IP 1 mg Riboflavin IP 1 mg Cyanocobalamin IP 1 mcg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red, Iron oxide Yellow |
| Tapentadol Hydrochloride Sustain Release Tablet | General / Unclassified | Each film coated sustain realease tablet contains Tapentadol Hydrochloride IP Eq. to Tapentadol 100 mg Approved colour to used |
| Tapentadol Hydrochloride Sustain Release Tablets | General / Unclassified | Each film coated sualain realease tablet contains Tapentadol Hydrochloride IP Eq. to Tapentadol 50 mg Excipients q.s. Approved colour to used |
| Tapentadol Hydrochloride Tablet | General / Unclassified | Each film coated tablet contains Tapentadol Hydrochloride IP Eq. to Tapentadol 100 mg Approved colour lo used |
| Tapentadol Hydrochloride Tablets | General / Unclassified | Each film coated contains Tapentadol Hydrochloride IP Eq. to Tapentado 25 mg Approved coloured used |
| Tapentadol Hydrochloride and Carisoprodol Tablets | General / Unclassified | Each uncoated tablet contains Tapentadol Hydrochloride IP Eq. to Tapentadol 125 mg Carisoprodol IP 100 mg Excipients q.s. |
| Tapentadol Hydrochloride and Carisoprodol Tablets | General / Unclassified | Each film coated tablet contains Tapentadol Hydrochloride IP Eq. to Tapentadol 100 mg Carisoprodol IP 350 mg Approved color to be use |
| Tapentadol Tablets | General / Unclassified | Each film coated tablets contains : Tapentadol Hydrochloride IP 75 mg Permitted Color Used |
| Tapentadol Tablets | General / Unclassified | Each film coated tablets contains : Tapentadol Hydrochloride IP 50 mg Permitted Color Used |
| Temazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Temazepam IP 10 mg |
| Temazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Temazepam BP 20 mg Excipients q.s. |
| Temazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Temazepam BP 10 mg Excipients q.s. |
| Temazepam Tablets | General / Unclassified | Each Uncoated tablet contains : Temazepam BP 20 mg Excipients q.s. |
| Tetrabenazine Tablets 25 mg | General / Unclassified | Each Uncoated tablet contains: Tetrabenazine 25 mg Excipients q.s. |
| Thiamine (Mono), Riboflavin Pyridoxine Hydrochloride | General / Unclassified | Each film coated tablet contains : Thiamine Mononitrate IP 10 mg Riboflavin IP 10 mg Pyridoxine Hydrochloride IP 3 mg Cyanocobalamin IP 15 mcg Naicinamide IP 45 mg Calcium Panthothenate IP 50 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Thiamine (Mono), Riboflavine Pyridoxine Hydrochloride | General / Unclassified | Each film coated tablet contains : Thiamine Monoitrate IP 4.5 mg Riboflavine IP 5 mg Nicotinamide IP 45 mg Pyridoxine Hydrochloride IP 1.5 mg Calcium Pantothenate IP 5 mg Cyanocobalamin IP 5 mcg Folic Acid IP 1 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Thiamine (Mono), Riboflavine Pyridoxine Hydrochloride | General / Unclassified | Each film coated tablet contains : Thiamine Monoitrate IP 1 mg Riboflavine IP 1 mg Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 0.5 mcg Naicinamide IP 5 mg Folic Acid IP 0.3 mg Calcium Panthothenate IP 2 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Thiamine Hydrochloride Tablets | General / Unclassified | Each film coated tablets contains : Thiamine Hydrochloride IP 100 mg Excipients q.s. Approved colour to be used |
| Tianeptine Sodium Tablets | General / Unclassified | Each sugar coated tablet contains : Tianeptine sodium BP 12.5 mg Approved colour to used |
| Ticagrelor Tablets IP 90 mg | General / Unclassified | Each film coated tablet contains : Ticagrelor IP 90 mg Approved colour to used |
| Tinidazole Tablets IP 300 mg | General / Unclassified | Each film coated tablet contains : Tinidazole IP 300 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Tinidazole Tablets IP 500 mg | General / Unclassified | Each film coated tablet contains : Tinidazole IP 500 mg Approved colour to used |
| Tinidazole Tablets IP 600 mg | General / Unclassified | Each film coated tablet contains : Tinidazole IP 600 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red Iron oxide Yellow |
| Tizanidine Tablets IP | General / Unclassified | Each uncoated tablet contains: Tizanidine Hydrochloride IP Equivalent to Tizanidine 2 mg Excipients q.s. Approved color to be use |
| Tizanidine Tablets IP | General / Unclassified | Each uncoated tablet contains: Tizanidine Hydrochloride IP Equivalent to Tizanidine 4 mg Excipients q.s. Approved color to be use |
| Tizanidine Tablets IP | General / Unclassified | Each uncoated tablet contains: Tizanidine Hydrochloride IP 6 mg Equivalent to Tizanidine Excipients q.s. Approved color to be use |
| Tofacitinib Tablets | General / Unclassified | Each film coated tablet contains Tofacitinb Citrate Eq. to Tofacitinib 5 mg Approved colour to be used |
| Tofisolam Tablets | General / Unclassified | Each uncoated tablet contains : Tofisoalm JP 100 mg |
| Tofisolam Tablets | General / Unclassified | Each uncoated tablet contains : Tofisoalm JP 50 mg |
| Tofisopam Tablets 100 mg | General / Unclassified | Each uncoated / film coated tablets contains : Tofisopam JP 100 mg Excipients q.s. |
| Tofisopam Tablets 50 mg | General / Unclassified | Each uncoated / film coated tablets contains : Tofisopam JP 50 mg Excipients q.s. |
| Tolperisone Hydrochloride Sustained Release Tablets | General / Unclassified | Each Sustained Release tablet contains : Tolperisone Hydrochloride JP 450 mg Excipients q.s. Approved colour to used |
| Tolperisone Hydrochloride Tablets 100 mg | General / Unclassified | Each film coated tablet contains : Tolperisone Hydrochloride JP 100 mg Excipients q.s Approved colour to used |
| Tolperisone Hydrochloride Tablets 150 mg | General / Unclassified | Each film coated tablet contains : Tolperisone Hydrochloride JP 150 mg Excipients q.s Approved colour to used |
| Tolperisone Hydrochloride Tablets 50 mg | General / Unclassified | Each film coated tablet contains : Tolperisone Hydrochloride JP 50 mg Excipients q.s Approved colour to used |
| Tolperisone Sustained Release Tablets | General / Unclassified | Each Sustained Release tablet contains : Tolperisone Hydrochloride JP 450 mg Excipients q.s. Approved colour to be used |
| Tolperisone Sustained Release Tablets | General / Unclassified | Each Sustained Release tablet contains : Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Tolperisone Sustained Release Tablets | General / Unclassified | Each Prolonged Release tablet contains : Tolperisone Hydrochloride JP 450 mg Excipients q.s. Approved colour to be used |
| Tolperisone Tablets | General / Unclassified | Each film coated tablet contains : Tolperisone Hydrochloride JP 150 mg Excipients q.s. Approved colour to be used |
| Topiramate Tablets IP | General / Unclassified | Each film coated tablet contains: Topiramate IP 25 mg Approved colour to be used |
| Topiramate Tablets IP | General / Unclassified | Each film coated tablet contains: Topiramate IP 50 mg Approved colour to be used |
| Topiramate Tablets IP | General / Unclassified | Each film coated tablet contains: Topiramate IP 100 mg Approved colour to be used |
| Topiramate Tablets IP | General / Unclassified | Each film coated tablet contains: Topiramate IP 200 mg Approved colour to be used |
| Topiramate Tablets IP | General / Unclassified | Each film coated tablet contains: Topiramate IP 300 mg Approved colour to be used |
| Topiramate Tablets IP | General / Unclassified | Each film coated tablet contains: Topiramate IP 400 mg Approved colour to be used |
| Torsemide and Amiloride Tablets | General / Unclassified | Each uncoated tablet contains : Torsemide IP 10 mg Amiloride Hydrochloride IP Eq. to Anhydrous Amiloride Hcl 5 mg Excipients q.s. Approved colour used |
| Torsemide tablets IP | General / Unclassified | Each uncoated tablet contains : Torsemide IP 5 mg |
| Torsemide tablets IP | General / Unclassified | Each uncoated tablet contains : Torsemide IP 10 mg |
| Torsemide tablets IP | General / Unclassified | Each uncoated tablet contains : Torsemide IP 20 mg |
| Torsemide tablets IP | General / Unclassified | Each uncoated tablet contains : Torsemide IP 100 mg |
| Tranexamic Acid & Mefenamic Acid Tablets | General / Unclassified | Each uncoated tablet contains Tranexamic Acid BP 500 mg Mefenamic Acid IP 250 mg |
| Tranexamic Acid Tablets | General / Unclassified | Each uncoated tablet contains Tranexamic Acid BP 500 mg |
| Tranexamic acid and Etamsylate Tablets | General / Unclassified | Each film coated tablet contains: Tranexamic Acid IP 250 mg Etamsylate BP 250 mg Excipients q.s. Approved colour to be used |
| Triazolam Tablets | General / Unclassified | Each Uncoated tablet contains : Triazolam USP 0.25 mg Excipients q.s. |
| Trifluoperazine Hydrochloride Tablets IP | General / Unclassified | Each film coated tablet contains : Trifluoperazine Hydrochloride IP Eq. to Trifluoperazine 1 mg |
| Trihexyphenidyl Hydrochloride Dispersible Tablets IP 2 mg | General / Unclassified | Each Uncoated dispersible tablet contains: Trihexyphenidyl Hydrochloride IP 2 mg Excipients q.s. Approved colour to be used |
| Trihexyphenidyl Hydrochloride Tablets IP 2 mg | General / Unclassified | Each Uncoated tablet contains: Trihexyphenidyl Hydrochloride IP 2 mg Excipients q.s. Approved colour to be used |
| Trihexyphenidyl Hydrochloride Tablets IP 5 mg | General / Unclassified | Each Uncoated tablet contains: Trihexyphenidyl Hydrochloride IP 5 mg Excipients q.s. Approved colour to be used |
| Trimetazidine HCI (SR) Tablets | General / Unclassified | Each Sustained release film coated tablet contains : Trimetazidine Hydrochloride IP 60 mg Approved colour to be used |
| Trimetazidine HCL (SR) Tablets | General / Unclassified | Each modified release film coated tablet contains : Trimetazidine Hydrochloride IP 35 mg Approved colour to be used |
| Trimetazidine Hydrochlorde Modified release tablets | General / Unclassified | Each modified release film coated tablet contains : Trimetazidine Hydrochlorde IP 35 mg Approved colour to be used |
| Trimetazidine Hydrochlorde Tablets IP 20 mg | General / Unclassified | Each uncoated tablets contains Trimetazidine Hydrochlorde IP 20 mg |
| Trimetazidine Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains Trimetazidine Hydrochloride IP 20 mg |
| Trimetazidine Hydrochloride Tablets | General / Unclassified | Each uncoated tablet contains Trimetazidine Hydrochloride IP 35 mg |
| Trimetazidine Tablets | General / Unclassified | Each uncoated tablet contains : Trimetazidine Hydrochloride IP 3 mg Approved colour to be used |
| Trimetazidine Tablets IP 20mg | General / Unclassified | Each film coated tablet contains : Trimetazidine Hydrochloride IP 20 mg Approved colour to be used |
| Triplodine Hcl & Pseudoephedrine Hcl Tablets | General / Unclassified | Each uncoated tablet contains Pseudoephedrine Hydrochloride IP 60 mg Triplodine Hydrochloride IP 2.5 mg Approved colour to be used |
| Trizolam Tablets | General / Unclassified | Each Uncoated tablet contains : Triazolam USP 0.25 mg Excipients q.s. |
| Trypsin, Bromelain with Rotoside Trihydrate Tablets | General / Unclassified | Each film coated tablet contains Trypsin IP 48 mg Bromelain 90 mg Rotoside Trihydrate USP 100 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP Apple Green/Iron oxide red, Iron oxide Yellow |
| Trypsin, Bromelain, Papain and Rotoside Trihydrate Tablets | General / Unclassified | Each film coated tablet contains : Trypsin BP 96 mg Bromelain 180 mg Rotoside Trihydrate BP 200 mg Papain IP 120 mg Excipients q.s. Approved colour to be use |
| Udenafil Tablets 100 mg | General / Unclassified | Each film coated tablet contains : Udenafil IP 100 mg Approved colour to used |
| Udenafil Tablets 200 mg | General / Unclassified | Each film coated tablet contains : Udenafil IP 200 mg Approved colour to used |
| Ursodeoxycholic Acid (SR) Tablets IP | General / Unclassified | Each sustain release coated tablet contains Ursodeoxycholic Acid IP 450 mg |
| Ursodeoxycholic Acid Tablet IP 150 mg | General / Unclassified | Each film coated tablet contains Ursodeoxycholic Acid IP 150 mg Approved coloured used |
| Ursodeoxycholic Acid Tablet IP 300 mg | General / Unclassified | Each film coated tablet contains Ursodeoxycholic Acid IP 300 mg Approved coloured used |
| Valsartan Tablets IP | General / Unclassified | Each film coated tablet contains : Valsartan IP 40 mg Approved colour to be used |
| Valsartan Tablets IP | General / Unclassified | Each film coated tablet contains : Valsartan IP 80 mg Approved colour to be used |
| Valsartan Tablets IP | General / Unclassified | Each film coated tablet contains : Valsartan IP 160 mg Approved colour to used |
| Valsartan Tablets IP | General / Unclassified | Each film coated tablet contains : Valsartan IP 320 mg Approved colour to used |
| Vardenafil Chewable Tablets | General / Unclassified | Each uncoated chewable tablet contains : Vardenafil Hydrochloride Eq. to Vardenafil 20 mg Approved colour to be used |
| Vardenafil Tablets 10 mg | General / Unclassified | Each film coated tablet contains : Vardenafil Hydrochloride Eq. to Vardenafil 10 mg Approved colour to be used |
| Vardenafil Tablets 20 mg | General / Unclassified | Each film coated tablet contains : Vardenafil Hydrochloride Eq. to Vardenafil 20 mg Approved colour to be used |
| Vardenafil Tablets 40 mg | General / Unclassified | Each film coated tablet contains : Vardenafil Hydrochloride Eq. to Vardenafil 40 mg Approved colour to be used |
| Venlafaxine Prolonged-release Tablets IP | General / Unclassified | Each uncoated Prolonged-release tablet contains : VenlafaxineHydrochloride IP Eq. to Venlafaxine 25 mg Excipients q.s |
| Venlafaxine Prolonged-release Tablets IP | General / Unclassified | Each uncoated Prolonged-release tablet contains : VenlafaxineHydrochloride IP Eq. to Venlafaxine 37.5 mg Excipients q.s |
| Venlafaxine Prolonged-release Tablets IP | General / Unclassified | Each uncoated Prolonged-release tablet contains : VenlafaxineHydrochloride IP Eq. to Venlafaxine 75 mg Excipients q.s |
| Venlafaxine Prolonged-release Tablets IP | General / Unclassified | Each uncoated Prolonged-release tablet contains : VenlafaxineHydrochloride IP Eq. to Venlafaxine 150 mg Excipients q.s |
| Vonoprazan Tablets | General / Unclassified | Each film coated tablets contains : Vonoprazan Fumarate Eq. to Vonoprazan 20 mg Approved colour to be used |
| Voriconazole Tablets IP | General / Unclassified | Each film coated tablets contains : Voriconazole IP 50 mg Approved colour to used |
| Voriconazole Tablets IP | General / Unclassified | Each film coated tablets contains : Voriconazole IP 200 mg Approved colour to used |
| Warfarin Sodium Tablets 4 mg | General / Unclassified | Each uncoated tablet contains : Warfarin Sodium IP 4 mg Approved colour to used |
| Warfarin Sodium Tablets IP 1 mg | General / Unclassified | Each uncoated tablet contains : Warfarin Sodium IP 1 mg Approved colour to used |
| Warfarin Sodium Tablets IP 10 mg | General / Unclassified | Each uncoated tablet contains : Warfarin Sodium IP 10 mg Approved colour to used |
| Warfarin Sodium Tablets IP 3 mg | General / Unclassified | Each uncoated tablet contains : Warfarin Sodium IP 3 mg Approved colour to used |
| Warfarin Sodium Tablets IP 5 mg | General / Unclassified | Each uncoated tablet contains : Warfarin Sodium IP 5 mg Approved colour to used |
| Yeast Tablets B.P.C | General / Unclassified | Each uncoated tablet contains Dried Yeast Powder BPC 300 mg Excipients q.s. |
| Zopiclone Tablets IP | General / Unclassified | Each film coated tablet contains : Zopiclone IP 3.75 mg Approved colour to be used |
| Zopiclone Tablets IP | General / Unclassified | Each film coated tablet contains : Zopiclone IP 7.5 mg Approved colour to be used |
| Zopiclone Tablets IP | General / Unclassified | Each film coated tablet contains : Zopiclone IP 10 mg Approved colour to be used |
| Citicoline & Piracetam Tablets | Neuroprotective | Each uncoated tablet contains Citicoline IP 500 mg Piracetam IP 800 mg |
| Citicoline Sodium Tablets IP | Neuroprotective | Each film coated tablet contains : Citicoline Sodium IP Eq. to Citicoline 500 mg Excipients q.s. Approved colour to used |
| Citicoline Sodium and Piracetam Tablets | Neuroprotective | Each film coated tablet contains : Citicoline Sodium IP Eq. to Citicoline 500 mg Piracetam IP 800 mg Excipients q.s. Approved colour to used |
| Citicoline Sodium and Piracetam Tablets | Neuroprotective | Each film coated tablet contains : Citicoline Sodium IP Eq. to Citicoline 500 mg Piracetam IP 400 mg Excipients q.s. Approved colour to used |
| Citicoline Tablets IP | Neuroprotective | Each uncoated tablet contains Citicoline Sodium IP 500 mg |
| Piracetam Tablets | Neuroprotective | Each uncoated tablet contains Piracetam IP 800 mg |
| Piracetam Tablets | Neuroprotective | Each film coated tablet contains : Piracetam IP 800 mg Excipients q.s. Approved colour to used |
| Amitriptyline and Methylcobalamin Tablets | Nutritional Supplement | Each film coated tablet contains : Amitriptyline Hydrochloride IP 5 mg Methylcobalamin IP 1500 mcg Excipients q.s. Approved colour to be use |
| Antioxident, Multivitamins, With Multiminerals Tablets | Nutritional Supplement | Each film coated tablet contains : Vitamin A Acetate IP 5000 IU Folic Acid IP 1 mg Vitamin E Acetate IP 25 mg Thiamine Monoitrate IP 10 mg Riboflavine IP 10 mg Pyridoxine Hydrochloride IP 3 mg Nicotinamide IP 50 mg Cyanocobalamin IP 5 mcg Calcium Pantothenate IP 12.5 mg Vitamin C IP 100 mg Zinc Sulphate IP Eq. to. Elemental Zinc 15 mg Copper Sulphate IP Eq. to. Elemental Copper 1.6 mg Manganese Gluconate USP 1.4 mg Selenium Selenite USP Eq. to Selenium 60 mcg Approved Color used in Tablet |
| Ascorbic Acid & Cholecalciferol Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic acid IP 20 mg Cholecalciferol (Vitamin D3) IP 200 IU Approved colour to be used |
| Ascorbic Acid & Cholecalciferol Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic acid IP 40 mg Cholecalciferol (Vitamin D3) IP 400 IU Approved colour to be used |
| Ascorbic Acid & Cholecalciferol with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic acid IP 40 mg Cholecalciferol (Vitamin D3) IP 400 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 10 mg Approved colour to be used |
| Ascorbic Acid & Cholecalciferol with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic acid IP 500 mg Cholecalciferol (Vitamin D3) IP 400 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 5 mg Approved colour to be used |
| Ascorbic Acid & Cholecalciferol with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic acid IP 1000 mg Cholecalciferol (Vitamin D3) IP 1000 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 10 mg Approved colour to be used |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic Acid IP 100 mg Sodium Ascorbate IP 450 mg Eq. to Ascorbic Acid 400 mg Zinc Sulphate IP eq. to elemental Zinc 50 mg Approved colour to be used |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains: Ascorbic Acid IP 100 mg Sodium Ascorbate IP 450 mg Eq. to Ascorbic acid 400 mg Excipients q.s. Approved colour to be use |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains: Ascorbic Acid IP 100 mg Sodium Ascorbate IP 450 mg Eq. to Ascorbic acid 400 mg Zinc Citrate IP Eq. to elemental Zinc 5 mg Excipients q.s. Approved colour to be use |
| Ascorbic Acid & Sodium Ascorbate with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains: Ascorbic Acid IP 100 mg Sodium Ascorbate IP 450 mg Eq. to Ascorbic acid 400 mg Zinc Sulphate Eq. to elemental Zinc 5 mg Excipients q.s. Approved colour to be use |
| Ascorbic Acid with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic Acid IP 500 mg Zinc Sulphate IP Eq. to elemental Zinc 5 mg Excipients q.s. Approved colour to be use |
| Ascorbic Add & Sodium Ascorbate with Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic Acid IP 100 mg Sodium Ascorbate IP 450 mg Eq. to Ascorbic Acid 400 mg Zinc Sulphate IP eq. to elemental Zinc 20 mg Approved colour to be used |
| Ascorbic acid, Menadione, Dibasic Calcium Phophate , Cholecalciferol and Rutin | Nutritional Supplement | Each film coated tablets contains : Ascorbic acid IP 50 mg Menadione Sodium Bisulphate 20 mg Dibasic Calcium Phosphate IP 150 g Cholecalciferol (Vitamin D3) IP 300 I.U Rutin U.S.S.R.P 100 mg Excipients q.s. Approved colour to be used |
| Calcium & Vitamin D 3 Tablets IP | Nutritional Supplement | Each uncoated tablet contains: Calcium Carbonate eq. to Elemental Calcium 250 mg Vitamin D 3 IP 200 IU Excipients q.s. Permitted Color Used |
| Calcium & Vitamin D 3 Tablets IP | Nutritional Supplement | Each uncoated tablet contains: Calcium Carbonate eq. to Elemental Calcium 500 mg Vitamin D 3 IP 200 IU Excipients q.s. Permitted Color Used |
| Calcium Carbonate Tablets | Nutritional Supplement | Each film coated tablet contains : Calcium Carbonate IP 1500 mg Eq. to Calcium 600 mg Approved colour to be use q.s. |
| Calcium Carbonate With Vitamin D 3 Tablets | Nutritional Supplement | Each film coated tablet contains : 1.25 gm. Of Calcium Carbonate from an Organic Source (Osystershell) eq. to Elemental Calcium 500 mg Vitamin D 3 IP 250 IU Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Calcium Carbonate and Vitamin D3 Tablets | Nutritional Supplement | Each film coated tablet contains: Calcium Carbonate IP 1250 mg Eq. to Elemental Calcium 500 mg Vitamin D3 IP 500 IU Excipients q.s. Approved colour use |
| Calcium Carbonate, Calcitriol, Zinc Sulphate,Methylcobalamin and Magnesium | Nutritional Supplement | Each film coated tablet contains: Calcium Carbonate IP 1250 mg Calcitriol IP 0.25 mcg Zinc sulphate IP 7.5 mg Methylcobalamin IP 1500 mcg Magnesium IP 50 mg Excipients q.s. Approved colour use |
| Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate | Nutritional Supplement | Each film coated tablet contains: Calcium Carbonate IP 1250 mg Eq. to Elemental Calcium 500 mg Vitamin D3 IP 2000 IU Methylcobalamin IP 1500 mcg L-Methylfolate Calcium 1 mg Pyridoxal-5-Phosphate 20 mg Excipients q.s Approved colour use |
| Calcium Citrate Maleate, Calcitriol , Methylcobalamin with Zinc | Nutritional Supplement | Each film coated tablet contains: Calcium Citrate Maleate Eq. to Elemental Calcium 250 mg Calcitriol IP 0.5 mcg Methylcobalamin IP 1500 mcg Zinc Sulphate Mononitrate IP Eq. to Elemental Zinc 15 mg Folic Acid IP 1 mg Excipients q.s. Approved colour to be used |
| Calcium Citrate Maleate, Folic Acid and Vitamin D3 Tablets | Nutritional Supplement | Each film coated tablet contains : Calcium Citrate Maleate Eq. to Calcium 250 mg Folic acid IP 50 mcg Vitamin D3 IP 250 IU Approved colour to be use |
| Calcium Citrate Maleate, Vitamin D3 and Folic acid | Nutritional Supplement | Each film coated tablet contains: Calcium Citrate Maleate 500 mg Vitamin D3 IP 200 IU Folic acid IP 5 mg Approved colour to be use q.s. |
| Calcium Citrate, Calcitriol with Zinc Tablets | Nutritional Supplement | Each film coated tablet contains Calcium Citrate Malate 1000 mg Calcitriol IP 0.25 mcg Zinc Sulphate IP 7.5 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron Oxide Yellow |
| Calcium Lactate Tablets IP | Nutritional Supplement | Each uncoated tablet contains : Calcium Lactate IP 300 mg |
| Calcium With Vitamin D3 Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Tribasic Calcium Phosphate IP 380 mg Vitamin D3 IP 400 IU Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red iron oxide Yellow |
| Calcium, Glucosamine, Methylcobalamin & Methyl sulphonylmethane | Nutritional Supplement | Each film coated tablet contains Calcim Carbonate IP 250 mg Glucosamine Sulphate Potassium Chloride USP 500 mg Manganese (Maganese Sulphate IP) 20 mg Vitamin E 4 mg Methyl sulphonyl Methane USP 250 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP Apple Green / Iron oxide red,Iron oxide Yellow |
| Calcium, Vitamin D3, Mecobalamin and Pyridoxal-5-Phosphate | Nutritional Supplement | Each film coated tablet contains : Calcium Carbonate IP 1250 mg Eq. to Elemental Calcium 500 mg Vitamin D3 IP 2000 IU Mecobalamin IP 1500 mcg L-Methylfolate Calcium 1 mg Pyridoxal-5-Phosphate IP 20 mg Excipients q.s. Approved colour to be use |
| Calciumn and Vitamin D3 Tablets | Nutritional Supplement | Each film coated tablet contains : Calcium Carbonate IP 1500 mg Eq. to Calcium 600 mg Vitammin D3 IP 200 IU Approved colour to be use q.s. |
| Cholecalciferol Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Cholecalciferol (Vitamin D3) IP 600 IU Approved colour to be used |
| Cholecalciferol Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Cholecalciferol (Vitamin D3) IP 400 IU Approved colour to be used |
| Cholecalciferol Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Cholecalciferol (Vitamin D3) IP 60000 IU Approved colour to be used |
| Diacerein, Glucosamine, Methylcobalamin & Methyl sulphonyl Methane | Nutritional Supplement | Each film coated tablet contains Diacerein IP 50 mg Glucosamine Sulphate Potassium Chloride IP 750 mg Methylcobalamin 750 mcg Methyl sulphonyl Methane USP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Doxylamine, Pyridoxine HCI and Folic Acid Tablets | Nutritional Supplement | Each enteric coated tablet contains : Doxylamine Succinate BP 10 mg Pyridoxine Hydrochloride IP 10 mg Folic acid IP 2.5 mg Approved colour to be use |
| Doxylamine, Pyridoxine HCL and Folic Acid Tablets | Nutritional Supplement | Each enteric coated tablet contains : Doxylamine Succinate BP 20 mg Pyridoxine HCI IP 20 mg Folic acid IP 5 mg Approved colour to be use |
| Ferrous Ascorbate & Folic Acid Tablets | Nutritional Supplement | Each film coated tablet contains: Ferrous Ascorbate IP 100mg Eq. to elemental Iron Folic Acid IP 1.5mg Excipients q.s. Approved colour to be used |
| Ferrous Ascorbate, Folic Acid and Zinc Tablets | Nutritional Supplement | Each film coated tablet contains : Ferrous Ascorbate Eq. to elemental Iron 100 mg Folic acid IP 1.5 mg Zinc Sulphate Monohydrate IP Eq. to Zinc 22.5 mg Approved colour to be use |
| Ferrous Ascorbate, Folic Acid, Zinc and Methylcobalamin Tablets | Nutritional Supplement | Each film coated tablet contains: Ferrous Ascorbate Eq. to elemental Iron 100 mg Folic acid IP 1 mg Zinc Sulphate Monohydrate IP Eq. to Zinc 10 mg Methylcobalamin IP 500 mcg Approved colour to be use |
| Ferrous Fumarate, Folic Acid and Zinc Tablets | Nutritional Supplement | Each film coated tablets contains Ferrous Fumarate IP 152 mg Eq. to Elemental Iron 49.5 mg Folic Acod IP 750 mcg Zinc Sulphate Monohydrate IP 61.8 mg Eq. to Elemental Zinc 22.5 mg Approved color to be use |
| Ferrous Sulphate Tablets | Nutritional Supplement | Each film coated tablet contains : Ferrous Sulphate IP 300 mg Eq. to elemental Iron 60 mg Approved colour to be use |
| Ferrous Sulphate Tablets IP | Nutritional Supplement | Each film coated tablet contains : Dried Ferrous Sulphate IP 200 mg Eq. to Ferrous Iron 60 mg Approved colour use |
| Ferrous Sulphate and Folic Acid Tablets IP | Nutritional Supplement | Each film coated tablet contains : Ferrous Sulphate IP 300 mg Eq. to elemental Iron 60 mg Folic acid IP 0 .25 mg Approved colour to be use |
| Ferrous Sulphate, Folic Acid and Zinc Tablets | Nutritional Supplement | Each film coated tablet contains : Ferrous Sulphate IP 300 mg Eq. to elemental Iron 60 mg Folic acid IP 1.5 mg Zinc Sulphate Monohydrate IP Eq. to Zinc 22.5 mg Approved colour to be use |
| Ferrous Sulphate, and Folic Acid Tablets | Nutritional Supplement | Each Sugar coated tablet contains : Dried Ferrous Sulphate IP 200 mg Eq. to Elemental Iron 60 mg Folic acid IP 1 mg Approved colour to be use |
| Folic Acid Tablets | Nutritional Supplement | Each uncoated tablet contains: Folic Acid IP 2 mg Excipients q.s |
| Folic Acid Tablets | Nutritional Supplement | Each uncoated tablet contains: Folic Acid IP 3 mg Excipients q.s |
| Folic Acid Tablets IP | Nutritional Supplement | Each uncoated tablet contains : Folic Acid IP 100 mcg Excipients q.s. |
| Folic Acid Tablets IP | Nutritional Supplement | Each uncoated tablet contains : Folic Acid IP 5 mg Excipients q.s. |
| Folic Acid Tablets IP | Nutritional Supplement | Each uncoated tablet contains: Folic Acid IP 1 mg Excipients q.s |
| Folic Acid Tablets IP | Nutritional Supplement | Each uncoated tablet contains: Folic Acid IP 10 mg Excipients q.s |
| Gabapentin and Methylcobalamin Tablets | Nutritional Supplement | Each film coated tablet contains : Gabapentin IP 100 mg Methylcobalamin IP 500 mcg Approved colour to be use q.s. |
| Gabapentin with Methylcobalamin | Nutritional Supplement | Each film coated tablet contains Gabapentin IP 100 mg Methylcobalamin 1500 mcg Colour: Brilliant Blue / Erythrosine/Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Glucosamine, Methylcobalamin Methyl sulphonyl Methane | Nutritional Supplement | Each film coated tablet contains Glucosamine Sulphate Potassium Chloride IP 750 mg Methylcobalamin 750 mcg Methyl sulphonyl Methane USP 250 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Iron & Folic Acid Tablets IP | Nutritional Supplement | Each film coated tablet contains: Ferrous Sulphate IP Eq. to elemental Iron 100 mg Folic Acid IP 1.5 mg Permitted Color Used |
| L-Ornithine – L-Aspartate, Silymarin with Mutil-Vitamins Tablets | Nutritional Supplement | Each film coated tablet contains: L-Ornithine – L-Aspartate 250 mg Silymarin 140 mg Calcium D Pantothenate IP 10 mg Thiamine Mononitrate IP 5 mg Riboflavine IP 5 mg Pyridoxine Hydrochloride IP 3 mg Methylcobalamin IP 20 mcg Excipients q.s. Approved colour to be used |
| Lactic acid basillus, Vitamin B12 and Folic acid Dispersible Tablets | Nutritional Supplement | Each Uncoated Dispersible tablet contains: Lactic acid basillus 120 mill. Spore Vitamin B 12 IP 5 mcg Folic acid IP 1500 mcg Excipients q.s. Approved colour to be used |
| Meclizine HCL (SR) with Folic Acid Tablets | Nutritional Supplement | Each film coated Sustain release tablets contains Meclizine Hydrochloride IP 50 mg Eq. to Meclizine (As sustain release) Folic acid IP 5 mg Excipients q.s. Approved colour to be used |
| Mecobalamin & Epalrestat Tablets | Nutritional Supplement | Each Uncoated tablet contains: Mecobalamin IP 500 mcg Epalrestat 50 mg Approved colour to be used |
| Mecobalamin, Folic Acid, Benfotiamine, Alpha Lipoic Acid and Chromium | Nutritional Supplement | Each film coated tablet contains : Mecobalamin IP 1500 mcg Folic acid IP 1.5 mg Benfotiamine IP 200 mg Alpha Lipoic Acid IP 100 mg Chromium Polynicotinate 200 mcg Myo Inositol 10 mg Pyridoxine HCl IP 20 mg Approved colour to be use |
| Mecobalamin, Pyridoxine HCI Alpha Lipoic Acid and Benfotiamine | Nutritional Supplement | Each film coated tablet contains: Mecobalamin IP 0.5 mg Pyridoxine Hydrochloride IP 50 mg Benfotiamine 100 mg Alpha Lipoic Acid IP 100 mg Excipients q.s. Approved colour to be use |
| Mecobalamin, Pyridoxine and Nicotinamide Tablets | Nutritional Supplement | Each film coated tablet contains : Mecobalamin IP 750 mcg Pyridoxine Hydrochloride IP 1.5 mg Nicotinamide IP 45 mg Excipients q.s. Approved colour to be use |
| Mecobalamine, Foilc Acid, Riboflavin, Pyridoxine, Naicinamide | Nutritional Supplement | Each film coated tablet contains: Mecobalamine IP 1000 mcg Foilc Acid, IP 1 mg Riboflavin IP 10 mg Pyridoxine Hydrochloride IP 3 mg Naicinamide IP 45 mg Calcium Panthothenate IP 50 mg Excipients q.s. Permitted Color Used |
| Methylcobalamin & Pregabaline Tablets | Nutritional Supplement | Each film coated tablet contains : Methylcobalamin IP 750 mcg Pregabaline IP 75 mg Approved colour to be use |
| Methylcobalamin Tablets | Nutritional Supplement | Each film coated tablet contains : Methylcobalamin IP 1500 mcg Approved colour to be use |
| Methylcobalamin Tablets | Nutritional Supplement | Each film coated tablet contains : Methylcobalamin IP 500 mcg Approved colour to be use |
| Methylcobalamin and Gabapentine Tablets | Nutritional Supplement | Each film coated tablet contains : Methylcobalamin IP 500 mcg Gabapentine IP 300 mg Approved colour to be use q.s. |
| Methylcobalamin, Biotin with Pyridoxine Hydrochloride | Nutritional Supplement | Each film coated tablet contains Methylcobalamin 1500 mcg Biotin IP 5 mg Pyridoxine Hydrochloride IP 10 mg Folic Acid IP 5 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP IApple Green / Iron oxide red,Iron oxide Yellow |
| Methylcobalamin, Folic acid and L-Carnitine Tartrate Tablets | Nutritional Supplement | Each film cooted tablet contains : Methylcobalamin IP 1500 mcg Folic Acid IP 1.5 mg L-Carnitine L-Tartrate IP Eq. L-Carnitine 500 mg Approved colour to be use |
| Methylcobalamin, Glutamic Acid and Folic Acid Tablets | Nutritional Supplement | Each film coated tablet contains : Methylcobalamin IP 1500 mcg Glutamic Acid IP 100 mg Folic acid IP 1 mg Approved colour to be use q.s. |
| Methylcobalamin, Pregabaline & Nortriptyline Tablets | Nutritional Supplement | Each film coated tablet contains : Methylcobalamin IP 1500 mcg Pregabaline IP 75 mg Nortriptyline HCl IP Eq. to Nortriptyline 10 mg Approved colour to be use q.s. |
| Methylcobalamin, Pyridoxine & Folic Acid Tablets | Nutritional Supplement | Each film coated tablet contains Methylcobalamin 500 mcg Pyridoxine Hydrochloride IP 5 mg Folic Acid IP 5 mg Colour: Brilliant Blue / Erythrosine / Tartrazine/ Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green/Iron oxide red,Iron oxide Yellow |
| Methylcobalamin, Pyridoxine Hydrochloride,Vit D3 and Folic Acid Tablets | Nutritional Supplement | Each uncoated mouth dissolving tablets contains Methylcobalamin IP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Vitamin d3 IP 1000 IU Folic Acid IP 5 mg Excipients q.s. Approved colour to be used |
| Multivitamins, Multiminerals With Ginseng Tablets | Nutritional Supplement | Each film coated tablet contains : Vitamin A IP 250 mcg Vitamin B 1 Mononitrate IP 1 mg Vitamin B 2 IP 1.5 mg Vitamin B3 IP 10 mg Vitamin B6 IP 1 mg Vitamin B 12 IP 1 mcg Vitamin D3 (As Cholecalciferol) IP 5 IU Vitamin E IP 1.25 mg Folic Acid IP 0.15 mg Biotin 30 mcg Zinc ( As Zinc Sulphate) USP 15 mg lodine (As Potassium lodide) IP 0.15 mg Carbonyl Iron 30 mg Maganesium Sulphate IP 100 mg Manganese USP 2.5 mg Copper USP 2 mg Calcium IP 250 mg Phosphorous 125 mg Potassium 40 mg Chloride IP 36.3 mg Selenium USP 30 mcg Nickel IP 5 mcg Silicon USP 2 mg Vanadium IP 10 mcg Boron IP 150 mcg Chromium 25 mcg Tin 10 mcg Ginseng extract powder 21.25 mg Excipients q.s. |
| Riboflavin, Folic Acid, Niacinamide and Lactic acid Bacillus Tablets | Nutritional Supplement | Each uncoated tablet contains : Riboflavin IP 10 mg Foilc Acid IP 1.5 mg Niacinamide IP 100 mg Lactic acid Bacillus 60 mil.spo Approved colour to be use |
| Silymarin, L-Onithine L-Aspartate, Pancreatin, Lecithin, Pyridoxine and Folic acid | Nutritional Supplement | Each film coated tablet contains : Silymarin 140 mg L-Onithine L-Aspartate 150 mg Pancreatin IP 100 mg Lecithin 125 mg Pyridoxine Hcl IP 2 mg Folic acid IP 1.5 mcg Approved colour to be use |
| Spironolactone Tablets IP | Nutritional Supplement | Each uncoated tablet contains Spironolactone IP 25 mg |
| Spironolactone Tablets IP | Nutritional Supplement | Each uncoated tablet contains Spironolactone IP 50 mg |
| Spironolactone Tablets IP | Nutritional Supplement | Each uncoated tablet contains Spironolactone IP 100 mg |
| Thiamine (Mono), Riboflavine , Nicotinamide & Pyridoxine Hcl,Calcium Pantothenate and Cyanocobalamin | Nutritional Supplement | Each film coated tablet contains : Thiamine Monoitrate IP 5 mg Riboflavine IP 5 mg Nicotinamide IP 50 mg Pyridoxine Hydrochloride IP 1.5 mg Calcium Pantothenate IP 10 mg Cyanocobalamin IP 5 mcg Foilc Acid IP 1000 mcg Approved Color to be use in Tablet |
| Thiamine (Mono), Riboflavine , Nicotinamide & Pyridoxine Hcl,Calcium Pantothenate and Cyanocobalamin | Nutritional Supplement | Each film coated tablet contains : Thiamine Monoitrate IP 10 mg Riboflavine IP 5 mg Nicotinamide IP 100 mg Pyridoxine Hydrochloride IP 3 mg Calcium Pantothenate IP 50 mg Cyanocobalamin IP 15 mcg Excipients q.s. Approved Color to be use in Tablet |
| Thiamine (Mono), Riboflavine Pyridoxine Hydrochloride,Naicinamide and Calcium Panthothenate | Nutritional Supplement | Each film coated tablet contains : Vitamin B 1 Mononitrate IP 2 mg Vitamin B 2 IP 2 mg Vitamin B6 IP 1 mg Vitamin B 12 IP 1 mcg Naicinamide IP 15 mg Calcium Panthothenate IP 5 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Torsemide and Spironolactone Tabiets | Nutritional Supplement | Each uncoated tablet contains : Torsemide IP 10 mg Spironolactone IP 25 mg Excipients q.s. Approved colour used |
| Torsemide and Spironolactone Tabiets | Nutritional Supplement | Each uncoated tablet contains : Torsemide IP 10 mg Spironolactone IP 50 mg Excipients q.s. Approved colour used |
| Vitamin A & Vitamin D Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin A IP 1000 IU Vitamin D3 IP 400 IU Approved colour to be used |
| Vitamin A & Vitamin D Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin A IP 10000 IU Vitamin D3 IP 1000 IU Approved colour to be used |
| Vitamin A Acetate, Vitamin D 3 Thiamine, Riboflavin and Naicinamide | Nutritional Supplement | Each film coated tablet contains : Vitamin A Acetate IP 750 mcg Vitamin D 3 IP 200 IU Thiamine Monanitrate IP 0.5 mg Riboflavin IP 0.5 mg Naicinamide IP 5 mg Excipients q.s. Permitted Color Used |
| Vitamin A Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin A IP 1000 IU Approved colour to be used |
| Vitamin A Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin A IP 5000 IU Approved colour to be used |
| Vitamin A Chewable Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin A IP 50000 IU Approved colour to be used |
| Vitamin B-Complex Tablets | Nutritional Supplement | Each film coated tablet contains Thiamine Mononitrate IP 2 mg Riboflavin IP 2 mg Pyridoxine Hydrochloride IP 1 mg Niacinamide IP 15 mg Calcium Pantothenate IP 5 mg Colour: Brilliant Blue / Erythrosine/Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red,Iron oxide Yellow |
| Vitamin B-Complex Tablets For Prophylactic Use | Nutritional Supplement | Each film coated tablet contains : Vitamin B1 IP 2 mg Vitamin B2 IP 2 mg Vitamin B6 IP 0.50 mg Naicinamide IP 25 mg Calcium Panthothenate IP 1 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Vitamin C & Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin C IP 1000 mg Zinc Sulphate IP eq. to elemental Zinc 20 mg Approved colour to be used |
| Vitamin C & Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin C IP 1000 mg Zinc Sulphate IP eq. to elemental Zinc 50 mg Approved colour to be used |
| Vitamin C & Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin C IP 500 mg Zinc Sulphate IP eq. to elemental Zinc 20 mg Approved colour to be used |
| Vitamin C & Zinc Tablets | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin C IP 500 mg Zinc Sulphate IP eq. to elemental Zinc 50 mg Approved colour to be used |
| Vitamin C Chewable Tablets IP | Nutritional Supplement | Each uncoated chewable tablet contains : Vitamin C IP 100 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Vitamin C Chewable Tablets IP | Nutritional Supplement | Each uncoated chewable tablet contains : Ascorbic Acid IP 500 mg Excipients q.s. Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / Iron oxide red, Iron oxide Yellow |
| Vitamin D3, Calcium, L-Methylfolate & Boron with Caclium Citrate Maleate, Methylcobalamin | Nutritional Supplement | Each film coated chewable tablet contains : Vitamin D3 IP 1000 IU Caclium Citrate Maleate IP 1180 mg Eq. to Calcium 250 mg L-Methylfolate 468 mg Boron 1.5 mg Methylcobalamin IP 1500 mcg Excipients q.s. Approved colour to be use |
| Vitamin K 2-7, Calcium Citrate, Calcitriol, Zinc Sulphate and Folic acid | Nutritional Supplement | Each film coated tablet contains: Vitamin K 2-7 50 mcg Calcium Citrate Maleate eq. to Elemental Calcium 250 mg Calcitriol IP 0.25 mcg Zinc Sulphate IP 7.5 mg Folic Acid IP 100 mcg Excipients q.s. Permitted Color Used |
| Vitamin K2-7, Calcium Carbonate, Calcitriol, Zinc Sulphate,L-Methyl Folate , Methylcobalamin and Magnesium | Nutritional Supplement | Each film coated tablet contains : Vitamin K 2-7 45 mcg Calcium Carbonate IP 1250 mg Calcitriol IP 0.25 mcg Zinc sulphate IP 7.5 mg L-Methyl Folate 800 mcg Methylcobalamin IP 1500 mcg Magnesium IP 50 mg Excipients q.s Approved colour use |
| Zinc Acetate Tablets | Nutritional Supplement | Each uncoated tablet contains: Zinc Acetate IP eq. to elemental Zinc 20 mg Approved colour to be used |
| Zinc Acetate Tablets | Nutritional Supplement | Each uncoated tablet contains: Zinc Acetate IP eq. to elemental Zinc 50 mg Approved colour to be used Contains : Povidone-lodine IP 5 % w/v Permitted Color Used |
| Zinc Sulphate Dispersible Tablets IP | Nutritional Supplement | Each uncoated dispersible tablet contains: Zinc Sulphate Monohydrate IP eq. to elemental Zinc 10 mg Approved colour to be used |
| Zinc Sulphate Dispersible Tablets IP | Nutritional Supplement | Each uncoated dispersible tablet contains: Zinc Sulphate Monohydrate IP eq. to elemental Zinc 20 mg Approved colour to be used |
| Zinc Sulphate Tablets | Nutritional Supplement | Each uncoated bless contains Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 5 mg Approved colour to used |
| Zinc Sulphate Tablets | Nutritional Supplement | Each uncoated tablet contains : Zinc Sulphate IP eq. to elemental Zinc 10 mg Approved colour to be used |
| Zinc Sulphate Tablets | Nutritional Supplement | Each uncoated tablet contains : Zinc Sulphate IP eq. to elemental Zinc 20 mg Approved colour to be used |
| Zinc Sulphate Tablets | Nutritional Supplement | Each uncoated tablet contains : Zinc Sulphate IP eq. to elemental Zinc 50 mg Approved colour to be used |
| Codeine Phosphate Tablets IP | Opioid Analgesic | Each uncoated tablet contains : Codeine Phosphate IP 10 mg Approved colour to used |
| Codeine Phosphate Tablets IP | Opioid Analgesic | Each uncoated tablet contains : Codeine Phosphate IP 30 mg Approved colour to used |
| Codeine Phosphate Tablets IP | Opioid Analgesic | Each uncoated tablet contains : Codeine Phosphate IP 60 mg Approved colour to used |
| Dihydrocodeine Tablets | Opioid Analgesic | Each uncoated tablet contains : Dihydrocodeine IP 30 mg Approved colour to used |
| Tramadol HCl Tablets | Opioid Analgesic | Each film coated tablet contains : Tramadol Hydrochloride IP 100 mg Approved colour to used |
| Tramadol Hydrochloride & Paracetmol Sustained Release Tablet | Opioid Analgesic | Each Film coated sustained release tablet contains: Tramadol Hydrochloride IP 37.5 mg Paracetmol IP 325 mg Approved colour to be used |
| Tramadol Hydrochloride & Paracetmol Tablets | Opioid Analgesic | Each film coated tablet contains : Tramadol Hydrochloride IP 37.5 mg Paracetmol IP 325 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide ir /Apple Green / Iron oxide red iron oxide Yellow |
| Tramadol Hydrochloride & Paracetmol Tablets | Opioid Analgesic | Each film coated tablet contains : Tramadol Hydrochloride IP 50 mg Paracetmol IP 325 mg Colour: Brilliant Blue / Erythrosine/Tartrazine/Quinoline Yellow / Sunset yellow or Titanium Dioxide ir /Apple Green / Iron oxide red iron oxide Yellow |
| Tramadol Hydrochloride Sustained Release Tablet | Opioid Analgesic | Each sustained release tablet contains Tramadol Hydrochloride IP 100 mg Approved colour to used |
| Tramadol Hydrochloride Tablets | Opioid Analgesic | Each uncoated tablet contains : Tramadol Hydrochloride IP 50 mg Colour: Brilliant Blue / Erythrosine / Tartrazine / Quinoline Yellow / Sunset yellow or Titanium Dioxide IP /Apple Green / tron oxide red,Iron oxide Yellow |
| Tramadol Hydrochloride Tablets | Opioid Analgesic | Each film coated tablet contains : Tramadol Hydrochloride IP 100 mg Approved colour to be used |
| Levothyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Levothyroxine Sodium IP eq.to Thyroxine Sodium 175 mcg |
| Levothyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Levothyroxine Sodium IP eq.to Thyroxine Sodium 350 mcg |
| Levothyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Levothyroxine Sodium IP eq.to Thyroxine Sodium 700 mcg |
| Thyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Thyroxine Sodium IP 25 mcg |
| Thyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Thyroxine Sodium IP 50 mcg |
| Thyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Thyroxine Sodium IP 75 mcg |
| Thyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Thyroxine Sodium IP 100 mcg |
| Thyroxine Sodium Tablets IP | Thyroid Hormone | Each uncoated tablet contains Thyroxine Sodium IP 125 mcg |
| Dutasteride & Alfuzocin Hydrochloride (ER) Tablets | Urological | Each film coated tablet contains: Dutasteride IP 0.5 mg Alfuzocin Hydrochloride IP 10.0 mg (As Modified Release) Excipients q.s. Approved colour to be used |
| Dutasteride & Tamsulosin Hydrochloride (MR) Tablets | Urological | Each film coated tablet contains: Dutasteride IP 0.5 mg Tamsulosin hydrochloride IP 0.4 mg (As Modified Release) Excipients q.s. Approved colour to be used |
| Dutasteride & Tamsulosin Hydrochloride Tablets | Urological | Each film coated tablet contains: Dutasteride IP 0.5 mg Tamsulosin hydrochloride IP 0.4 mg Excipients q.s. Approved colour to be used |
| Dutasteride Tablets | Urological | Each film coated tablet contains : Dutasteride IP 0.5 mg Excipients q.s. Approved colour to be used |
| Tamsulosin Hydrochloride (MR) Tablets | Urological | Each film coated tablet contains: Tamsulosin hydrochloride IP 0.4 mg (As Modified Release) Excipients q.s. Approved colour to be used |
| Tamsulosin Hydrochloride Tablets | Urological | Each film coated tablet contains: Tamsulosin hydrochloride IP 0.4 mg Excipients q.s. Approved colour to be used |
Capsules Index
- Analgesic (Pain Relief)
- Anti-allergic
- Anti-asthmatic / Cough & Cold
- Anti-fungal
- Anti-viral
- Antibiotic
- Cardiovascular
- CNS & Neuropathic
- Erectile Dysfunction
- Gastrointestinal & Antacid
- General / Unclassified
- Nutritional Supplement
- Opioid Analgesic
| Formulation | Therapeutic Usage | Composition |
|---|---|---|
| DICYCLOMINE HYDROCHLORIDE & DICLOFENAC SODIUM CAPSULES | Analgesic (Pain Relief) | Each hard gelatin capsule contains Dicyclomine Hydrochloride IP 20 mg Diclofenac Sodium IP 50 mg Approved colour used in empty capsule shell |
| DICYCLOMINE HYDROCHLORIDE & PARACETAMOL CAPSULES | Analgesic (Pain Relief) | Each hard gelatin capsule contains Dicyclomine Hydrochloride IP 10 mg Paracetamol IP 325 mg Excipients q.s. Approved colour used in empty capsule shell |
| Diclofenac Sodium (SR) and Eperisone HCI (SR) | Analgesic (Pain Relief) | Each hard gelatin capsule contains Diclofenac Sodium IP 100 mg As sustained release pellets) Eperisone Hydrochloride JP 150 mg (As sustained release pellets) Approved colour used in empty capsule shell |
| Dicyclomine HCI , Tramadol HCI And Paracetamol | Analgesic (Pain Relief) | Each hard gelatin capsule contains Dicyclomine Hydrochloride IP 10 mg Tramadol Hydrochloride IP 50 mg Paracetamol IP 325 mg Excipients q.s. Approved colour used in empty capsule shell |
| PIROXICAM CAPSULE IP 10 mg. | Analgesic (Pain Relief) | Each hard gelatin capsule contains Piroxicam IP 10 mg Excipients q.s. Approved colour used in empty capsule shell |
| PIROXICAM CAPSULE IP 20 mg. | Analgesic (Pain Relief) | Each hard gelatin capsule contains Piroxicam IP 20 mg Excipients q.s. Approved colour used in empty capsule shell |
| Sildenafil, Dapoxetine Hcl, Diclofenac sodium and Pyridoxine Hydrochloride | Analgesic (Pain Relief) | Each hard gelatin capsule contains : Sildenafil Citrate IP Eq. to Sildenafil 100 mg Dapoxetine Hydrochloride IP Eq. to Dapoxetine 30 mg Diclofenac sodium IP 50 mg Pyridoxine Hydrochloride IP 10 mg Approved colour used in empty capsule shell |
| CHLORPHENIRAMINE MALEATE CAPSULES IP | Anti-allergic | Each hard gelatin capsule contains Chlorpheniramine Maleate IP 8 mg Approved colour used in empty capsule shell |
| Cyproheptadine Hydrochloride Capsules | Anti-allergic | Each hard gelatin capsule contains Cyproheptadine Hydrochloride IP 4 mg Excipients q.s. Approved colour use in empty capsule shell |
| Cyproheptadine Hydrochloride Capsules | Anti-allergic | Each hard gelatin capsule contains Cyproheptadine Hydrochloride IP 4 mg Colour: Brilliant Blue / Tartrazine / Ponceau 4R Approved colour used in empty capsule shell |
| DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE IP | Anti-allergic | Each hard gelatin capsule contains Diphenhydramine Hydrochloride IP 25 mg Excipients q.s. Approved colour used in empty capsule shell |
| PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE CAPSULES | Anti-allergic | Each hard gelatin capsule contains Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 4 mg Excipients q.s. Approved colour used in empty capsule shell |
| Acebrophylline Capsules | Anti-asthmatic / Cough & Cold | Each hard gelatin capsule : Acebrophylline 200 mg Approved colour used in empty capsule shell |
| Acebrophylline Capsules | Anti-asthmatic / Cough & Cold | Each hard gelatin capsule contains Acebrophylline 100 mg Approved colour used in empty capsule shell |
| FLUCONAZOLE CAPSULES IP | Anti-fungal | Each hard gelatin capsule contains Fluconazole IP 150 mg Approved colour used in empty capsule shell |
| Itraconazole Capsules | Anti-fungal | Each hard gelatin capsule contains Itraconazole (As pellets) BP 100 mg Approved colour used in empty capsule shell |
| Itraconazole Capsules | Anti-fungal | Each hard gelatin capsule contains Itraconazole (As pellets) BP 200 mg Approved colour used in empty capsule shell |
| Itraconazole IR Pellets 20.00 % W/W | Anti-fungal | Each 1 gm coated pellets contains Itraconazole 200 mg Approved colour to be use |
| Itraconazole IR Pellets 22.00 % W/W | Anti-fungal | Each 1 gm coated pellets contains Itraconazole 220 mg Approved colour to be use |
| Itraconazole IR Pellets 35.00 % w/w | Anti-fungal | Each 1 gm coated pellets contains Itraconazole 350 mg Approved colour to be use |
| Oseltamivir Phosphate Capsules IP | Anti-viral | Each hard gelatin capsule contains Oseltamivir Phosphate IP 75 mg Eq. to Oseltamivir Excipients q.s. Approved colour use in empty capsule shell |
| Oseltamivir Phosphate Capsules IP | Anti-viral | Each hard gelatin capsule contains Oseltamivir Phosphate IP 45 mg Eq. to Oseltamivir Excipients q.s. Approved colour use in empty capsule shell |
| Oseltamivir Phosphate Capsules IP | Anti-viral | Each hard gelatin capsule contains Oseltamivir Phosphate IP 30 mg Eq. to Oseltamivir Excipients q.s. Approved colour use in empty capsule shell |
| DOXYCYCLINE HYDROCHLORIDE CAPSULES IP | Antibiotic | Each hard gelatin capsule contains Doxycycline Hydrochloride IP Equivalent to Doxycycline 100 mg Excipients q.s. Approved colour used in empty capsule shell |
| DOXYCYCLINE WITH LACTIC ACID BACILLUS CAPSULES | Antibiotic | Each hard gelatin capsule contains Doxycycline Hyclate IP Equivalent to Doxycycline 100 mg (Coated Pellets) Lactic Acid Bacillus 90 mill.Spor (As Enteric Coated Pellets) Excipients q.s. Approved colour used in empty capsule shell |
| Doxycycline Hydrochloride & Sarratiopeptidase | Antibiotic | Each hard gelatin capsule contains Doxycycline Hydrochloride IP 100 mg Sarratiopeptidase IP 10 mg (As enteric coated granules) Approved colour used in empty capsule shell |
| Diazepam Capsules IP | CNS & Neuropathic | Each hard gelatin capsule contains Diazepam IP 5 mg Approved colour used in empty capsule shell |
| Diazepam Capsules IP | CNS & Neuropathic | Each hard gelatin capsule contains Diazepam IP 10 mg Approved colour used in empty capsule shell |
| Fluoxetine Capsules IP 10 mg | CNS & Neuropathic | Each hard gelatin capsule contains Fluoxetine Hydrochloride IP Eq.to Fluxetine 10 mg Approved colour use in empty capsule shell |
| Fluoxetine Capsules IP 20 mg | CNS & Neuropathic | Each hard gelatin capsule contains Fluoxetine Hydrochloride IP Eq.to Fluxetine 20 mg Approved colour use in empty capsule shell |
| Methylcobalmin, & Pregabalin | CNS & Neuropathic | Each hard gelatin capsule contains Methylcobalmin 1500 mcg Pregabalin IP 75 mg Approved colour used in empty capsule shell |
| Methylcobalmin, & Pregabalin | CNS & Neuropathic | Each hard gelatin capsule contains Methylcobalmin 750 mcg Pregabalin IP 75 mg Approved colour used in empty capsule shell |
| Pregabalin Capsules IP 100 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 100 mg Approved colour use in empty capsule shell |
| Pregabalin Capsules IP 150 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 150 mg Approved colour use in empty capsule shell |
| Pregabalin Capsules IP 225 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 225 mg Approved colour use in empty capsule shell |
| Pregabalin Capsules IP 25 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 25 mg Approved colour use in empty capsule shell |
| Pregabalin Capsules IP 300 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 300 mg Approved colour use in empty capsule shell |
| Pregabalin Capsules IP 50 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 50 mg Approved colour use in empty capsule shell |
| Pregabalin Capsules IP 75 mg | CNS & Neuropathic | Each hard gelatin capsule contains Pregabalin IP 75 mg Approved colour use in empty capsule shell |
| Atorvastatin & Aspirin Capsules | Cardiovascular | Each hard gelatin capsule: Atorvastatin Calcium IP eq. to Atorvastatin (As pellets) 10 mg Aspirin (As Enteric coated pellets) IP 150 mg. Approved coloured used in empty capsule shell |
| Atorvastatin & Aspirin Capsules | Cardiovascular | Each hard gelatin capsule: Atorvastatin Calcium IP eq. to Atorvastatin (As pellets) 20 mg Aspirin (As Enteric coated pellets) IP 150 mg. Approved coloured used in empty capsule shell |
| Atorvastatin & Aspirin Capsules | Cardiovascular | Each hard gelatin capsule: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Aspirin IP 75 mg |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Cardiovascular | Each hard gelatin capsule contains Atorvastatin Calcium IP Eq. to Atorvastatin (As pellets) 10 mg Clopidogrel Bisulphate IP Eq. Clopidogrel (As pellets) 75 mg Aspirin IP 75 mg (As Enteric coated pellets) Approved colour use in empty capsule shell |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Cardiovascular | Each hard gelatin capsule contains Atorvastatin Calcium IP Eq. to Atorvastatin (As pellets) 20 mg Clopidogrel Bisulphate IP Eq. Clopidogrel (As pellets) 75 mg Aspirin IP 75 mg (As Enteric coated pellets) Approved colour use in empty capsule shell |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Cardiovascular | Each hard gelatin capsule contains Atorvastatin Calcium IP Eq. to Atorvastatin (As pellets) 20 mg Clopidogrel Bisulphate IP Eq. Clopidogrel (As pellets) 75 mg Aspirin IP 150 mg (As Enteric coated pellets) Approved colour use in empty capsule shell |
| Atorvastatin, Clopidogrel and Aspirin Capsules | Cardiovascular | Each hard gelatin capsule contains Atorvastatin Calcium IP Eq. to Atorvastatin (As pellets) 40 mg Clopidogrel Bisulphate IP Eq. Clopidogrel (As pellets) 75 mg Aspirin IP 75 mg (As Enteric coated pellets) Approved colour used in empty capsule shell |
| Nebivolol and Valsartan Capsules | Cardiovascular | Each hard gelatin capsule contains Valsartan IP 80 mg Nebivolol Hydrochloride IP Eq. to Nebivolol 5 mg Approved colour use in empty capsule shell |
| Rosuvastatin & Aspirin Capsules | Cardiovascular | Each hard gelatin capsule : Rosuvastatin Calcium IP eq. to Rosuvastatin 5 mg Aspirin IP 75 mg |
| Rosuvastatin & Aspirin Capsules | Cardiovascular | Each hard gelatin capsule : Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg Aspirin IP 75 mg |
| Rosuvastatin & Aspirin Capsules | Cardiovascular | Each hard gelatin capsule : Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg Aspirin IP 150 mg |
| Rosuvastatin & Clopidogrel Aspirin Capsules | Cardiovascular | Each hard gelatin capsule : Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg Aspirin IP 75 mg Approved colour used in empty capsule shell |
| Rosuvastatin & Clopidogrel Aspirin Capsules | Cardiovascular | Each hard gelatin capsule : Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg Aspirin IP 75 mg Approved colour used in empty capsule shell |
| Rosuvastatin & Clopidogrel Aspirin Capsules | Cardiovascular | Each hard gelatin capsule : Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg Aspirin IP 150 mg Approved colour used in empty capsule shell |
| Rosuvastatin and Aspirin Capsules | Cardiovascular | Each hard gelatin capsule contains Rosuvastatin Calcium IP Eq. to Rosuvastatin (As pellets) 20 mg Aspirin IP 75 mg (As Enteric coated pellets) Approved coloured used in empty capsule shell |
| Rosuvastatin and Aspirin Capsules | Cardiovascular | Each hard gelatin capsule contains Rosuvastatin Calcium IP Eq. to Rosuvastatin (As pellets) 20 mg Aspirin IP 150 mg (As Enteric coated pellets) Approved coloured used in empty capsule shell |
| Rosuvastatin and Clopidogrel Capsules | Cardiovascular | Each hard gelatin capsule contains Rosuvastatin Calcium IP Eq. to Rosuvastatin (As pellets) 20 mg Clopidogrel Bisulphate IP Eq. Clopidogrel (As pellets) 75 mg Excipients q.s. Approved coloured used in empty capsule shell |
| Sildenafil Citrate Capsules | Erectile Dysfunction | Each hard gelatin capsule contains : Sildenafil Citrate IP Eq. to Sildenafil 25 mg Approved colour use in empty capsule shell |
| Sildenafil Citrate Capsules | Erectile Dysfunction | Each hard gelatin capsule contains : Sildenafil Citrate IP Eq. to Sildenafil 50 mg Approved colour use in empty capsule shell |
| Sildenafil Citrate Capsules | Erectile Dysfunction | Each hard gelatin capsule contains : Sildenafil Citrate IP Eq. to Sildenafil 100 mg Approved colour use in empty capsule shell |
| Dexrabeprazole Sodium And Domperidone Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Dexrabeprazole Sodium 60 mg (As modified release pellets) Domperidone IP 30 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Dexrabeprazole Sodium and Domperidone Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Dexrabeprazole Sodium 10 mg (As entric coated pellets) Domperidone IP 30 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Esomeprazole (EC) and Itopride HCl (SR) Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Esomeprazole Magnesium Trihydrate IP Eq.to Esomeprazole 40 mg (As enteric coated pellets) Itopride Hydrochloride IP 150 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Esomeprazole (EC) and Levosulpiride (SR) Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Esomeprazole Magnesium Trihydrate IP Eq.to Esomeprazole 40 mg (As enteric coated pellets) Levosulpiride 75 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Esomeprazole Gastro resistant Capsules IP | Gastrointestinal & Antacid | Each hard gelatin capsule contains Esomeprazole Magnesium Trihydrate IP Eq.to Esomeprazole 40 mg (As enteric coated pellets) Approved colour use in empty capsule shell |
| Esomeprazole Gastro resistant Capsules IP | Gastrointestinal & Antacid | Each hard gelatin capsule contains Esomeprazole Magnesium Trihydrate IP Eq.to Esomeprazole 20 mg (As enteric coated pellets) Approved colour use in empty capsule shell |
| Esomeprazole and Domperidone Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Esomeprazole Magnesium Trihydrate IP Eq.to Esomeprazole 40 mg (As enteric coated pellets) Domperidone IP 30 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Indomethacin (SR) & Omeprazole Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Indomethacin IP 75 mg (As per sustain Release pellets) Omeprazole IP 20 mg (As per enteric coated pellets) Approved colour used in empty capsule shell |
| LANSOPRAZOLE & DOMPERIDONE CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Lansoprazole (As enteric coated pellets) IP 30 mg Domperidon (As coated pellets) IP 10 mg Excipients q.s. Approved colour used in empty capsule shell |
| OMEPRAZOLE & DOMPERIDONE CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Omeprazole (As enteric coated pellets) IP 20 mg Domperidon (As coated pellets) IP 10 mg Excipients q.s. Approved colour used in empty capsule shell |
| OMEPRAZOLE CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Omeprazole (As enteric coated pellets IP 40 mg Approved colour used in empty capsule shell |
| OMEPRAZOLE CAPSULES IP | Gastrointestinal & Antacid | Each hard gelatin capsule contains Omeprazole (As enteric coated pellets) IP 20 mg Excipients q.s. Approved colour used in empty capsule shell |
| OMEPRAZOLE EC PELLETS 10.00 % w/w | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Omeprazole 100 mg Approved colour to be use |
| OMEPRAZOLE EC PELLETS 12.5 % w/w | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Omeprazole 125 mg Approved colour to be use |
| OMEPRAZOLE EC PELLETS 25.0 % w/w | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Omeprazole 250 mg Approved colour to be use |
| OMEPRAZOLE EC PELLETS 7.50 % w/w | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Omeprazole 75 mg Approved colour to be use |
| OMEPRAZOLE EC PELLETS 8.50 % w/w | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Omeprazole 85 mg Approved colour to be use |
| Omeprazole (EC) and Cinitapride (ER) Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Omeprazole IP 20 mg (As Gastro-resistant pellets) Cinitapride Hydrogen Tartrate Eq. to Cinitapride 3 mg (As extended release pellets) Approved colour use in empty capsule shell |
| PANTOPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole (As enteric coated pellets) 20 mg Domperidon (As sustained release pellets) IP 10 mg Excipients q.s. Approved colour used in empty capsule shell |
| PANTOPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole (As enteric coated pellets) 40 mg Domperidon (As sustained release pellets) IP 30 mg Excipients q.s. Approved colour used in empty capsule shell |
| PANTOPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Pantoprazole Sodium eq. to IP Pantoprazole 40 mg Domperidone IP 10 mg Approved colour used in emply capsule shell |
| PANTOPRAZOLE SODIUM EC PELLETS 15.0 % W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Pantoprazole sodium 150 mg Approved colour to be use |
| PANTOPRAZOLE SODIUM EC PELLETS 20.0 % W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Pantoprazole sodium 200 mg Approved colour to be use |
| PANTOPRAZOLE SODIUM EC PELLETS 22.50% W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Pantoprazole sodium 225 mg Approved colour to be use |
| PANTOPRAZOLE SODIUM EC PELLETS 8.50 % W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Pantoprazole sodium 85 mg Approved colour to be use |
| Pantoprazole (EC) and Levosulpiride (SR) Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Pamotprazole Sodium IP Eq.to Pantoprazole 40 mg (As enteric coated pellets) Levosulpiride 75 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Pantoprazole Sodium (EC) and Cinitapride (SR) Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Pantoprazole Sodium IP Eq.to Pantoprazole 40 mg (As Gastro-resistant pellets) Cinitapride Hydrogen Tartrate Eq. to Cinitapride 3 mg (As extended release pellets) Approved colour use in empty capsule shell |
| Pantoprazole Sodium (EC) and Itopride HCI (SR) Capsules | Gastrointestinal & Antacid | Each hard gelatin capsule contains Pantoprazole Sodium IP Eq.to Pantoprazole 40 mg (As enteric coated pellets) Itopride Hydrochloride IP 150 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| RABEPRAZOLE SODIUM & DOMPERIDONE (SR) CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Rabeprazole Sodium (As enteric coated pellets) IP 20 mg Domperidon (As sustained release pellets) IP 10 mg Excipients q.s. Approved colour used in empty capsule shell |
| RABEPRAZOLE SODIUM (EC) & DOMPERIDONE (SR) CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Rabeprazole Sodium (As enteric coated pellets) IP 20 mg Domperidon (As sustained release pellets) IP 30 mg Excipients q.s. Approved colour used in empty capsule shell |
| RABEPRAZOLE SODIUM (EC) & ITOPRIDE HYDROCHLORIDE (SR) CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Rabeprazole Sodium (As enteric coated pellets) IP 20 mg Itopride Hydrochloride (As sustained release pellets) IP 150 mg Excipients q.s. Approved colour used in empty capsule shell |
| RABEPRAZOLE SODIUM CAPSULES | Gastrointestinal & Antacid | Each hard gelatin capsule contains Rabeprazole Sodium (As enteric coated pellets) IP 20 mg Excipients q.s. Approved colour used in empty capsule shell |
| RABEPRAZOLE SODIUM EC PELLETS 11.2 % W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Rabeprazole Sodium 112mg Approved colour to be use |
| RABEPRAZOLE SODIUM EC PELLETS 15.0 % W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Rabeprazole Sodium 150mg Approved colour to be use |
| RABEPRAZOLE SODIUM EC PELLETS 8.50% W/W | Gastrointestinal & Antacid | Each 1 gm enteric coated pellets contains Rabeprazole Sodium 85mg Approved colour to be use |
| Rabeprazole Sodium & Levosulpiride | Gastrointestinal & Antacid | Each hard gelatin capsule contains Rabeprazole Sodium IP 20 mg (As per enteric coated pellets) Levosulpiride 75 mg (As per sustain Release pellets) Approved colour used in empty capsule shell |
| Rabeprazole Sodium & Levosulpiride | Gastrointestinal & Antacid | Each hard gelatin capsule contains Rabeprazole Sodium IP 20 mg (As per enteric coated pellets) Levosulpiride 20 mg (As per sustain Release pellets) Approved colour used in empty capsule shell |
| llaprazole & Domperidone (SR) | Gastrointestinal & Antacid | Each hard gelatin capsule contains llprazole IP 10 mg (As per enteric coated pellets) Domperidone 30 mg (As per sustain Release pellets) Approved colour used in empty capsule shell |
| CHLORAMPHENICOL CAPSULES IP | General / Unclassified | Each hard gelatin capsule contains Chloramphenicol IP 250 mg Excipients q.s. Approved colour used in empty capsule shell |
| CHLORAMPHENICOL CAPSULES IP | General / Unclassified | Each hard gelatin capsule contains Chloramphenicol IP 500 mg Excipients q.s. Approved colour used in empty capsule shell |
| Carisoprodol Capsules | General / Unclassified | Each hard gelatin capsule contains : Carisoprodol IP 350 mg Excipients q.s. Approved colour to be use in empty capsule shall |
| Carisoprodol Capsules | General / Unclassified | Each hard gelatin capsule contains : Carisoprodol IP 500 mg Excipients q.s. Approved colour to be use in empty capsule shall |
| Caroverine Hydrochloride Capsules | General / Unclassified | Each hard gelatin capsule: Caroverine Hydrochloride eq. to Caroverine 20 mg Approved colour used in empty capsule shell |
| Cefdinir Capsules IP 300 mg 02.09.2023 | General / Unclassified | Each hard gelatin capsule contains Cefdinir IP 300 mg Approved colour used in empty capsule shell |
| Celecoxib Capsules 100 mg | General / Unclassified | Each hard gelatin capsule contains Celecoxib IP 100 mg Approved colour use in empty capsule shell |
| Celecoxib Capsules 200 mg | General / Unclassified | Each hard gelatin capsule contains Celecoxib IP 200 mg Approved colour use in empty capsule shell |
| Celecoxib and Diacerein Capsules | General / Unclassified | Each hard gelatin capsule contains Celecoxib IP 100 mg Diacerein IP 50 mg Approved colour use in empty capsule shell |
| Celecoxib and Diacerein Capsules | General / Unclassified | Each hard gelatin capsule contains Celecoxib IP 200 mg Diacerein IP 50 mg Approved colour use in empty capsule shell |
| Clindamycin Hydrochloride | General / Unclassified | Each hard gelatin capsule contains Clindamycin Hydrochloride BP Eq. to Clindamycin 150 mg Approved colour used in empty capsule shell |
| Clindamycin Hydrochloride | General / Unclassified | Each hard gelatin capsule contains Clindamycin Hydrochloride BP Eq. to Clindamycin 300 mg Approved colour used in empty capsule shell |
| Colostrum Capsules | General / Unclassified | Each hard gelatin capsule : Colostrum 500 mg Approved colour used in empty capsule shell |
| Dabigatran Etexilate Capsules 110 mg | General / Unclassified | Each hard gelatin capsule contains Dabigatran Etexilate Mesilate Eq.to Dabigatran Etexilate 110 mg Approved colour use in empty capsule shell |
| Dabigatran Etexilate Capsules 150 mg | General / Unclassified | Each hard gelatin capsule contains Dabigatran Etexilate Mesilate Eq.to Dabigatran Etexilate 150 mg Approved colour use in empty capsule shell |
| Dabigatran Etexilate Mesyalte Capsules | General / Unclassified | Each hard gelatin capsule contains Dabigatran Etexilate Mesyalte IP 110 mg Eq. to Dabigatran Etexilate Approved colour used in empty capsule shell |
| Diacerein Capsules IP 50 mg | General / Unclassified | Each hard gelatin capsule contains Diacerein IP 50 mg Approved colour use in empty capsule shell |
| Diosmin Capsules | General / Unclassified | Each hard gelatin capsule contains Diosmin (Micronised) BP 150 mg Approved coloured used in empty capsule shell |
| Domeperdone SR Pellets 10.00% w/w | General / Unclassified | Each 1 gm of Sustain Release pellets contains Domperidone 100 mg Release Profile 1st hour -Between 15%-40% 4th hour -Between 30%-60% 8th hour -Between 55%-85% 12th hour -NLT-70% |
| Domeperdone SR Pellets 20.00% w/w | General / Unclassified | Each 1 gm of Sustain Release pellets contains Domperidone 200 mg Release Profile 1st hour -Between 15%-40% 4th hour -Between 30%-60% 8th hour -Between 55%-85% 12th hour -NLT-70% |
| Domeperdone SR Pellets 30.00% w/w | General / Unclassified | Each 1 gm of Sustain Release pellets contains Domperidone 300 mg Release Profile 1st hour -Between 15%-40% 4th hour -Between 30%-60% 8th hour -Between 55%-85% 12th hour -NLT-70% |
| Domeperdone SR Pellets 40.00% w/w | General / Unclassified | Each 1 gm of Sustain Release pellets contains Domperidone 400mg Release Profile 1st hour -Between 15%-40% 4th hour -Between 30%-60% 8th hour -Between 55%-85% 12th hour -NLT-70% IHS IP IP IHS IP IP IP IP IP IP IP IP 50mg IP 0.5mg |
| Eperisone Hydrochloride Sustained Release Capsules | General / Unclassified | Each hard gelatin capsule contains Eperisone Hydrochloride JP 75 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Eperisone Hydrochloride Sustained Release Capsules | General / Unclassified | Each hard gelatin capsule contains Eperisone Hydrochloride JP 150 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| Flunarizine Dihydrochloride Capsules | General / Unclassified | Each hard gelatin capsule contains Flunarizine Dihydrochloride IP Eq. to Flunarizine 5 mg Approved colour use in empty capsule shell |
| Flunarizine Dihydrochloride Capsules | General / Unclassified | Each hard gelatin capsule contains Flunarizine Dihydrochloride IP 10 mg Eq. to Flunarizine Approved colour use in empty capsule shell |
| Flurazepam HCI Capsules | General / Unclassified | Each hard gelatin capsules contains : Flurazepam HCI IP Eq. to Flurazepam 15.0 mg Excipients q.s. |
| Flurazepam HCI Capsules | General / Unclassified | Each hard gelatin capsules contains : Flurazepam HCI IP Eq. to Flurazepam 5 mg Excipients q.s. |
| Flurazepam HCI Capsules | General / Unclassified | Each hard gelatin capsules contains : Flurazepam HCI IP Eq. to Flurazepam 10 mg Excipients q.s. |
| Flurazepam HCI Capsules | General / Unclassified | Each hard gelatin capsules contains : Flurazepam HCI IP Eq. to Flurazepam 15 mg Excipients q.s. |
| INDOMETHACIN CAPSULE IP | General / Unclassified | Each hard gelatin capsule contains Indomethacin IP 25 mg Excipients q.s. Approved colour used in empty capsule shell |
| Indomethacin (SR) Capsules | General / Unclassified | Each hard gelatin capsule contains Indomethacin IP 75 mg (As per sustain Release pellets) Approved colour used in empty capsule shell |
| Isotretinoin Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Isotretinoin IP 5 mg Excipients q.s. Approved colour use in empty capsule shells |
| Isotretinoin Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Isotretinoin IP 10 mg Excipients q.s. Approved colour use in empty capsule shells |
| Isotretinoin Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Isotretinoin IP 20 mg Excipients q.s. Approved colour use in empty capsule shells |
| Isotretinoin Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Isotretinoin IP 30 mg Excipients q.s. Approved colour use in empty capsule shells |
| Isotretinoin Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Isotretinoin IP 40 mg Excipients q.s. Approved colour use in empty capsule shells |
| Itopride HCI (SR) Capsules | General / Unclassified | Each hard gelatin capsule contains Itopride Hydrochloride IP 150 mg (As sustained release pellets) Approved colour use in empty capsule shell |
| LANSOPRAZOLE CAPSULES IP | General / Unclassified | Each hard gelatin capsule contains Lansoprazole (As enteric coated pellets) IP 30 mg Excipients q.s. Approved colour used in empty capsule shell |
| LANSOPRAZOLE EC PELLETS 10.0 % W/W | General / Unclassified | Each 1 gm enteric coated pellets contains Lansoprazole 100mg Approved colour to be use |
| LANSOPRAZOLE EC PELLETS 11.20 % W/W | General / Unclassified | Each 1 gm enteric coated pellets contains Lansoprazole 112mg Approved colour to be use |
| LANSOPRAZOLE EC PELLETS 8.5 % w/w | General / Unclassified | Each 1 gm enteric coated pellets contains Lansoprazole 85 mg Approved colour to be use |
| LANSOPRAZOLE EC PELLETS 9.25 % W/W | General / Unclassified | Each 1 gm enteric coated pellets contains Lansoprazole 92.5 mg Approved colour to be use |
| LOPERAMIDE HYDROCHLORIDE CAPSULE IP | General / Unclassified | Each hard gelatin capsule contains Loperamide Hydrochloride IP 2 mg Excipients q.s. Approved colour used in empty capsule shell |
| Lactic Acid Bacillus Capsules | General / Unclassified | Each hard gelatin capsule contains Lactic Acid Bacillus IP 1000 mill.Spor Approved colour used in empty capsule shell |
| Lenalidomide Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenalidomide IP 5 mg Excipients q.s. Approved colour use in empty capsule shells |
| Lenalidomide Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenalidomide IP 10 mg Excipients q.s. Approved colour use in empty capsule shells |
| Lenalidomide Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenalidomide IP 15 mg Excipients q.s. Approved colour use in empty capsule shells |
| Lenalidomide Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenalidomide IP 25 mg Excipients q.s. Approved colour use in empty capsule shells |
| Lenvatinib Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenvatinib Mesylate IP Eq. to Lenvatinib 4 mg Excipients q.s. Approved colour use in empty capsule shells |
| Lenvatinib Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenvatinib Mesylate IP Eq. to Lenvatinib 8 mg Excipients q.s. Approved colour use in empty capsule shells |
| Lenvatinib Capsules IP | General / Unclassified | Each hard gelatin capsule contains: Lenvatinib Mesylate IP Eq. to Lenvatinib 10 mg Excipients q.s. Approved colour use in empty capsule shells |
| Levodopa Capsules IP | General / Unclassified | Each hard gelatin capsule contains Levodopa IP 125 mg Excipients q.s. Approved colour use in empty capsule shell |
| Levodopa Capsules IP | General / Unclassified | Each hard gelatin capsule contains Levodopa IP 250 mg Excipients q.s. Approved colour use in empty capsule shell |
| Levodopa Capsules IP | General / Unclassified | Each hard gelatin capsule contains Levodopa IP 500 mg Excipients q.s. Approved colour use in empty capsule shell |
| Lithium Carbonate Capsules | General / Unclassified | Each hard gelatin capsule contains Lithium Carbonate IP 250 mg Approved colour used in empty capsule shell q.s. |
| Lithium Carbonate Capsules | General / Unclassified | Each hard gelatin capsule contains Lithium Carbonate IP 300 mg Approved colour used in empty capsule shell q.s. |
| Loxapine Capsules USP | General / Unclassified | Each hard gelatin capsule contains Loxapine Succinate USP Eq. to Loxapine 5 mg Approved colour to used |
| Loxapine Capsules USP | General / Unclassified | Each hard gelatin capsule contains Loxapine Succinate USP Eq. to Loxapine 10 mg Approved colour to used |
| Loxapine Capsules USP | General / Unclassified | Each hard gelatin capsule contains Loxapine Succinate USP Eq. to Loxapine 20 mg Approved colour to used |
| Loxapine Capsules USP | General / Unclassified | Each hard gelatin capsule contains Loxapine Succinate USP Eq. to Loxapine 50 mg Approved colour to used |
| MEFENAMIC ACID & DICYCLOMINE HYDROCHLORIDE CAPSULES | General / Unclassified | Each hard gelatin capsule contains Dicyclomine Hydrochloride IP 10 mg Mefenamic Acid IP 250 mg Excipients q.s. Approved colour used in empty capsule shell |
| Mycophenolate Mofetil Capsules IP 250 mg | General / Unclassified | Each hard gelatin capsule contains Mycophenolate Mofetil IP 250 mg Excipients q.s. Approved colour used in empty capsule shell |
| Mycophenolate Mofetil Capsules IP 500 mg | General / Unclassified | Each hard gelatin capsule contains Mycophenolate Mofetil IP 500 mg Excipients q.s. Approved colour used in empty capsule shell |
| OXYTETRACYCLINE HYDROCHLORIDE CAPSULES IP | General / Unclassified | Each hard gelatin capsule contains Oxytetracycline Hydrochloride IP 250 mg Excipients q.s. Approved colour used in empty capsule shell |
| Orlistat Capsules USP | General / Unclassified | Each hard gelatin capsule contains Orlistat USP 120 mg Approved colour used in flavoured syrupy base |
| Orlistat Capsules USP | General / Unclassified | Each hard gelatin capsule : Orlistat (As Pellets) USP 60 mg Approved colour used in empty capsule shell |
| Phentermine Hydrochloride Capsules USP | General / Unclassified | Each hard gelatin capsule contains Phentermine Hydrochloride USP 37.5 mg Approved colour used in empty capsule shell |
| Prebiotic & Probiotic Capsules | General / Unclassified | Each hard gelatin capsule contains Streptococcus faecalis 30 million Clostridium Butyricum 2 million Bacillus Mesentericus IP 1 million Lactic Acid Bacillus IP 50 million Colour: Brilliant Blue / Erythrosine / Tartrazine / Ponceau 4R or Titanium Dioxide IP / Sunset Yellow |
| Propranolol Hydrochloride & Flunarizine Di hydrochloride | General / Unclassified | Each hard gelatine capsule contains Propranolol Hydrochloride IP 40 mg Flunarizine Di hydrochloride 10 mg Approved colour used in empty capsule shell |
| Propranolol Hydrochloride Sustained release Capsules | General / Unclassified | Each hard gelatin capsule contains Propranolol Hydrochloride IP 80 mg (As Sustained release Pellets) Approved colour used in empty capsule shell |
| Propranolol Hydrochloride and Benodrofluazide Capsules | General / Unclassified | Each hard gelatin capsule contains Propranolol Hydrochloride IP 80 mg Benodrofluazide IP 2.5 mg Approved colour used in empty capsule shell |
| Rececadotril Dispersible Capsule | General / Unclassified | Each uncoated dispersible Capsule contains : Rececadotril IP 100 mg Excipients q.s. |
| Sulpiride Capsules | General / Unclassified | Each hard gelatin capsule contains Sulpiride IP 50 mg Approved colour use in empty capsule shell |
| Sulpiride Capsules | General / Unclassified | Each hard gelatin capsule contains Sulpiride IP 200 mg Approved colour use in empty capsule shell |
| TETRACYCLINE HYDROCHLORIDE CAPSULES IP | General / Unclassified | Each hard gelatin capsule contains Tetracycline Hydrochloride IP 250 mg Excipients q.s. Approved colour used in empty capsule shell |
| TETRACYCLINE HYDROCHLORIDE CAPSULES IP | General / Unclassified | Each hard gelatin capsule contains Tetracycline Hydrochloride IP 500 mg Excipients q.s. Approved colour used in empty capsule shell |
| THIAMINE (MONO), RIBOFLAVINE, CYANOCOBALAMIN and Pyridoxine Hydrochloride | General / Unclassified | Each hard gelatin capsule contains Thiamine Mononitrate IP 1 mg Riboflavine IP 1 mg Cyanocobalamin IP 0.5 mcg Pyridoxine Hydrochloride IP 0.5 mg Approved colour used in empty capsule shell |
| Tapentadol Capsules | General / Unclassified | Each hard gelatin capsule : Tapentadol Hydrochloride IP 75 mg |
| Tapentadol Capsules | General / Unclassified | Each hard gelatin capsule : Tapentadol Hydrochloride IP 50 mg |
| Tapentadol Hydrochloride Capsules | General / Unclassified | Each hard gelatin capsule contains Tapentadol Hydrochloride IP Eq. to Tapentadol 25 mg Approved colour use in empty capsule shell |
| Tapentadol Hydrochloride Capsules | General / Unclassified | Each hard gelatin capsule contains Tapentadol Hydrochloride IP Eq. to Tapentadol 100 mg Approved colour use in empty capsule shell |
| Tapentadol and Carisoprodol Capsules | General / Unclassified | Each hard gelatin capsule contains Tapentadol HCI IP Eq. to Tapentadol 70 mg Carisoprodol IP 50 mg Approved colour use in empty capsule shell |
| Topotecan Hydrochloride IP Capsules | General / Unclassified | Each hard gelatin capsule contains: Topotecan Hydrochloride IP 1 mg Eq. to Topotecan Excipients q.s. Approved colour use in empty capsule shells |
| Ubiquinol Capsules | General / Unclassified | Each hard gelatin capsule contains Ubiquinol 100 mg Approved colour use in empty capsule shell |
| Valsartan Capsules | General / Unclassified | Each hard gelatin capsule contains Valsartan IP 80 mg Approved coloured used in empty capsule shell |
| Valsartan Capsules | General / Unclassified | Each hard gelatin capsule contains Valsartan IP 160 mg Approved coloured used in empty capsule shell |
| Zaleplon Capsules IP | General / Unclassified | Each hard gelatin capsule contains Zaleplon IP 5 mg Approved colour use in empty capsule shell |
| Zaleplon Capsules IP | General / Unclassified | Each hard gelatin capsule contains Zaleplon IP 10 mg Approved colour use in empty capsule shell |
| ANTIOXIDANT, MULTIVITAMINS & MULTIMINERALS CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Pyridoxine Hydrochloride IP 3 mg Niacinamide IP 50 mg Cyanocobalamin IP 5 mcg Folic Acid IP 1 mcg Copper Sulphate USP 2.5 mg Calcium Panthothenate IP 12.5 mg Zinc Sulphate Monohydrate IP 15 mg Chromium Chloride Hexahydrate USP 65 mcg Manganese Chloride IP 1 mcg Lactic Acid Bacillus 60 mill. spor Selenium Dioxide Monohydrate USP 60 mcg Calcium Ascorbate BP 25 mg Di Basic Calcium Phosphate IP 200 mg Containing: Calcium 45.0 mg Phosphorous 36.2 mg Excipients q.s. Approved colour used in empty capsule shell |
| ANTIOXIDANT, MULTIVITAMINS & MULTIMINERALS CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Calcium Ascorbate BP 50 mg Lycopene 6% USP 5000 mcg Mix Carotene 10% 10.33 mg Wheat Germ Oil BP 25 mg Zinc Sulphate Monohydrate IP 24.5 mg Selenium Dioxide Monohydrate USP 75 mcg Excipients q.s. Approved colour used in empty capsule shell |
| ANTIOXIDANT, MULTIVITAMINS & MULTIMINERALS CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Calcium Ascorbate BP 50 mg Lycopene 6 % USP 5000 mcg Mix Carotene 10% 10.33 mg Wheat Germ Oil BP 25 mg Zinc Sulphate Monohydrate IP 24.5 mg Selenium Dioxide Monohydrate USP 75 mcg L-Cartnitine L-Tartrate USP 125 mg Excipients q.s. Approved colour used in empty capsule shell |
| Alpha Lipoic Acid, Mecobalamin, Pyridoxine, Foilc Acid and Vitamin B1 | Nutritional Supplement | Each hard gelatin capsule : Alpha Lipoic Acid USP 10 mg Mecobalamin IP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Foilc Acid IP 1.5 mg Vitamin B1 (Mono) IP 10 mg Excipients q.s. Approved colour used in empty capsule shell |
| Alpha Lipoic Acid, Mecobalamin, Pyridoxine, Foilc Acid,BENFOTIAMINE,BIOTIN,CHROMUIM PICOLINATE AND CHROMUIM | Nutritional Supplement | Each hard gelatin capsule : Alpha Lipoic Acid USP 100 mg Mecobalamine IP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Foilc Acid IP 2 mg Benfotiamine 50 mg Biotin USP 5 mg Chromuim Picolinate USP Chromuim 200 mcg Excipients q.s. Permitted Color Used |
| CHOLECALCIFEROL (Vitamin D3 ) CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Vitamin D3 (As Cholecalciferol) IP 60000 IU Excipients q.s. Approved colour used in empty capsule shell |
| CHOLECALCIFEROL (Vitamin D3) CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Vitamin D3 (As Cholecalciferol) IP 10000 IU Excipients q.s. Approved colour used in empty capsule shell |
| Calcium Citrate, Calcitriol with Zinc | Nutritional Supplement | Each hard gelatin capsule contains Calcium Citrate Malate 500 mg Calcitriol IP 0.25 mcg Zinc Sulphate IP 7.5 mg Approved colour used in empty capsule shell |
| ELEMENTAL IRON, ZINC SULPHATE WITH FOLIC ACID CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Elemental Iron 50 mg (In the form of Carbonyl Iron) Zinc Sulphate Monohydrate USP 61.8 mg (Equivalent to 22.5 Mg of Elemental Zinc) Folic Acid IP 0.5 mg Excipients q.s. Approved colour used in empty capsule shell |
| Elemental Iron, Zinc Sulphate, Folic Acid, Vitamin B12 and Vitamin C (Coated) | Nutritional Supplement | Each hard gelatin capsule contains Elemental Iron 100 mg (In the form of Carbonyl Iron) Zinc Sulphate Monohydrate USP 61.8 mg (Equivalent to 22.5 Mg of Elemental Zinc) Folic Acid IP 1.5 mg Vitamin B12 IP 15 mcg Vitamin C (Coated) IP 75 mg Excipients q.s. Approved colour used in empty capsule shell |
| FERROUS FUMARATE, L-LYSINE, FOLIC ACID, CYANOCOBALAMIN | Nutritional Supplement | Each hard gelatin capsule contains Ferrous Fumarate IP 350 mg L-Lysine Hydrochloride IP 150 mg Folic Acid IP 1.5 mg Cyanocobalamin IP 15 mcg Zinc Sulphate IP Eq. to Elemental Zinc 66 mg Copper Sulphate IP Eq. to Elemental Copper 80 mcg Manganese Sulphate USP 250 mg Approved colour used in empty capsule shell |
| FERROUS FUMERATE WITH FOLIC ACID CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Ferrous Fumerate IP 200 mg Folic Acid IP 1500 mcg Excipients q.s. Approved colour used in empty capsule shell |
| Ginseng with Multi Vitamin, Calcium Panthothenate,Vitamin C, Zinc Sulphate, Niacinamide, Ferrous Fumarate and Folic acid | Nutritional Supplement | Each hard gelatin capsule contains : Ginseng Extract IP 45 mg Vitamin A Palmetate IP 2500 IU Vitamin D3 (As Cholecalciferol) IP 200 IU Vitamin E Acetate IP 10 mg Vitamin B1 Mono IP 2 mg Vitamin B2 IP 3 mg Vitamin B6 HCI IP 1 mg Vitamin B12 IP 1 mcg Calcium Panthothenate IP 5 mg Vitamin C (Coated) IP 50 mg Zinc Sulphate IP Equivalent to elemental zinc 1mg Niacinamide IP 25 mg Ferrous Fumarate IP 200 mg Folic Acid IP 300 mcg Excipients q.s. Approved colour used in empty capsule shell |
| LACTIC ACID, THIAMINE (MONO), RIBOFLAVINE, NICOTINAMIDE,Pyridoxine HCL, D panthenol and Folic acid | Nutritional Supplement | Each hard gelatin capsule contains Lactic Acid Bacillus 40 mill.Sp Thiamine Monoitrate IP 2 mg Riboflavine IP 2.5 mg Nicotinamide IP 22.5 mg Pyridoxine Hydrochloride IP 0.75 mg D-Panthenol IP 2.5 mg Folic Acid IP 300 mcg Approved colour used in empty capsule shell |
| MULTIVITAMIN CAPSULES For Prophylactic Use | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 1 mg Riboflavine IP 1 mg Pyridoxine Hydrochloride IP 0.5 mg Vitamin A Concentrate ( As Palmitate) Eq. to Vitamin A IP 2000 IU Vitamin D, (As Cholecalciferol) IP 100 IU Niacinamide IP 15 mg Excipients q.s. Approved colour used in empty capsule shell |
| MULTIVITAMIN CAPSULES For Prophylactic Use | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 1 mg Riboflavine IP 1 mg Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 1 mcg Niacinamide IP 15 mg Excipients q.s. Approved colour used in empty capsule shell |
| MULTIVITAMIN WITH L-LYSINE, ZINC SULPHATE CAPSULES | Nutritional Supplement | Each Capsule Contains Vitamin A Acetate IP 5000 IU Vitamin D3 (As Cholecalciferol) IP 500 IU Vitamin E Acetate IP 15 mg Vitamin B1 Mono IP 10 mg Vitamin B2 IP 10 mg Vitamin B6 HCI IP 3 mg L-Lysine Mono HCI IP 50 mg Vitamin B12 IP 10 mcg Calcium Panthothenate IP 25 mg Vitamin C (Coated) IP 75 mg Zinc Sulphate IP 20 mg Equivalent to elemental zinc 4.50 mg Excipients q.s. Approved colour used in empty capsule shell |
| MULTIVITAMIN, FOLIC ACID WITH CALCIUM PANTHOTHENATE CAPSULES | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 1 mg Riboflavine IP 1 mg Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 1 mcg Calcium Panthothenate IP 1 mg Folic Acid IP 100 mcg Niacinamide IP 20 mg Excipients q.s. Approved colour used in empty capsule shell |
| MULTIVITAMIN, FOLIC ACID, ZINC SULPHATE | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 5 mg Riboflavine IP 5 mg Pyridoxine Hydrochloride IP 1.5 mg Cyanocobalamin IP 5 mcg Calcium Panthothenate IP 5 mg Folic Acid IP 1000 mcg Niacinamide IP 45 mg Zinc Sulphate IP 20 mg Eq. to elemental Zinc 4.5 mg Excipients q.s. Approved colour used in empty capsule shell |
| Mecobalamin, Benfotiamine and Pyridoxine HCI Capsules | Nutritional Supplement | Each hard gelatin capsule contains Mecobalamin IP 0.5 mg Benfotiamine 100 mg Pyridoxine HCI IP 50 mg Excipients q.s. Approved colour used in empty capsule shell |
| Mecobalamin,Alpha Lipoic Acid, Thiamine, Pyridoxine HCI,Calcium Pantothenate and Folic acid | Nutritional Supplement | Each hard gelatin capsule contains Mecobalamin IP 1500 mcg Alpha Lipoic Acid USP 100 mg Thiamine IP 10 mg Pyridoxine Hydrochloride IP 3 mg Calcium Pantothenate IP 5 mg Folic acid IP 1.5 mg Approved colour use in empty capsule shell |
| Methylcobalamin, Alpha Lipoic Acid, Pyridoxine HCl and Folic Acid | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalamin IP 1500 mcg Alpha Lipoic acid IP 100 mg Pyridoxine HCI IP 3 mg Folic Acid IP 1.5 mg Excipients q.s. Approved colour used in empty capsule shell |
| Methylcobalamin, Nortriptyline Pregabalin Capsules | Nutritional Supplement | Each hard gelatin capsule : Methylcobalamin IP 1500 mcg Nortriptyline Hydrochloride IP Eq. to Nortriptyline 10 mg Pregabalin IP 75 mg Approved colour used in empty capsule shell |
| Methylcobalamin, Pregabalin, Alpha Lipoic Acid, Pyridoxine HCI | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalamin IP 1500 mcg Alpha Lipoic acid IP 200 mg Pregabalin IP 75 mg Pyridoxine HCI IP 5 mg Folic Acid IP 2.5 mg Excipients q.s. Approved colour used in empty capsule shell |
| Methylcobalamin, Pregabalin, Pyridoxine HCI, Benfotiamine | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalamin IP 750 mcg Pregabalin IP 75 mg Pyridoxine HCI IP 2 mg Benfotiamine 7.5 mg Folic Acid IP 0.75 mg Excipients q.s. Approved colour use in empty capsule shell |
| Methylcobalmin , Pyridoxine Hcl With Pyridoxine Hydrochloride, Alpha Lipoic Acid | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalmin 1500 mcg Pyridoxine Hydrochloride IP 1.5 mg Alpha Lipoic Acid IP 100 mg Approved colour used in empty capsule shell |
| Methylcobalmin, Alpha Lipoic Acid,Glucosamine Sulphate and Chondrotine Sulphate | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalmin 500 mcg Alpha Lipoic Acid 100 mg Glucosamine Sulphate IP 500 mg Chondrotine Sulphate 400 mg Approved colour used in empty capsule shell |
| Methylcobalmin, Alpha Lipoic Acid,Glucosamine Sulphate and Chondrotine Sulphate | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalmin 1500 mcg Alpha Lipoic Acid 200 mg Pregabalin IP 75 mg Folic Acid IP 1500 mcg Approved colour used in empty capsule shell |
| Methylcobalmine, Alpha Lipoic Acid, Biotin | Nutritional Supplement | Each hard gelatin capsule contains Methylcobalmine IP 1500 mcg Alpha Lipoic Acid 200 mg Biotin IP 200 mcg Folic Acid IP 1500 mcg Pyridoxine HCl IP 3 mg Vitamin D3 IP 1000 IU |
| Riboflavin, Pyridoxine HCI Nicotinamide, Cyanocobalamin,Calcium Pantothenate and Folic Acid | Nutritional Supplement | Each hard gelatine capsule contains: Riboflavin IP 5 mg Pyridoxine Hydrochloride IP 1.5 mg Cyanocobalamin IP 10 mcg Nicotinamide IP 15 mg Calcium Pantothenate IP 5 mg Folic Acid IP 100 mcg Approved colour use |
| Riboflavin, Pyridoxine HCI Nicotinamide, Cyanocobalamin,Calcium Pantothenate and Folic Acid | Nutritional Supplement | Each hard gelatine capsule contains: Riboflavin IP 2 mg Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 10 mcg Nicotinamide IP 15 mg Calcium Pantothenate IP 5 mg Folic Acid IP 100 mcg Approved colour use |
| THIAMINE (MONO), RIBOFLAVINE, NICOTINAMIDE, PYRIDOXINE HCL,Calcium Hydrochloride,Cyanocobalmin,Folic Acid and Vitamin C | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Monoitrale IP 10 mg Riboflavine IP 10 mg Nicotinamide IP 50 mg Pyridoxine Hydrochloride IP 3 mg Calcium Pantothenate IP 12.5 mg Cyanocobalamin IP 5 mcg Folic Acid IP 1 mg Vitamin C IP 100 mg Approved colour used in empty capsule shell |
| Thiamine, Riboflavin, Pyridoxine Niacinamide, Calcium Pantothenate | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 10 mg Riboflavin IP 5 mg Pyridoxine Hydrochloride IP 1.5 mg Niacinamide IP 45 mg Calcium Pantothenate IP 5 mg Cyanocobalamin IP 5 mcg Approved colour use in empty capsule shell |
| VITAMIN B-COMPLEX CAPSULES For Prophylactic Use | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 1 mg Riboflavine IP 1 mg Cyanocobalamin IP 0.5 mcg Excipients q.s. Approved colour used in empty capsule shell |
| Vitamin B-Complex Capsules | Nutritional Supplement | Each hard gelatin capsule contains Thiamine Mononitrate IP 1 mg Riboflavin IP 1 mg Pyridoxine Hydrochloride IP 0.5 mg Niacinamide IP 15 mg Lactic Acid Bacillus IP 1000 mill.spor Approved colour used in empty capsule shell |
| TRAMADOL HYDROCHLORIDE CAPSULES IP | Opioid Analgesic | Each hard gelatin capsule contains Tramadol Hydrochloride IP 50 mg Excipients q.s. Approved colour used in empty capsule shell |
Syrups Index
- Analgesic (Pain Relief)
- Anti-allergic
- Anti-asthmatic / Cough & Cold
- Anti-parasitic
- Anti-viral
- Antibiotic
- CNS & Neuropathic
- Corticosteroid
- Erectile Dysfunction
- Gastrointestinal & Antacid
- General / Unclassified
- Neuroprotective
- Nutritional Supplement
- Opioid Analgesic
| Formulation | Therapeutic Usage | Composition |
|---|---|---|
| ACECLOFENAC & PARACETAMOL SUSPENSION | Analgesic (Pain Relief) | Each 5 ml contains : Aceclofenac IP 50 mg Paracetamol IP 125 mg Approved colour used in flavoured syrupy base |
| Aceclofenac & Paracetamol Suspension | Analgesic (Pain Relief) | Each 5 ml contains : Aceclofenac IP 50 mg Paracetamol IP 250 mg Approved colour used in flavoured syrupy base |
| CETIRIZINE HYDROCHLORIDE, PHENYLEPHERINE HYDROCHLORIDE AND PARACETAMOL | Analgesic (Pain Relief) | Each 5 ml contains : Cetirizine Hydrochloride IP 2.5 mg Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 2.5 mg Approved colour used in flavoured syrupy base |
| CETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE,PARACETAMOL | Analgesic (Pain Relief) | Each 5 ml contains : Cetirizine Hydrochloride IP 2.5 mg Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| DICYCLOMINE HYDROCHLORIDE PARACETAMOL SUSPENSION | Analgesic (Pain Relief) | Each 5 ml contains : Dicyclomine Hydrochloride IP 5 mg Paracetamol IP 125 mg Approved colour used in flavoured syrupy base |
| IBUPROFEN & PARACETAMOL ORAL SUSPENSION IP | Analgesic (Pain Relief) | Each 5 ml contains : Ibuprofen IP 100 mg Paracetamol IP 125 mg Approved colour used in flavoured syrupy base |
| IBUPROFEN & PARACETAMOL ORAL SUSPENSION IP | Analgesic (Pain Relief) | Each 5 ml contains : Ibuprofen IP 100 mg Paracetamol IP 162.5 mg Approved colour used in flavoured syrupy base |
| LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE and Paracetamol | Analgesic (Pain Relief) | Each 5 ml contains : Levocetirizine Hydrochloride IP 2.5 mg Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| MEFENAMIC ACID & PARACETAMOL SUSPENSION | Analgesic (Pain Relief) | Each 5 ml contains : Mefenamic Acid IP 50 mg Paracetamol IP 125 mg Approved colour used in flavoured syrupy base |
| Mefenamic Acid & Paracetamol Suspension | Analgesic (Pain Relief) | Each 5 ml. contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg Approved colour used in flavoured syrupy base |
| PARACETAMOL & PROMETHAZINE HYDROCHLORIDE SUSPENSION | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 125 mg Promethazine Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| PARACETAMOL SUSPENSION IP | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 125 mg Approved colour used in flavoured syrupy base |
| PARACETAMOL SUSPENSION IP For paediatric use | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 250 mg Approved colour used in flavoured syrupy base |
| PARACETAMOL SYRUP IP | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 125 mg Approved colour used in flavoured syrupy base |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL,Chlorpheniramine Maleate | Analgesic (Pain Relief) | Each 5 ml contains : Phenylephrine Hydrochloride IP 5 mg Paracetamol IP 250 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL,Chlorpheniramine Maleate | Analgesic (Pain Relief) | Each 5 ml contains : Phenylephrine Hydrochloride IP 5 mg Paracetamol IP 125 mg Chlorpheniramine Maleate IP 1 mg Approved colour used in flavoured syrupy base |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL,Chlorpheniramine Maleate | Analgesic (Pain Relief) | Each 5 ml contains : Phenylephrine Hydrochloride IP 2.5 mg Paracetamol IP 125 mg Chlorpheniramine Maleate IP 1 mg Approved colour used in flavoured syrupy base |
| Paracetamol Oral Suspension IP | Analgesic (Pain Relief) | Each ml. contains Paracetamol IP 100 mg Colour: Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| Paracetamol Paediatric Oral Suspension IP | Analgesic (Pain Relief) | Each ml contains : Paracetamol IP 150 mg Approved colour used in flavoured syrupy base |
| Paracetamol Suspension | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 240 mg Approved colour used in flavoured syrupy base |
| Paracetamol Suspension | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 120 mg Approved colour used in flavoured syrupy base |
| Paracetamol and Domperidone Suspension | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 250 mg Domperidone IP 5 mg Approved coloured use in a flavoured syrup base |
| Paracetamol, Cetirizine Hydrochloride | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 250 mg Cetirizine HCl IP 5 mg Phenylephrine Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate Drops | Analgesic (Pain Relief) | Each ml contains : Paracetamol IP 125 mg Chlorpheniramine Maleate IP 1 mg Phenylephrine Hcl IP 5 mg Approved colour used in flavoured syrupy base |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate and Menthol | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 125 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine Hcl IP 2.5 mg Menthol IP Approved colour used in flavoured syrupy base |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate and Sodium Citrate | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 125 mg Chlorpheniramine Maleate IP 1 mg Phenylephrine Hcl IP 5 mg Sodium Citrate IP 60 mg Menthol qs Approved colour used in flavoured syrupy base |
| Paracetamol, Phenylephrine Hcl, Chlorpheniramine Maleate and Sodium Citrate | Analgesic (Pain Relief) | Each 5 ml contains : Paracetamol IP 250 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine Hcl IP 5 mg Sodium Citrate IP 60 mg Menthol qs Approved colour used in flavoured syrupy base |
| AMMONIUM CHLORIDE, SODIUM CITRATE,CHLORPHENIRAMINE MALEATE AND MENTHOL | Anti-allergic | Each 5 ml contains : Ammonium Chloride IP 125 mg Sodium Citrate IP 55 mg Chlorpheniramine Maleate IP 2.5 mg Menthol IP 1 mg Approved colour used in flavoured syrupy base |
| CETIRIZINE HYDROCHLORIDE SYRUP IP | Anti-allergic | Each 5 ml contains : Cetirizine Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE DROPS | Anti-allergic | Each ml contains : Cyproheptadine Hydrochloride IP 1.50 mg Tricholine Citrate 55 mg Approved colour used in flavoured syrupy base |
| CYPROHEPTADINE HYDROCHLORIDE SYRUP IP | Anti-allergic | Each 5 ml contains : Cyproheptadine Hydrochloride IP 2 mg Approved colour used in flavoured syrupy base |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE SYRUP | Anti-allergic | Each 5 ml contains : Cyproheptadine HCl IP 2 mg Tricholine Citrate 275 mg Approved colour used in flavoured syrupy base |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE WITH Sorbitol Soluion (Non crysatallizing | Anti-allergic | Each 5 ml contains : Cyproheptadine Hydrochloride IP 2 mg Tricholine citrate IP 275 mg Sorbitol Soluion (Non crysatallizing 70%) IP 2 gm Approved colour used in flavoured syrupy base |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE WITH Sorbitol Soluion (Non crystallizing | Anti-allergic | Each 5 ml contains : Cyproheptadine Hydrochloride IP 2 mg Tricholine citrate 275 mg Sorbitol Soluion (Non crystallizing 70%) 3.575 gm Approved colour used in flavoured syrupy base |
| Chlorpheniramine Maleate and Codeine Phosphate Syrup | Anti-allergic | Each 5 ml contains : Codeine Phosphate IP 10 mg Chlorpheniramine Maleate IP 4 mg Approved colour used in flavoured syrupy base |
| DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE,Sodium Citrate and Menthol | Anti-allergic | Each 5 ml contains : Diphenhydramine Hydrochloride IP 14.08 mg Ammonium chloride IP 1.38 mg Sodium citrate IP 57.03 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| Diphenhydramine Hcl, Terpine Hydrate Ammonium chloride, Sodium Citrate | Anti-allergic | Each 5 ml contains : Diphenyhydramine Hcl IP 12.5 mg Terpine Hydrate IP 7.5 mg Ammonium Chloride IP 125 mg Sodium Citrate IP 55 mg Mentheol IP qs Approved colour used in flavoured syrupy base |
| Diphenhydramine Hydrochloride Ammonium Chloride | Anti-allergic | Each 5 ml contains : Diphenhydramine Hydrochloride IP 12.5 mg Ammonium Chloride IP 80 mg Sodium Citrate IP 50 mg Menthol IP q.s Approved colour used in flavoured syrupy base |
| Diphenhydramine Hydrochloride Ammonium chloride | Anti-allergic | Each 5 ml contains : Diphenhydramine Hydrochloride IP 15 mg Ammonium chloride IP 125 mg Sodium citrate IP 60 mg Menthol IP q.s. Approved colour used in flavoured syrupy base |
| Fexofenadine Suspension For paediatric use | Anti-allergic | Each 5 ml. contains Fexofenadine Hydrochloride IP 30 mg. Colour: Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine in flavoured syrupy base |
| LEVOCETIRIZINE HYDROCHLORIDE SYRUP IP | Anti-allergic | Each 5 ml contains : Levocetirizine Hydrochloride IP 2.5 mg Approved colour used in flavoured syrupy base |
| Levodropropizine and Chlorpheniramine Maleate Syrup | Anti-allergic | Each 5 ml contains : Levodropropizine IP 30 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| Multivitamin With Cyproheptadine Syrup | Anti-allergic | Each 5 ml contains : Thiamine Mononitrate IP 1 mg Pyridoxine HCL IP 1.5 mg Cyanocobalamin IP 1 mcg Nicotinamide IP 15 mg D-Panthenol IP 5 mg Zinc Sulphate Monohydrate IP Eq. to elemantel Zinc 1.82 mg Cyproheptadine Hydrochloride IP 2 mg Approved colour used in flavoured syrupy base |
| AMBROXOL HYDROCHLORIDE, GUAIPHENESIN,CHLORPHENIRAMINE MALEATE AND MENTHOL | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Ambroxol Hydrochloride IP 10 mg Guaiphenesin IP 50 mg Chlorpheniramine Maleate IP 2 mg Menthol q.s Approved colour used in flavoured syrupy base |
| Acebrophylline Syrup 29.04.2022 | Anti-asthmatic / Cough & Cold | Each ml contains : Acebrophylline 10 mg Approved colour used in flavoured syrupy base |
| Ambroxol Hcl, Guaiphenesin, Phenylephrine Hcl and Menthol | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Ambroxol Hcl IP 15 mg Guaiphenesin IP 50 mg Phenylephrine Hcl IP 2.5 mg Chlorpheniramine Maleate IP 2 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| DEXTROMETHORPHAN HBr , AMMONIUM CHLORIDE,CHLORPHENIRAMINE MALEATE AND GUAIPHENESIN | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan Hydrobromide IP 10 mg Ammonium chloride IP 60 mg Chlorpheniramine Maleate IP 2.5 mg Guaiphenesin IP 50 mg Approved colour used in flavoured syrupy base |
| DEXTROMETHORPHAN HBr , PHENYLEPHRINE HYDROCHLORIDE,CHLORPHENIRAMINE MALEATE | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan Hydrobomide IP 10 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| DEXTROMETHORPHAN HBr , PHENYLEPHRINE HYDROCHLORIDE,PARACETAMOL AND CHLORPHENIRAMINE MALEATE | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan Hydrobromide IP 5 mg Phenylephrine Hydrochloride IP 5 mg Paracetamol IP 125 mg Chlorpheniramine Maleate IP 1 mg Approved colour used in flavoured syrupy base |
| DEXTROMETHORPHAN HBr BROMHEXINE HYDROCHLORIDE,Ammonium Chloride and Menthol | Anti-asthmatic / Cough & Cold | Each 10 ml contains : Dextromethorphan Hydrobomide IP 10 mg Bromhexine Hydrochloride IP 8 mg Ammonium chloride IP 100 mg Menthol qs Approved colour used in flavoured syrupy base |
| DEXTROMETHORPHAN HBr BROMHEXINE HYDROCHLORIDE,Ammonium Chloride and Menthol | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan Hydrobomide IP 5 mg Bromhexine Hydrochloride IP 4 mg Chlorpheniramine Maleate IP 2 mg Guaiphenesin IP 50 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| DEXTROMETHORPHAN Hbr, CHLORPHENRAMINE MALEATE SYRUP | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan Hydrobomide IP 5 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| Dextromethorphan HBr and Chlorpheniramine Syrup | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan HBr IP 10 mg Chlorpheniramine Maleate IP 2 mg Approved coloured use in a flavoured syrup base |
| Dextromethorphan HBr and Chlorpheniramine Syrup | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan HBr IP 10 mg Chlorpheniramine Maleate IP 4 mg Approved colour used in flavoured syrupy base |
| Dextromethorphan HBr, Cetirizine Ambroxol HCl Syrup | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan HBr IP 10 mg Cetirizine HCl IP 5 mg Ambroxol Hydrochloride IP 15 mg Menthol q.s Approved colour used in flavoured syrupy base |
| Dextromethorphan HBr, Cetirizine Phenylephrine, Ambroxol HCl,Guaiphenesin and Sodium Citrate | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan HBr IP 15 mg Cetirizine HCl IP 5 mg Phenylephrine Hydrochloride IP 8 mg Ambroxol Hydrochloride IP 30 mg Guaiphenesin IP 100 mg Sodium Citrate IP 75 mg Approved colour used in flavoured syrupy base |
| Dextromethorphan HBr, Phenylephrine Hcl, Chlorpheniramine Maleate Syrups | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Dextromethorphan HBr IP 15 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Approved coloured use in a flavoured syrup base |
| Doxofylline Syrup 29.04.2022 | Anti-asthmatic / Cough & Cold | Each ml contains : Doxofylline IP 20 mg Approved colour used in flavoured syrupy base |
| Fexofenadine & Montelukast Suspension | Anti-asthmatic / Cough & Cold | Each 5 ml. contains Fexofenadine Hydrochloride IP 30 mg Montelukast Sodium IP Jeq. to Montelukast 4 mg Colour : Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| Fexofenadine and Montelukast Suspension | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Fexofenadine IP 60 mg Montelukast Sodium IP eq. to Montelukast 4 mg Approved colour used in flavoured syrupy base |
| LEVOCETIRIZINE HYDROCHLORIDE & AMBROXOL HYDROCHLORIDE | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Levocetirizine Hydrochloride IP 2.5 mg Ambroxol Hydrochloride IP 15 mg Approved colour used in flavoured syrupy base |
| LEVOCETIRIZINE HYDROCHLORIDE & MONTELUKAST SUSPENSION | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Levocetirizine Hydrochloride IP 2.5 mg Montelukast Sodium IP eq. to Montelukast 4 mg Approved colour used in flavoured syrupy base |
| LEVOSALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE,Guaiphenesin and Menthol | Anti-asthmatic / Cough & Cold | Each 10 ml contains : Levosalbutamol Sulphate IP Equivalent to Levosalbutamol 2 mg Bromhexine Hydrochloride IP 4 mg Guaiphenesin IP 100 mg Menthol qs Approved colour used in flavoured syrupy base |
| Levocetirizine Hcl & Ambroxol Hcl Syrup | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Levocetirizine HCl IP 5 mg Ambroxol Hcl IP 30 mg Approved colour used in flavoured syrupy base |
| Levocetirizine Hcl & Ambroxol Hcl Syrup | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Levocetirizine HCl IP 2.5 mg Ambroxol Hcl IP 30 mg Approved colour used in flavoured syrupy base |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Levosalbutamol Sulphate IP Eq. to Levosalbutamol 0.5 mg Ambroxol Hydrochloride IP 15 mg Guaiphenesin IP 25 mg Approved colour used in flavoured syrupy base |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride | Anti-asthmatic / Cough & Cold | Each ml contains : Levosalbutamol Sulphate IP eq. to Levosalbutamol 0.25 mg Ambroxol Hydrochloride IP 7.5 mg Guaiphenesin IP 12.5 mg Approved colour used in flavoured syrupy base |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Levosalbutamol Sulphate IP eq. to Levosalbutamol 1 mg Ambroxol Hydrochloride IP 15 mg Guaiphenesin IP 50 mg Approved colour used in flavoured syrupy base |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & | Anti-asthmatic / Cough & Cold | Each 5 ml. contains Levosalbutamol Sulphate eq. to Levosalbutamol IP 1 mg Ambroxol Hydrochloride IP 30 mg Guaiphenesin IP 50 mg Colour: Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & | Anti-asthmatic / Cough & Cold | Each 5 ml. contains Levosalbutamol Sulphate eq. to Levosalbutamol IP 1 mg Ambroxol Hydrochloride IP 30 mg Guaiphenesin IP 50 mg Colour: Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| PARACETAMOL, AMBROXOL Hcl, PHENYLEPHRINE HYDROCHLORIDE and Chlorpheniramine Maleate | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Paracetamol IP 125 mg Ambroxol Hydrochloride IP 15 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| PARACETAMOL, AMBROXOL Hcl, PHENYLEPHRINE HYDROCHLORIDE and Chlorpheniramine Maleate | Anti-asthmatic / Cough & Cold | Each ml contains : Paracetamol IP 100 mg Ambroxol Hydrochloride IP 7.5 mg Phenylephrine Hydrochloride IP 2.5 mg Chlorpheniramine Maleate IP 1 mg Approved colour used in flavoured syrupy base |
| SALBUTAMOL SULPHATE SYRUP IP | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Salbutamol Sulphate IP Equivalent to Salbutamol 2 mg Approved colour used in flavoured syrupy base |
| SALBUTAMOL SULPHATE, BROMHEXINE | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Salbutamol Sulphate IP Equivalent to Salbutamol 2 mg Bromhexine Hydrochloride IP 4 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| SALBUTAMOL SULPHATE, BROMHEXINE HYDROCHLORIDE,Guaiphenesin and Menthol | Anti-asthmatic / Cough & Cold | Each 10 ml contains : Salbutamol Sulphate IP Equivalent to Salbutamol 2 mg Bromhexine Hydrochloride IP 4 mg Guaiphenesin IP 100 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| TERBUTALINE SULPHATE, AMBROXOL HYDROCHLORIDE,and Guaiphenesin | Anti-asthmatic / Cough & Cold | Each 10 ml contains : Terbutaline Sulphate IP 2.5 mg Ambroxol Hydrochloride IP 30 mg Guaiphenesin IP 100 mg Menthol qs Approved colour used in flavoured syrupy base |
| TERBUTALINE SULPHATE, AMBROXOL HYDROCHLORIDE,and Guaiphenesin | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Terbutaline Sulphate IP 1.25 mg Ambroxol Hydrochloride IP 15 mg Guaiphenesin IP 50 mg Ammonium chloride IP 100 mg Menthol qs Approved colour used in flavoured syrupy base |
| TERBUTALINE SULPHATE, BROMHEXINE HYDROCHLORIDE, Guaiphenesin and Menthol | Anti-asthmatic / Cough & Cold | Each 10 ml contains : Terbutaline Sulphate IP 2.5 mg Bromhexine Hydrochloride IP 8 mg Guaiphenesin IP 100 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| Terbutaline Sulphate, Acebrophylline with Guaiphenesin | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Terbutaline Sulphate IP 1.25 mg Acebrophylline IP 50 mg Guaiphenesin IP 50 mg Approved colour used in flavoured syrupy base |
| Terbutaline Sulphate, Ambroxol Hydrochloride | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Terbutaline Sulphate IP 0.63 mg Ambroxol Hydrochloride IP 10 mg Guaiphenesin IP 25 mg Approved colour used in flavoured syrupy base |
| Terbutaline Sulphate, Ambroxol Hydrochloride | Anti-asthmatic / Cough & Cold | Each ml contains : Terbutaline Sulphate IP 0.25 mg Ambroxol Hydrochloride IP 7.5 mg Guaiphenesin IP 12.5 mg Approved colour used in flavoured syrupy base |
| Terbutaline Sulphate, Bromhexine HCl Guaiphenesin With Menthol Syrup | Anti-asthmatic / Cough & Cold | Each 5 ml contains : Terbutaline Sulphate IP 1.25 mg Bromhexine Hydrochloride IP 2 mg Guaiphenesin IP 50 mg Menthol IP q.s. Approved colour used in flavoured syrupy base |
| ALBENDAZOLE & IVERMECTIN SUSPENSION | Anti-parasitic | Each 5 ml contains : Albendazole IP 200 mg Ivermectin IP 1.5 mg Approved colour used in flavoured syrupy base |
| ALBENDAZOLE SUSPENSION IP | Anti-parasitic | Each ml contains : Albendazole IP 25 mg Approved colour used in flavoured syrupy base |
| ALBENDAZOLE SUSPENSION IP | Anti-parasitic | Each 5 ml contains : Albendazole IP 200 mg Approved colour used in flavoured syrupy base |
| Oseltamivir Phosphate Oral Suspension IP | Anti-viral | Each ml of Reconstituted Suspension contains : Oseltamivir Phosphate IP Eq. to Oseltamivi 15 mg Approved colour used in flavoured syrupy base |
| Oseltamivir Phosphate Oral Suspension IP | Anti-viral | Each ml of Reconstituted Suspension contains : Oseltamivir Phosphate IP Eq. to Oseltamivi 12 mg Approved colour used in flavoured syrupy base |
| AZITHROMYCIN ORAL SUSPENSION IP | Antibiotic | Each 5 ml contains : Azithromycin IP eq. to Anhydrous Azithromycin 200 mg Approved colour used in flavoured syrupy base |
| AZITHROMYCIN ORAL SUSPENSION IP | Antibiotic | Each 5 ml contains : Azithromycin IP eq. to Anhydrous Azithromycin 100 mg Approved colour used in flavoured syrupy base |
| AZITHROMYCIN ORAL SUSPENSION IP For Paediatric Use | Antibiotic | Each 5 ml contains : Azithromycin IP eq. to Anhydrous Azithromycin 125 mg Approved colour used in flavoured syrupy base |
| CIPROFLOXACIN & TINIDAZOLE SUSPENSION | Antibiotic | Each 5 ml contains : Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 125 mg Tinidazole IP 100 mg Approved colour used in flavoured syrupy base |
| Levofloxacin Oral Solution IP | Antibiotic | Each 5 ml contains: Levofloxacin Hemihydrate IP eq. to Levofloxacin 125 mg Approved colour used in flavoured syrupy base |
| Linezolid Oral Suspension Paediatric used | Antibiotic | Each 5 ml contains: Linezolid IP 100 mg Approved colour used in flavoured syrupy base |
| OFLOXACIN & METRONIDAZOLE ORAL SUSPENSION | Antibiotic | Each 5 ml contains : Ofloxacin IP 50 mg Metronidazole Benzoate IP Equivalent to Metronidazole 100 mg Approved colour used in flavoured syrupy base |
| OFLOXACIN ORAL SUSPENSION IP | Antibiotic | Each 5 ml contains : Ofloxacin IP 50 mg Approved colour used in flavoured syrupy base |
| OFLOXACIN WITH ORNIDAZOLE ORAL SUSPENSION | Antibiotic | Each 5 ml contains : Ofloxacin IP 50 mg Ornidazole IP 125 mg Approved colour used in flavoured syrupy base |
| Ofloxacin & Metronidazole Oral Suspension | Antibiotic | Each 5 ml contains : Ofloxacin IP 100 mg Metronidazole Benzoate IP Equivalent to Metronidazole 200 mg Approved colour used in flavoured syrupy base |
| Fluoxetine Oral Solution | CNS & Neuropathic | Each 5 ml contains : Fluoxetine Hydrochloride IP 20 mg Eq.to Fluxetine Approved colour used in flavoured syrupy base |
| DEFLAZACORT ORAL SUSPENSION For Paediatric Use | Corticosteroid | Each 5 ml contains : Deflazcort IP 6 mg Approved colour used in flavoured syrupy base |
| Prednisolone Sodium Phosphate Syrup | Corticosteroid | Each 5 ml contains : Prednisolone Sodium Phosphate IP Eq. to Prednisolone 5 mg Approved colour used in flavoured syrupy base |
| Prednisolone Syrup USP | Corticosteroid | Each 5 ml Contains : Prednisolone IP 5 mg Approved colour used in flavoured syrupy base |
| Sildenafil Oral Suspension | Erectile Dysfunction | Each ml contains : Sildenafil Citrate IP Eq. to Sildenfil 10 mg Approved colour used in flavoured syrupy q.s. |
| Sildenafil Oral Suspension | Erectile Dysfunction | Each ml contains : Sildenafil Citrate IP Eq. to Sildenfil 5 mg Approved colour used in flavoured syrupy q.s. |
| Activated Dimethicone & Domperidone | Gastrointestinal & Antacid | Each 5 ml contains: Activated Dimethicone IP 40 mg Domperidone Maleate IP Eq. to Domperidone 5 mg Dicyclomine Hydrochloride IP 10 mg Approved colour used in flavoured syrupy base |
| DOMPERIDONE ORAL SUSPENSION IP | Gastrointestinal & Antacid | Each ml contains : Domperidone IP 1 mg Approved colour used in flavoured syrupy base |
| DRIED ALUMINIUM HYDROXIDE MAGNESIUM HYDROXIDE and Activated Dimethicone | Gastrointestinal & Antacid | Each 5 ml contains : Dried Aluminium Hydroxide Gel IP 250 mg Magnesium Hydroxide IP 250 mg Activated Dimethicone IP 25 mg Approved colour used in flavoured syrupy base |
| Domperidone Suspension | Gastrointestinal & Antacid | Each 5 ml contains : Domperidone IP 5 mg Approved coloured use in a flavoured syrup base |
| Dried Aluminium Hydroxide Magnesium Hydroxide with Dried Aluminium Hydroxide Gel, Activated Dimethicone | Gastrointestinal & Antacid | Each 10 ml contains Dried Aluminium Hydroxide Gel IP 250 mg Magnesium Hydroxide IP 250 mg Activated Dimethicone IP 50 mg Approved colour used in flavoured syrupy base |
| Dried Aluminium Hydroxide Magnesium Hydroxide, Oxetacaine | Gastrointestinal & Antacid | Each 5 ml contains : Dried Aluminium Hydroxide Gel IP 300 mg Magnesium Hydroxide IP 250 mg Activated Dimethicone IP 50 mg Oxetacaine BP 10 mg Approved colour used in flavoured syrupy base |
| Dried Aluminium Hydroxide Magnesium Hydroxide, Oxetacaine | Gastrointestinal & Antacid | Each 5 ml contains : Dried Aluminium Hydroxide Gel IP 300 mg Magnesium Hydroxide IP 150 mg Activated Dimethicone IP 125 mg Oxetacaine BP 10 mg Excipients q.s. Approved colour used in flavoured syrupy base |
| Dried Aluminium Hydroxide, Magnesium Hydroxide and Oxetacaine | Gastrointestinal & Antacid | Each 5 ml contains: Dried Aluminium Hydroxide Gel IP 291 mg Magnesium Hydroxide IP 98 mg Oxetacaine IP 10 mg Approved colour used in flavoured syrupy base |
| Dried Aluminium Hydroxide, Magnesium Hydroxide and Simethicone | Gastrointestinal & Antacid | Each 10 ml contains : Aluminuum Hydroxide Past Eq. to Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide Eq. to Magnesium Hydroxide IP 250 mg Simethicone IP 50 mg Approved coloured use in a flavoured syrup base |
| Dried Aluminium Hydroxide, Magnesium Hydroxide and Simethicone | Gastrointestinal & Antacid | Each 5 ml contains : Aluminuum Hydroxide 0.291 gm (Added as Aluminium Hydroxide paste Eq. to 0.380 gm Dried Aluminium Hydroxide IP) Magnesium Hydroxide IP 98 mg (Added as Magnesium Hydroxide paste) Oxetacaine BP 10 mg Approved coloured use in a flavoured syrup base |
| MAGALDRATE WITH ACTIVATED DIMETHICONE | Gastrointestinal & Antacid | Each 5 ml contains : Magaldrate IP 400 mg Activated Dimethicone IP 52.5 mg Approved colour used in flavoured syrupy base |
| MAGALDRATE WITH ACTIVATED DIMETHICONE & | Gastrointestinal & Antacid | Each 5 ml contains : Magaldrate IP 400 mg Activated Dimethicone IP 52.5 mg Oxythacaine 5 mg Approved colour used in flavoured syrupy base |
| MAGALDRATE WITH ACTIVATED DIMETHICONE SUSPENSION | Gastrointestinal & Antacid | Each 5 ml contains : Magaldrate IP 450 mg Activated Dimethicone IP 20 mg Approved colour used in flavoured syrupy base |
| MAGALDRATE, ACTIVATED DIMETHICONE | Gastrointestinal & Antacid | Each 5 ml contains : Magaldrate IP 400 mg Activated Dimethicone IP 52.5 mg Benzocaine IP 5 mg Approved colour used in flavoured syrupy base |
| Magaldrate and Simethicone Oral Suspension IP | Gastrointestinal & Antacid | Each 5 ml contains: Magaldrate IP 400 mg Simethicone IP 60 mg Approved colour used in flavoured syrupy base |
| Magaldrate with Simethicone Suspension | Gastrointestinal & Antacid | Each 5 ml contains: Magaldrate IP 480 mg Simethicone IP 20 mg Approved colour used in flavoured syrupy base |
| Magaldrate, Alginic Acid and Activated Dimethicone | Gastrointestinal & Antacid | Each 5 ml contains: Magaldrate IP 540 mg Alginic Acid IP 50 mg Activated Dimethicone IP 50 mg Approved colour used in flavoured syrupy base |
| Magaldrate, Oxetacaine and Activated Dimethicone Suspension | Gastrointestinal & Antacid | Each 5 ml contains Magaldrate IP 540 mg Oxetacaine BP 10 mg Activated Dimethicone IP 50 mg Approved colour used in flavoured syrupy base |
| Magaldrate, Oxetacaine and Simethicone Suspension | Gastrointestinal & Antacid | Each 5 ml contains : Magaldrate IP 480 mg Oxetacaine BP 10 mg Simethicone IP 20 mg Approved coloured use in a flavoured syrup base |
| Magaldrate, Simethicone and Oxetacaine Suspension | Gastrointestinal & Antacid | Each 5 ml contains : Magaldrate IP 540 mg Simethicone IP 20 mg Oxetacaine BP 10 mg Approved colour used in flavoured syrupy base |
| ONDANSETRON ORAL SOLUTION IP | Gastrointestinal & Antacid | Each 5 ml contains : Ondansetron Hydrochloride IP Eq. to Ondansetron 2 mg Approved colour used in flavoured syrupy base |
| Ondansetron Oral Solution IP | Gastrointestinal & Antacid | Each 5 ml contains: Ondansetron Hydrochloride IP Eq. to Ondansetron 4 mg Approved colour used in flavoured syrupy base |
| Ranitidine Oral Solution IP | Gastrointestinal & Antacid | Each 5 ml contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 75 mg Approved colour used in flavoured syrupy base |
| SUCRALFATE & BENZOCAINE SUSPENSION | Gastrointestinal & Antacid | Each 5 ml contains : Sucaralfate USP 1 gm Benzocaine IP 5 mg Approved colour used in flavoured syrupy base |
| SUCRALFATE SUSPENSION | Gastrointestinal & Antacid | Each 5 ml contains : Sucaralfate USP 1 gm Approved colour used in flavoured syrupy base |
| Sucralfate Suspension | Gastrointestinal & Antacid | Each 5 ml contains : Sucralfate IP 500 mg Approved colour used in flavoured syrupy base |
| Sucralfate and Oxetacaine Suspension | Gastrointestinal & Antacid | Each 5 ml contains : Sucralfate IP 500 mg Oxetacaine BP 10 mg Approved coloured use in a flavoured syrup base |
| Sucralfate and Oxetacaine Suspension | Gastrointestinal & Antacid | Each 10 ml contains : Sucralfate IP 1000 mg Oxetacaine IP 20 mg Approved coloured used in a flavoured syrup base |
| Sucralfate and Oxetacaine Suspension | Gastrointestinal & Antacid | Each 5 ml contains : Sucralfate IP 1000 mg Oxetacaine IP 10 mg Approved coloured used in a flavoured syrup base |
| Artemether & Lumefantrine Suspension | General / Unclassified | Each 5 ml Reconstituted Suspension contains : Artemether IP 40 mg Lumefantrine 240 mg Approved colour used in flavoured syrupy base |
| BETAMETHASONE SODIUM PHOSPHATE ORAL SOLUTION IP | General / Unclassified | Each ml contains : Betamethasone Sodium Phosphate IP Equivalent to Betamethasone 0.5 mg Approved colour used in flavoured syrupy base |
| Bilastine Oral Solution | General / Unclassified | Each ml contains : Bilastine 2.5 mg Approved coloured use in a flavoured syrup base |
| CHLORMPHENICOL PALMETATE ORAL SUSPENSION IP | General / Unclassified | Each 5 ml contains : Chloramphenicol Palmetate IP Eq. To Chloramphenicol 125 mg Approved colour used in flavoured syrupy base |
| CHLOROQUINE SYRUP IP | General / Unclassified | Each 5 ml contains : Chloroquine Phosphate IP Equivalent to Chloroquine 50 mg Approved colour used in flavoured syrupy base |
| CHLORPHENRAMINE MALEATE, AMMONIUM CHLORIDE,SODIUM CITRATE AND MENTHOL | General / Unclassified | Each 5 ml contains : Chlorpheniramine Maleate IP 2 mg Ammonium chloride IP 100 mg Sodium Citrate IP 50 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| CO-TRIMOXAZOLE SUSPENSION IP | General / Unclassified | Each 5 ml contains : Trimethoprim IP 40 mg Sulphamethoxazole IP 200 mg Approved colour used in flavoured syrupy base |
| Cefdinir Oral Solution IP 02.09.2023 | General / Unclassified | Each 5 ml of Reconstituted Suspension contains : Cefdinir IP 125 mg Flavoured syrupy base |
| Clarithromycin Oral Suspension | General / Unclassified | Each 5 ml Contains: Clarithromycin IP 125 mg Approved colour used in flavoured syrupy base |
| Clarithromycin Oral Suspension | General / Unclassified | Each 5 ml Contains: Clarithromycin IP 250 mg Approved colour used in flavoured syrupy base |
| DIASTASE AND PEPSIN DROPS For Paediatric Use | General / Unclassified | Each ml contains : Diastase (1:1200) IP 33.33 mg (Digest not less than 40 gm of cooked starch) Pepsin (1:3000) IP 5 mg (Digests not less than 15gm of coagulated egg albumen) Approved Colour used inFlavoured Syrupy Base |
| DICYCLOMINE HYDROCHLORIDE & ACTIVATED DIMETHICONE SUSPENSION | General / Unclassified | Each ml contains : Dicyclomine Hydrochloride IP 10 mg Activated Dimethicone IP 40 mg Approved colour used in flavoured syrupy base |
| DISODIUM HYDROGEN CITRATE SYRUP IP | General / Unclassified | Each 5 ml contains : Disodium Hydrogen citrate BP 1.4 gm Approved colour used in flavoured syrupy base |
| Dicyclomine Hydrochloride Suspension | General / Unclassified | Each 5 ml contains : Dicyclomine Hydrochloride IP 10 mg Approved coloured use in a flavoured syrup base |
| Dicyclomine Hydrochloride and Simethicone Suspension | General / Unclassified | Each 5 ml contains : Dicyclomine Hydrochloride IP 10 mg Simethicone IP 40 mg Approved coloured use in a flavoured syrup base |
| Disodium Hydrogen Citrate Syrup | General / Unclassified | Each 5 ml contains Disodium Hydrogen citrate BP 1.53 gm Approved colour used in flavoured syrupy base |
| ERYTHROMYCIN SYRUPS IP For Paediatric Use | General / Unclassified | Each 5 ml contains : Erythromycin Estolate IP 125 mg Equivalent to Erythromycin Base Approved colour used in flavoured syrupy base |
| FUNGAL DIASTASE & PEPSIN SYRUPS | General / Unclassified | Each 5 ml contains : Fungal Diastase(1:1200) IP 50 mg From Aspergillus Oryzae (Digest Not less than 60gms of cooked starch) Pepsin(1:3000) IP 10 mg (Digest Not less than 30gms of cogulated egg albumin) Approved colour used in flavoured syrupy base |
| FUNGAL DIASTASE & PEPSIN SYRUPS | General / Unclassified | Each 15 ml contains : Fungal Diastase (1:1200) IP 50 mg (Digest not less than 60 gm of cooked starch) Pepsin (1:3000) IP 10 mg (Digest not less than 30 gm of coagulated ezz albumnen) Approved colour used in flavoured syrupy base |
| FURAZOLIDONE & METRONIDAZOLE | General / Unclassified | Each 5 ml contains : Furazalidone IP 30 mg Metronidazole Benzoate IP Equivalent to Metronidazole IP 100 mg Approved colour used in flavoured syrupy base |
| FURAZOLIDONE SUSPENSION IP | General / Unclassified | Each 5 ml contains : Furazalidone IP 25 mg Approved colour used in flavoured syrupy base |
| Hydroxyzine Hydrochloride Oral Suspension IP | General / Unclassified | Each 5 ml contains : Hydroxyzine Hydrochloride IP 10 mg Approved colour used in flavoured syrupy base |
| LIQUOR BISMUTH, AMMONIUM CHLORIDE | General / Unclassified | Each 5 ml contains : Liquor Bismuth Ammonium Citrate BP 2.50 ml (Equivalent to Bi2 O3 140 mg) Belladonna Dry Extract IP 9 mg Thymol IP 0.15 mg Menthol IP qs Approved colour used in flavoured syrupy base |
| Lactulose Oral Solution USP | General / Unclassified | Each 15 ml. contains : Lactulose Concentrate USP eq. to Lactulose 10 g Approved colour used in flavoured syrupy base |
| METOCLOPRAMIDE HYDROCHLORIDE SYRUP IP | General / Unclassified | Each 5 ml contains : Metoclopramide Hydrochloride Eq.to Anhydrous Metoclopramide Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| METRONIDAZOLE BENZOATE SUSPENSION IP | General / Unclassified | Each 5 ml contains : Metronidazole Benzoate IP Equivalent to Metronidazole 100 mg Approved colour used in flavoured syrupy base |
| Mefenaimic Acid Suspension | General / Unclassified | Each 5 ml contains : Mefenamic acid IP 100 mg Approved colour used in flavoured syrupy base |
| Mycophenolate Mofetil Suspension | General / Unclassified | Each ml contains : Mycophenolate Mofetil IP 200 mg Approved colour used in flavoured syrupy base |
| NORFLOXACIN & METRONIDAZOLE | General / Unclassified | Each 5 ml contains : Norfloxacin IP 100 mg Metronidazole Benzoate IP Equivalent to Metronidazole 120 mg Approved colour used in flavoured syrupy base |
| NORFLOXACIN WITH METRONIDAZOLE ORAL SUSPENSION | General / Unclassified | Each 5 ml contains : Norfloxacin IP 100 mg Metronidazole Benzoate IP Equivalent to Metronidazole 100 mg Approved colour used in flavoured syrupy base |
| NORFLOXACIN, METRONIDAZOLE & FURAZOLIDONE ORAL SUSPENSION | General / Unclassified | Each 5 ml contains : Norfloxacin IP 100 mg Metronidazole Benzoate IP Equivalent to Metronidazole 100 mg Furazolidone IP 20 mg Approved colour used in flavoured syrupy base |
| Nitazoxanide Suspension | General / Unclassified | Each 5 ml contains : Nitazoxanide 100 mg Approved coloured use in a flavoured syrup base |
| Oral Rehydration Salts IP | General / Unclassified | Each sachet 21g contains Sodium chloride IP 2.60 g Dextrose anhydrose IP 13.5 g Potassium Chloride IP 1.50 g Sodium Carate IP 2.90 g Excipients q.s. |
| Oral Rehydration Salts Solution | General / Unclassified | Each 200 ml. contains Sodium Chloride IP 0.52 g Dextrose Monohydrate IP 2.97 g Potassium Chloride IP 0.30 g Sodium Citrate IP 0.58 g Approved colour in flavoured syrupy base |
| PHENYLEPHERINE HYDROCHLORIDE, CHLORPHENRAMINE MALEATE SYRUP | General / Unclassified | Each 5 ml contains : Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENRAMINE MALEATE SYRUP | General / Unclassified | Each 5 ml contains : Phenylephrine Hydrochloride IP 2.5 mg Chlorpheniramine Maleate IP 2 mg Approved colour used in flavoured syrupy base |
| PIPERAZINE CITRATE & DIETHYL CARBAMAZINE CITRATE SYRUP | General / Unclassified | Each 5 ml contains : Piperazine Citrate IP eq. to Piperazine Hydrate 500 mg Diethyl Carbamazine Citrate IP 25 mg Approved colour used in flavoured syrupy base |
| PIPERAZINE CITRATE SYRUP IP | General / Unclassified | Each 5 ml contains : Piperazine Citrate IP Equivalent to Piperazine Hydrate 750 mg Approved colour used in flavoured syrupy base |
| PIPERAZINE CITRATE SYRUP IP For paediatric use | General / Unclassified | Each 5 ml contains : Piperazine Citrate IP Eq. to Piperazine Hydrate 500 mg Approved colour used in flavoured syrupy base |
| POTASSIUM CITRATE & MAGNESIUM CITRATE SYRUP | General / Unclassified | Each 5 ml contains : Potassium Citrate IP 1100 mg Magnesium Citrate USP 375 mg Approved colour used in flavoured syrupy base |
| PROMETHAZINE HYDROCHLORIDE SYRUP IP | General / Unclassified | Each 5 ml contains : Promethazine Hydrochloride IP 5 mg Approved colour used in flavoured syrupy base |
| Pheniramine Maleate Syrups | General / Unclassified | Each 5 ml Contains : Pheniramine Maleate IP 15 mg Approved colour used in flavoured syrupy base |
| Pheniramine Maleate Syrups | General / Unclassified | Each 5 ml Contains : Pheniramine Maleate IP 30 mg Approved colour used in flavoured syrupy base |
| Phenobarbitone Syrup | General / Unclassified | Each 5 ml Contains : Phenobarbitone Sodium IP Eq. to Phenobarbitone 20 mg Approved colour used in flavoured syrupy base |
| Posaconazole Oral Suspension | General / Unclassified | Each ml contains : Posaconazole 40 mg Approved colour used in flavoured syrupy base |
| Pyridoxine Hcl, Nicotinamide, Cyanocobalamin and Lysine Hcl | General / Unclassified | Each 5 ml contains : Pyridoxine Hydrochloride IP 0.75 mg Nicotinamide IP 15 mg Cyanocobalamin IP 2 mcg Lysine Hcl USP 37.5 mg Approved colour used in flavoured syrupy base |
| ROXITHROMYCIN SUSPENSION IP For Paediatric Use | General / Unclassified | Each 5 ml contains : Roxithromycin BP 50 mg Approved colour used in flavoured syrupy base |
| Racecadotril Suspension | General / Unclassified | Each 5 ml contains : Racecadotril IP 10 mg Approved colour used in flavoured syrupy base |
| Rifaximin Oral Suspension | General / Unclassified | Each 5 ml contains : Rifaximin BP 100 mg Approved colour used in flavoured syrupy base |
| Simethicone, Dill Oil with Fennel Oil Drops | General / Unclassified | Each ml contains : Simethicone IP 40 mg Dill Seed Oil IP 0.005 ml Fennel Oil IP 0.0007 ml Approved Colour used inFlavoured Syrupy Base |
| Sodium Plcosulphate Oral Solution BP | General / Unclassified | Each 5 ml contains Sodium Picosulphate BP 5 mg Approved colour used in flavoured syrupy base |
| THEOPHYLLINE & ETOFYLLINE SYRUPS | General / Unclassified | Each 5 ml contains : Theophylline IP 14 mg Etofylline IP 46.5 mg Approved colour used in flavoured syrupy base |
| TRICHOLINE CITRATE SYRUP | General / Unclassified | Each 5 ml contains : Tricholine citrate 275 mg Approved colour used in flavoured syrupy base |
| TRICHOLINE CITRATE WITH SORBITOL 70% SYRUP | General / Unclassified | Each 10 ml contains : Tricholine citrate 0.55 gm Sorbitol Soluion (Non crystallizing 70%) IP 7.15 gm Approved colour used in flavoured syrupy base |
| Tricholine Citrate, Thiamine HCl Riboflavin, Cyanocobalamin | General / Unclassified | Each 5 ml contains : Tricholine Citrate 250 mg Thiamine Hydrochloride IP 2.5 mg Riboflavin IP 2.5 mcg Cyanocobalmin IP 5.0 mcg Pyridoxine Hydrochloride IP 0.75 mg Approved Colour used inFlavoured Syrupy Base |
| Triclofos Oral Solution IP 02.09.2023 | General / Unclassified | Each 5 ml contains: Triclofos Sodium IP 500 mg Approved colour used in flavoured syrupy base |
| Ursodeoxycholic Acid Oral Suspension | General / Unclassified | Each 5 ml contains : Ursodeoxycholic Acid IP 125 mg Approved coloured use in a flavoured syrup base |
| Ursodeoxycholic Acid Oral Suspension | General / Unclassified | Each 5 ml contains : Ursodeoxycholic Acid IP 250 mg Approved coloured use in a flavoured syrup base |
| Voriconazole Oral powder for solution | General / Unclassified | Each ml contains : Voriconazole IP 40 mg Approved colour used in flavoured syrupy base |
| Xylometazoline HCI Nasal Solution IP | General / Unclassified | Each 5 ml contains : Xylometazoline HCI IP 0.05 % w/v Benzalkonium Chloride (As preservapive) IP 0.02 % w/v Sterile aqueous base q.s. |
| Citicoline Sodium and Piracetam Syrup | Neuroprotective | Each 5 ml contains : Citicoline Sodium IP Eq. to Citicoline 500 mg Piracetam IP 400 mg Approved colour used in flavoured syrupy base |
| CALCIUM GLUCONATE, VITAMIN B12 & VITAMIN D3 SYRUPS | Nutritional Supplement | Each 15 ml contains : Calcium Gluconate IP Eq. To Elemental Calcium 200 mg Vitamin B12 IP 5 mcg Vitamin D3 (As Cholecalciferol) IP 400 IU Approved colour used in flavoured syrupy base |
| CALCIUM WITH VITAMIN B12 & VITAMIN D3 SUSPENSION | Nutritional Supplement | Each 5 ml contains : Tribasic Calcium Phosphate Eq. To Elemental Calcium 82 mg Vitamin B12 IP 2.50 mcg Vitamin D3(As Cholecalciferol) IP 200 I.U Approved colour used in flavoured syrupy base |
| CHOLECALCIFEROL ORAL SUSPENSION (DROPS) | Nutritional Supplement | Each ml contains : Cholecalciferol (Vitamin D3 ) IP 400 IU (As stabilized) Approved colour used in flavoured syrupy base |
| Calcium Carbonate and Vitamin D₃ Syrup | Nutritional Supplement | Each 5 ml contains : Calcium Carbonate IP 625 mg Eq. To Elemental Calcium 250 mg Vitamin D₃ (As Cholecalciferol) IP 125 I.U Approved colour used in flavoured syrupy base |
| Calcium Carbonate, Vitamin D₃ and Zinc Sulphate Syrup | Nutritional Supplement | Each 5 ml contains : Calcium Carbonate IP 625 mg Eq. To Elemental Calcium IP 250 mg Vitamin D₃ (As Cholecalciferol) IP 400 I.U Zinc Sulphate IP 7.5 mg Approved colour used in flavoured syrupy base |
| Calcium With Cholecalciferol, Suspension | Nutritional Supplement | Each 5 ml. contains Calcium Carbonate IP eq. to Calcium 250 mg Cholecalciferol IP 125 IU Colour : Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| Cholecalciferol Syrup For Therapeutic Use | Nutritional Supplement | Each 5 ml Contains : Cholecalciferol (Vitamin D3) IP 1000 IU Approved colour used in flavoured syrupy base |
| FERRIC AMMONIUM CITRATE, CYANOCOBALAMIN WITH Vitamin B, Folic Acid | Nutritional Supplement | Each 15 ml contains : Ferric Ammonium Citrate IP 160 mg (equivalent to Elemental Iron 32 mg) Vitamin B 12 IP 7.5 mcg Folic Acid IP 1 mg Approved Colour used in Flavoured Syrupy Base |
| FERROUS FUMERATE, VITAMIN B12 WITH Eq, to Ferrous Iron, Folic Acid, Zinc Sulphate | Nutritional Supplement | Each 5 ml contains : Ferrous Fumerate IP 100 mg Eq, to Ferrous Iron IP 32.5 mg Vitamin B12 IP 5 mcg Folic Acid IP 0.5 mg Zinc Sulphate Eq. to Zinc 10 mg Approved colour used in flavoured syrupy base |
| Ferric Ammonium Citrate, Cyanocobalamin With Cyanocobalmin, Folic Acid | Nutritional Supplement | Each 15 ml contains : Ferric Ammonium Citrate IP 160 mg (equivalent to Elemental Iron 32 mg) Cyanocobalmin IP 7.5 mcg Folic Acid IP 0.5 mg Approved Colour used inFlavoured Syrupy Base |
| Ferric Ammonium Citrate, Cyanocobalamin, Folic Acid | Nutritional Supplement | Each 15 ml contains : Ferric Ammonium Citrate IP 160 mg (equivalent to Elemental Iron 32 mg) Cyanocobalamin IP 7.5 mcg Folic Acid IP 0.5 mg Cupric Sulphate IP 30 mcg Manganese Sulphate IP 30 mcg Approved Colour used inFlavoured Syrupy Base |
| Ferrous Gluconate, Folic Acid Cyanocobalamin with Cyanocobalmin, Calcium Lactate | Nutritional Supplement | Each 15 ml contains : Ferrous Gluconate IP 129.5 mg (equivalent to Elemental Iron 15 mg) Cyanocobalmin IP 1.3 mcg Folic Acid IP 0.25 mg Calcium Lactate IP 75 mg Approved Colour used inFlavoured Syrupy Base |
| IRON & FOLIC ACID SYRUPS For Therapeutic Use | Nutritional Supplement | Each 5 ml contains : Iron (III) Hydroxide Polymaltose Complex Eq. to Elemental Iron IP 50 mg Folic Acid IP 500 mcg Approved colour used in flavoured syrupy base |
| IRON, CYANOCOBALAMIN wITH FOLIC ACID SYRUPS | Nutritional Supplement | Each 15 ml contains Ferric Ammonium Citrate IP 160 mg (equivalent to Elemental Iron 32 mg) Folic Acid IP 1500 mcg Cyanocobalamin IP 15 mcg Approved Colour used in Flavoured Syrupy Base |
| IRON, FOLIC ACID WITH ZINC SYRUPS | Nutritional Supplement | Each 15 ml contains: Iron (III) Hydroxide Polymaltose Complex Eq. to Elemental Iron IP 100 mg Folic Acid IP 1500 mcg Zinc Sulphate IP Eq.to Elemental Zinc 10 mg Approved Colour used inFlavoured Syrupy Base |
| IRON, FOLIC ACID, WITH CYANOCOBALAMIN & ZINC SYRUPS | Nutritional Supplement | Each 15 ml contains: Elemental Iron (As Carbonyl Iron USP) 75 mg Folic Acid IP 1500 mcg Cyanocobalamin IP 5 mcg Zinc Sulphate Monohydrate IP Elemental Zinc 20 mg Approved colour used in flavoured syrupy base |
| IRON, L-LYSIN HYDROCHLORIDE WITH FOLIC ACID SYRUP | Nutritional Supplement | Each 5 ml contains : Iron (III) Hydroxide Polymaltose Complex eq. to Elemental Iron IP 50 mg L-Lysine Hydrochloride USP 10 mg Cyanocobalamin IP 5 mcg Folic Acid IP 1 mg Approved colour used in flavoured syrupy base |
| IRON,MULTIVITAMIN &MULTIMINERAL SYRUPS | Nutritional Supplement | Each 15 ml contains: Iron Choline Citrate IP 200 mg L-Lysine Hydrochloride USP 100 mg Nicotinamide IP 45 mg Thiamine Mononitrate IP 5 mg Riboflavine (As Riboflavine Sodium Phosphate) IP 5 mg D Panthenol IP 5 mg Pyridoxine HCL IP 1.5 mg Zinc Sulphate Monohydrate IP 10 mg Cyanocobalamin IP 7.5 mcg Choline Dihydrogen Citrate 30 mg Glutamic Acid USP 10 mg Approved colour used in flavoured syrupy base |
| Iron (III) Polymaltose, Folic acid Syrup | Nutritional Supplement | Each 15 ml contains : Iron (III) Hydroxide Polymaltose Complex Eq. to Elemental Iron 50 mg Folic acid IP 0.5 mg Approved coloured use in a flavoured syrup base |
| Iron, Cyanocobalamin, Zinc Folic Acid, and Pyridoxine Hcl | Nutritional Supplement | Each 15 ml contains : Ferric Ammonium Citrate IP 200 mg (Equivalent to Elemental Iron 41 mg) Folic Acid IP 0.5 mg Cyanocobalamin IP 7.5 mcg Zinc Sulphate IP 7 mg Pyridoxine Hcl IP 1.5 mg Sorbitol solution 70 % q.s. Approved Colour used inFlavoured Syrupy Base |
| Iron, Folic acid and Cyanocobalamin Syrup | Nutritional Supplement | Each 5 ml contains : Ferric Amonium Citrate IP 110 mg Eq. to Elemental Iron 22.5 mg Folic acid IP 1.5 mg Cyanocobalamin IP 15 mcg Sorbitol solution (70%) Non crystalling q.s. Approved coloured use in a flavoured syrup base |
| LYCOPENE WITH MULTIVITAMIN & MULTIMINERAL SYRUPS | Nutritional Supplement | Each 5 ml contains : Lycopene 6% USP 1000 mcg Zinc Sulphate Monohydrate USP 7.5 mg Sodium Selenite USP eq. to Selenite 35 mcg Manganese Gluconate USP 2.75 mg Potassiu lodid IP eq. to Elemental lodine 75 mcg Copper Sulphate IP eq. to elemental Copper 1.1 mg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN & MULTIMINERAL SYRUP | Nutritional Supplement | Each 5 ml contains : Ferrous Gluconate IP 100 mg Cyanocobalamin IP 1 mcg Folic Acid IP 0.25 mg L-Lysine Hydrochloride USP 25 mg Pyridoxine Hydrochloride IP 0.5 mg D Panthenol IP 1.25 mg Nicotinamide IP 15 mg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN & MULTIMINERAL SYRUPS | Nutritional Supplement | Each 10 ml contains : Lycopene 6% USP 2000 mcg Nicotinamide IP 25 mg Pyridoxine Hydrochloride IP 1.5 mg Cyanocobalamin IP 1 mcg Sodium Selenite USP eq. to Selenite 35 mcg Zinc Gluconate USP eq.to Zinc 3 mg Manganese Gluconate eq. to Manganese 2.00 mg Potassium lodide IP eq. to Elemental lodine 100 mcg Cupric Sulphte Pentahydrate eq.to Copper USP 500 mcg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN & MULTIMINERAL WITH L-LYSINE HYROCHLORIDE SYRUP | Nutritional Supplement | Each 5 ml contains : Pyridoxine Hydrochloride IP 0.5 mg Cholecalciferol (Vitamin D3 ) IP 100 IU Nicotinamide IP 15 mg Cyanocobalamin IP 0.5 mcg Folic Acid IP 300 mcg Copper Sulphate USP 100 mcg D Panthenol IP 1.25 mg Zinc Sulphate Monohydrate IP 22.5 mg Chromium (As Chromium Chloride) IP 1 mcg Manganese Chloride IP 3 mcg L-Lysine HCL USP 5 mg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN DROPS For Paediatric Use | Nutritional Supplement | Each ml contains : Vitamin A Concentrate(Oily Form as Palmil IP 4000 IU Vitamin D3 (As Cholecalciferol) IP 400 IU Thiamin HCl IP 1 mg Vitamin B2 Sodium Phosphate IP 1 mg Eq. to Vitamin B2 Vitamin B6 HCI 1 mg Vitamin B12 IP 3 mcg Naicinamide IP 10 mg L-Lysine hydrochloride IP 10 mg D-Panthenol IP 3 mg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN DROPS For infants less then 1 year | Nutritional Supplement | Each ml contains : Vitamin A Concentrate(Oily Form as Palmitate) IP 2500 IU Vitamin D3 (As Cholecalciferol) IP 200 IU Thiamin Hcl IP 1 mg Vitamin B2 Sodium Phosphate IP Eq. to Vitamin B2 0.5 mg Naicinamide IP 5 mg Vitamin B6 HCI IP 0.5 mg D-Panthenol IP 1.5 mg Vitamin E Acetate IP 2.5 IU Approved colour used in flavoured syrupy base |
| MULTIVITAMIN DROPS For infants less then 1 year | Nutritional Supplement | Each ml contains : Vitamin A Concentrate(Oily Form as Palmitate) IP 3000 IU Vitamin D3 (As Cholecalciferol) IP 400 IU Thiamin Hcl IP 1 mg Vitamin B2 Sodium Phosphate IP Eq. to Vitamin B2 1 mg Naicinamide IP 5 mg Vitamin B6 HCI IP 1 mg D-Panthenol IP 3 mg Vitamin E Acetate IP 5 I.U Approved colour used in flavoured syrupy base |
| MULTIVITAMIN SYRUP For Therapeutic Use | Nutritional Supplement | Each 5 ml contains : Thiamine Mononitrate IP 5 mg Riboflavine Us Riboflavine Sodium Phosphate) IP 5 mg Nicotinamide IP 45 mg Pyridoxine Hydrochloride IP 1.5 mg Cyanocobalamin IP 7.5 mcg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN SYRUPS For Prophylactic Use | Nutritional Supplement | Each 5 ml contains : Vitamin B1 Hcl IP 1 mg Vitamin B2 IP 1 mg Vitamin B12 IP 1 mcg Naicinamide IP 15 mg D-Panthenol IP 2.5 mg Approved colour used in flavoured syrupy base |
| MULTIVITAMIN SYRUPS For Prophylactic Use | Nutritional Supplement | Each 5 ml contains : Vitamin B1 IP 1 mg Vitamin B2 IP 1 mg Vitamin B6 IP 0.5 mg Vitamin B12 IP 1 mcg Naicinamide IP 15 mg D-Panthenol IP 2.5 mg Approved colour used in flavoured syrupy base |
| Mecobalamine, Alfacacidol, Riboflavin, Thiamine, Pyridoxine, Nicotinamide,Calcium D Pantothenate and Zinc Sulphate | Nutritional Supplement | Each 5 ml contains : Mecobalamine IP 1 mcg Alfacalcidol IP 0.25 mcg Thiamine mononitrate IP 1 mg Riboflavin IP 1.1 mg Pyridoxine hydrochloride IP 0.80 mg Nicotinamide IP 15 mg Calcium D Pantothenate IP 3 mg Zinc sulphate monohydrate IP Eq. to elemntal Zinc 1.82 mg Approved coloured used in flavoured syrupy base |
| Multi-Vitamin, Multi-Mineral with Lycopene & Methylcobalamin | Nutritional Supplement | Each 5 ml contains : Methylcobalamin IP 500 mcg Lycopene 6% USP 1500 mcg L-Lysine Hydrochloride 60 mg Vitamin A (As Palmetate) IP 5000 IU Vitamin E IP 15 IU Vitamin D3 IP 400 IU Thiamine Mononitrate IP 5 mg Riboflavine (As Sodium Phosphate) IP 5 mg Sodium Selenite USP eq. to Selenite 20 mcg Zinc Gluconate USP eq.to Zinc 2 mg Mangnesium Chloride IP 2 mg Potassium lodide IP eq. to Elemental lodine 100 mcg Chromium Chloride IP 16 mcg Approved colour used in flavoured syrupy base |
| Multi-Vitamin, Multi-Mineral with Lycopene & Methylcobalamin | Nutritional Supplement | Each 5 ml contains : Methylcobalamin IP 500 mcg Lycopene 6% USP 1500 mcg L-Lysine Hydrochloride 60 mg Vitamin A (As Palmetate) IP 5000 IU Vitamin E IP 15 IU Thiamine Mononitrate IP 5 mg Riboflavine (As Sodium Phosphate) IP 5 mg Sodium Selenite USP eq. to Selenite 20 mcg Zinc Gluconate USP eq.to Zinc 2 mg Mangnesium Chloride IP 2 mg Potassium lodide IP eq. to Elemental lodine 100 mcg Chromium Chloride IP 16 mcg Approved colour used in flavoured syrupy base |
| Multivitamin Drops For paediatric use | Nutritional Supplement | Each ml contains : Thiamine Mononitrate IP 1 mg Riboflavine IP 1.5 mg Pyridoxine HCL IP 1.5 mg Cyanocobalamin IP 3 mcg Nicotinamide IP 15 mg Cholecalciferol (Vitamin D3) IP 400 IU Zinc Sulphate Monohydrate IP Eq. to elemantel Zinc 2.50 mg Vitamin A (As Palmetate) IP 2000 IU Omega 3 30 mg Selenium Dioxide IP 15 mcg Approved colour used in flavoured syrupy base |
| Multivitamin Syrups For Prophylatic use | Nutritional Supplement | Each 5 ml contains : Thiamine Mononitrate IP 2 mg Riboflavine IP 2 mg Pyridoxine HCL IP 1.0 mg Cyanocobalamin IP 3 mcg Nicotinamide IP 25 mg Cholecalciferol (Vitamin D3) IP 400 IU Zinc Sulphate Monohydrate IP Eq. to elemantel Zinc IP 5 mg Vitamin A (As Palmetate) IP 3000 IU Selenium Dioxide IP 25 mcg Approved colour used in flavoured syrupy base |
| Multivitamin, Mineral with Lycopene Syrup | Nutritional Supplement | Each 15 ml contains : Lycopene 10% 1000 mcg Niacitamide IP 25 mg Pyridoxine HCl IP 1.5 mg Cyanocobalamin IP 1 mg Folic acid IP 100 mcg Selenium (As sodium seleneate) 35 mcg Zinc (As Zinc Glucotate) BP 3 mg lodine (As Potassium lodide) IP 100 mcg Copper (As Copper Sulphate) BP 500 mcg Biotine BP 100 mcg Magnesium Gluconate BP 100 mcg Approved coloured use in a flavoured syrup base |
| PROTEIN WITH MULTIVITAMIN SYRUPS | Nutritional Supplement | Each 15 ml contains: Protein Hydrolysate (100 %) IP 500 mg (Elemental Nitrogen 112 mg.) L-Lysine Monohydrochloride USP 70 mg Folic Acid IP 0.5 mg Vitamin B6 IP 1.5 mg Naicinamide IP 25 mg D-Panthenol IP 5 mg Vitamin B 12 IP 1 mcg Approved colour used in flavoured syrupy base |
| PROTIN & MULTIVITAMIN SYRUP | Nutritional Supplement | Each 5 ml contains : Why Protein 20% 800 mg Ferric Ammonium Citrate IP 160 mg L-Lysine Hydrochloride USP 20 mg Cyanocobalamin IP 1 mcg Zinc Sulphate IP Eq. to Elemental Zinc 22 mg Pyridoxine Hydrochloride IP 1 mg Naicinamide IP 15 mg D-Panthenol IP 2.5 mg Approved colour used in flavoured syrupy base |
| Pyridoxine, Nicotinamide, Mecobalamine, L-Lysine Syrup | Nutritional Supplement | Each 5 ml contains : Pyridoxine hydrochloride IP 0.75 mcg Nicotinamide IP 15 mg Mecobalamine IP 2 mg L-Lysine Hydrochloride IP 37.5 mg Sorbitol Solution (70%) IP q.s (Non Crystallizing) Approved coloured used in flavoured syrupy base |
| Sodium Alginate. Sodium bicarbonate and Calcium Carbonate Suspension | Nutritional Supplement | Each 5 ml contains : Sodium Alginate IP 250 mg Sodium bicarbonate IP 133.5 mg Calcium carbonate IP 80 mg Excipients q.s. Approved colour used in flavoured syrupy base |
| THIAMINE (MONO), RIBOFLAVINE, PYRIDOXINE HCL, NICOTINAMIDE, Cyanocobalamin and Zinc Sulphate | Nutritional Supplement | Each 5 ml contains : Thiamine Monoitrate IP 1.5 mg Riboflavine IP 1.5 mg Pyridoxine Hydrochloride IP 1 mg Nicotinamide IP 15 mg Cyanocobalamin IP 1 mcg Zinc Sulphate IP eq. to Elemental Zinc 7 mg L-Lysine Hydrochloride IP 70 mg Excipients q.s Approved colour used in flavoured syrupy base |
| VITAMIN A DROPS | Nutritional Supplement | Each ml contains : Vitamin A (As Palmitate) IP 100000 IU Approved colour used in flavoured syrupy base |
| Vitamin A Drops For paediatric use | Nutritional Supplement | Each ml contains : Vitamin A (As Palmetate) IP 1500 IU Approved colour used in flavoured syrupy base |
| Vitamin A Drops For paediatric use | Nutritional Supplement | Each ml contains : Vitamin A (As Palmetate) IP 2500 IU Approved colour used in flavoured syrupy base |
| Zinc Sulphate Syrup | Nutritional Supplement | Each 5 ml. contains Zinc Sulphate IP eq. to Zinc 10 mg Colour : Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| Zinc Sulphate Syrup For paediatric use | Nutritional Supplement | Each 5 ml. contains Zinc Sulphate IP eq. to Zinc 5 mg Colour : Erythrosine / Tartrazine / Sunset Yellow Ponceau-4R or Carmosine In flavoured syrupy base |
| Triprolidine Hydrochloride and Codeine Phosphate Syrup | Opioid Analgesic | Each 5 ml contains : Codeine Phosphate IP 10 mg Triprolidine Hydrochloride IP 1.25 mg Approved colour used in flavoured syrupy base |
Other Formulations Index
Show All Other Formulations| Formulation | Therapeutic Usage | Composition |
|---|---|---|
| Ketoprofen & Paracetamol Bolus For Veterinary Use | Analgesic (Pain Relief) | Each uncoated bolus contains Ketoprofen USP 1500 mg Paracetamol IP 1500 Mg |
| Paracetamol , Nimesulide & Chlorzoxazone Bolus | Analgesic (Pain Relief) | Each uncoated bolus contains Paracetamol IP 1500 mg Nimesulide BP 400 mg Chlorzoxazone USP 1000 mg Colour : Quinoline Yellow |
| Albendazole Bolus For Veterinary Use | Anti-parasitic | Each uncoated bolus contains Albendazole IP 3000 mg |
| Ciprofloxacin Hydrocloride Bolus For Veterinary Use | Antibiotic | Each uncoated bolus contains Ciprofloxacin HCL IP Equivalent to Ciprofloxacin 1500 mg |
| Oxfendazole Bolus For Veterinary Use | General / Unclassified | Each uncoated bolus contains Oxfendazole IP 150 mg Colour : Sunset Yellow FCF |
| Oxfendazole E Bolus For Veterinary Use | General / Unclassified | Each uncoated bolus contains Oxfendazole IP 2200 mg Colour: Sunset Yellow FCF |
| Oxytetracycline Bolus For Veterinary Use | General / Unclassified | Each uncoated bolus contains Oxytetracycline Hcl IP 500 mg |
| Sulpdimidine Bolus For Veterinary Use | General / Unclassified | Each uncoated bolus contains Sulpdimidine IP 5000 mg |
| Trimethoprim & Sulphamethoxazole Bolus | General / Unclassified | Each uncoated bolus contains Trimethoprim IP 400 mg Sulphamethoxazole IP 2000 mg |
| Lycopene, Protine, Amino Acids With Multivitamins | Nutritional Supplement | Each 100 g contains : Lycopene 6% USP 6000 mcg Protine (Whey Protine 20% ) 40 g Carbohydrate 60 g Fat (Less than ) 2 g Glutamic Acid 10 mg Vitamin A 3000 IU Vitamin D3 (As Cholecalciferol) 300 IU Thiamine Monoitrate IP 3 mg Riboflavine IP 3 mg Pyridoxine Hydrochloride IP 2 mg Methylocabalamine IP 50 mcg Vitamin C IP 50 mg Vitamin E IP 5 mg Folic Acid IP 1 mg Calcium Pantothenate IP 3 mg Naicinamide IP 30 mg Calcium 1000 mg Phosphorous 425 mg Magnesium Sulphate IP 12 mg Manganese (As Sulphate) USP 50 mcg Zinc (As Zinc Sulphate) USP 10.0mg Carbonyl Iron IP 20 mg Magnesium Oxide IP 4 mg Copper 2.5 mg Chromium (As Sulphate) IP 75 mcg Selenium Dioxide Monohydrate USP 60 mcg lodine ( As Potassium lodide ) IP 0.1 mg Excipients q.s. |
| Multivitamins, Mutiminerals Calcium, Iron & Zinc Powder | Nutritional Supplement | Each 30 g contains : Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 1mcg Vitamin D3 As Cholecalciferol) IP 100 I.U Folic Acid IP 300 mcg Naicinamide IP 15 mg Calcium ( As Dibasic Calcium Phosphate Dihydrate IP 200 mg Manganese (As Sulphate) USP 1.5 mcg Zinc (As Zinc Sulphate) USP 1.5 mg Iron (Ferric Ammonium Citrate ) IP 10 mg Magnesium Oxide IP 4 mg Cupperic Sulphate USP 2.5 mg Chromium (As Chromium Chloride) IP 25 mg Selenium Dioxide Monohydrate USP 20 mcg Potassium Chloride IP 5 mg Sodium Chloride IP 33 mg lodine ( As Potassium lodide ) IP 100 mcg Excipients q.s. |
| Protein , Multivitamins, Calcium , Iron | Nutritional Supplement | Each 30 g contains : Protein Hydrolysate 20% 5 mg Elemental Calcium 225 mg Elemental Phosphorus 174 mg (As Dibasic Calcium Phosphate Dihydrate IP) Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 1 mcg Vitamin D3 (As Cholecalciferol) IP 100 I.U. Niacinamide IP 15 mg Zinc (As Zinc Sulphate) USP 1.5 mg Iron (As Ferric Ammonium Citrate IP) Manganese (As Sulphate) USP 1.5 mcg Excipients q.s. |
| Protine With Multivitamins, Multiminerals &Lycoene Powder | Nutritional Supplement | Each 30 g contains : Protine (Whey Protine 20% ) 5 g Calcium Phosphorous ( Derived from IP 225 mg Dibasic Calcium Phosphate Dihydrate) 174 mg Lycoene 6 % USP 2000 mcg Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 1 mcg Vitamin D3 (As Cholecalciferol) IP 100 IU Folic Acid IP 0.3 mg Naicinamide IP 15 mg Manganese (As Sulphate) USP 1.5 mcg Zinc (As Zinc Sulphate) USP 5 mg Iron (Ferric Ammonium Citrate ) IP 7.5 mg Magnesium Oxide IP 4 mg Cupperic Sulphate USP 2.5 mg Chromium (As Chromium Chloride) IP 25 mg Selenium Dioxide Monohydrate USP 20 mcg Potassium Chloride IP 5 mg Sodium Chloride IP 33 mg lodine (As Potassium lodide) IP 100 mcg Excipients q.s. |
| Protine, Calcium, Multivitamins, DHA, Iron & Zinc Powder | Nutritional Supplement | Each 30 g contains : Protine (Whey Protine 20% ) 5 g DHA 10 % 25 mg Pyridoxine Hydrochloride IP 0.5 mg Cyanocobalamin IP 1 mcg Vitamin D3 (As Cholecalciferol) IP 100 IU Folic Acid IP 300 mcg Naicinamide IP 15 mg Calcium (As Dibasic Calcium Phosphate Dihydrate) IP 200 mg Manganese (As Sulphate) USP 1.5 mcg Zinc ( As Zinc Sulphate) USP 1.5 mg Iron (Ferric Ammonium Citrate ) IP 10 mg Magnesium Oxide IP 4 mg Cupperic Sulphate USP 2.5 mg Chromium (As Chromium Chloride) IP 25 mg Selenium Dioxide Monohydrate USP 20 mcg Potassium Chloride IP 5 mg Sodium Chloride IP 33 mg lodine (As Potassium lodide) IP 100 mcg Excipients q.s. |